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ABSTRACT
Aim: Previous work carried out at the Institute of Child Health revealed that 
in the fetal sheep, combined urethral and urachal occlusion initiated at 75 
days gestation (full term = 145 days) and maintained for 30 days resulted in 
dilated, hypocontractile and hypercompliant bladders, associated with 
uniformly disrupted kidney development. The aim of this project was to 
create a less severe model of fetal bladder outlet obstruction, and to define 
the role of the urachus. This model would then be utilised to investigate the 
prenatal onset of obstructive bladder dysfunction by means of in-utero 
radiotelemetered urodynamics. We hypothesised that short-term obstruction 
would result in a thick-walled bladder with preserved contractility and 
compliance, and that urachal ligation alone would result in similar features.
Methods: Male fetal lambs were assigned to urachal ligation and partial 
urethral occlusion, urachal ligation only, or sham, groups. Histological 
analyses, filling cystometry and contractility studies were performed 
following nine days of obstruction. Natural-fill radiotelemetered urodynamics 
were performed on the urachal and urethral occlusion group,
Results: Nine days urachal and urethral occlusion from mid-gestation 
caused hydronephrosis and increased bladder weight, protein and DNA 
content. Detrusor smooth muscle architecture was maintained but urothelia 
were thickened and showed basal apoptosis. Bladder compliance, wall 
stress and contractility were not significantly deranged. The thickest, most
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compliant bladders were found to be associated with kidneys exhibiting 
glomerular cysts. Urachal obstruction alone also resulted in similar changes, 
suggesting that the male fetal lamb urethra is a high-resistance conduit at 
this gestation. Radiotelemetered urodynamics were only feasible in the 
obstructed group from 94 days gestation, and revealed the presence of 
early-onset hypercontractility. Fetal voids became increasingly frequent and 
prolonged, occurring at higher voiding pressures; baseline filling pressures 
did not vary significantly over the nine-day period of observation.
Conclusion: Short-term fetal bladder outflow obstruction from mid-gestation 
generated thick-walled bladders without evidence of contractile failure; these 
were associated with cystic kidneys. Detrusor hypercontractility and raised 
voiding pressures were observed within hours of obstruction, although filling 
pressures remained stable. Future work will investigate the effect of vesico- 
amniotic shunting on bladder function.
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1. INTRODUCTION
1.1 Overview
Congenital obstructive uropathy is a leading cause of renal failure in 
childhood, and currently accounts for 15% of children in end-stage renal 
failure (ESRF) in the United Kingdom (Lewis et al. 2007). The incidence of 
congenital BOO in the northern region of England is 2.2 per 10000 births, 
and it is most commonly caused by posterior urethral valves (PUV), with an 
incidence of 1.4 per 10000 births (Fig. 1) (Anumba et al. 2005). Other causes 
of BOO include urethral atresia (incidence 0.7/10000 births) and the Prune 
Belly Syndrome (PBS). Congenital BOO is still a major cause of fetal and 
neonatal mortality: recent figures reveal an antenetal termination rate of 
60%, resulting in an overall mortality of 75% in antenatally-detected cases. 
There is also a significant mortality of up to 20% in postnatally diagnosed 
cases (Anumba et al. 2005). Death in the neonatal period is most commonly 
due to associated pulmonary hypoplasia (Anumba et al. 2005).
Congenital obstructive uropathy is also associated with life-long morbidity, 
which includes renal, bladder and sexual dysfunction. Valve ablation in the 
neonatal period does not affect prognosis, with the rate of onset of renal 
failure progressing from 6.5% at five years, to 25% at ten years and 50% at 
15 years of age (Woodhouse 2001). So far, prenatal treatment involving 
bladder decompression via vesicoamniotic shunting has also been 
disappointing. Holmes et al. (2001) reported that 63% of children who 
underwent in-utero bladder decompression progressed to renal failure.
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These disturbing figures suggest that the pathophysiology, and hence the 
appropriate management, of these conditions has not been entirely 
elucidated, and the scope of this thesis is to explore this pathophysiology in 
more detail.
This introductory chapter begins with an overview of the normal and 
pathological development of the human urinary tract, PUV in particular. This 
is followed by an overview of the urinary tract embryology of the sheep, with 
reference to how this animal can be used to model human nephrogenesis. 
The clinical aspects of congenital obstructive uropathy are then elucidated. 
This is followed by a section summarising the genetic and surgical models of 
fetal BOO. The chapter concludes with my aims and hypotheses.
1 .2 Normal and pathological development of the human urinary tract
1.2.1 Human urinary tract embryology
The human kidneys develop from the intermediate mesoderm, which is 
situated on either side of the dorsal body wall of the human embryo (Larsen 
2001). Three different, slightly overlapping, kidney systems derive from the 
intermediate mesoderm: the pronephros, mesonephros, and the 
metanephros, the latter appearing during the fifth week of gestation. The 
pronephros is transitory and non-functional, and presumably represents a 
vestige of the primitive kidneys which develop in some lower vertebrates 
(Fig.2A). The pronephros is succeeded by the mesonephros (Fig.2B), which 
develops in the thoracic and lumbar regions during the fourth week of 
gestation (Larsen 2001). The mesonephros is drained by a pair of
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mesonephric (Wolffian) ducts, which grow caudally to open into the posterior 
wall of the primitive urogenital sinus. By the fifth week, a pair of ureteric buds 
sprout from the distal mesonephric ducts and induce the overlying sacral 
intermediate mesoderm to develop into the metanephros (Fig. 3A and B), or 
definitive kidney. Fusion of the ureteric buds and metanephros at about 32 
days gestation initiates the process of nephrogenesis via a process known 
as ‘reciprocal induction’ (Fig. 4). This process depends on glial-derived 
neurotropic factor (Gdnf) released from mesenchymal cells, which binds to 
Ret and G fral receptors in the mesonephric duct (Schedl et al. 2007). 
Several hours of direct contact with a ureteric bud ampulla are required to 
induce nephron differentiation in blastema tissue. If the ureteric bud is 
abnormal or missing, the kidney does not develop. Conversely, reciprocal 
inductive signals from the metanephric blastema regulate the orderly 
branching and growth of the bifurcating tips of the ureteric buds (Larsen 
2001).
Induction signals from the ampulla cause the metanephric blastema to 
condense and form a closed tube of epithelial cells, the nephrogenic vesicle. 
As this vesicle elongates into a tubule, a capillary glomerulus forms near one 
end of it. The tubule epithelium near the differentiating glomerulus thins and 
then invaginates to form a Bowman’s capsule that surrounds the glomerulus. 
The lengthening tubule then goes on to form the remaining elements of the 
nephron: the proximal convoluted tubule, the descending and ascending 
limbs of the loop of Henle, and the distal convoluted tubule. The definitive 
nephron with its renal corpuscle is also called the metanephric excretory
20
unit. During the tenth week, the tips of the distal convoluted tubules connect 
to the collecting ducts, and the metanephroi become functional. Further 
branching and nephron formation continue around the outer rim of the 
kidney, the nephrogenic cortex, until 34 weeks (Larsen 2001). About two- 
thirds of nephrons are generated in the last third of human gestation, so that 
the range of nephrons found in healthy human kidneys is around 0.7 to 1.4 
million (Keller et al. 2003).
Meanwhile, the cloaca (the distal expansion of the hind-gut) is partitioned 
into a posterior rectum and an anterior urogenital sinus, the latter continuous 
superiorly with the allantois via the urachus. It is unknown whether this 
tubular structure derives from the allantois or urogenital sinus (Zieger et al. 
1998). During the fourth and fifth months of gestation, the urachus narrows 
to a small-calibre epithelial tube, and gradually loses its patency as the 
bladder descends into the pelvis. The apical portion narrows progressively 
into a fibromuscular strand and often loses its attachment to the umbilicus. 
The urachus lies between the peritoneum and the transversialis fascia and is 
composed of three tissue layers: a central lumen lined with transitional 
epithelium, a submucosal connective tissue layer and an outer layer of 
smooth muscle (Zieger et al. 1998).
In a study of the role of the Sonic Hedgehog (Shh) gene in urinary tract 
development, Jenkins et al. (2007) have shown that the human embryo 
urogenital sinus expresses Shh at four weeks of gestation, preceding its 
separation from the hind-gut and the interposition of the mesonephric ducts
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at seven weeks. The appearance of Shh precedes the uptake of uroplakin 
and a-smooth muscle actin associated with the development of the bladder, 
suggesting that Shh initiates bladder smooth muscle development (Jenkins 
et al. 2007). The expanded superior portion of the primitive urogenital sinus 
becomes the bladder, whereas its inferior portion gives rise (in males) to the 
pelvic urethra and to the penile urethra, or (in females) to the pelvic urethra 
and vestibule of the vagina. During this period, it was thought that the 
openings of the mesonephric ducts are translocated down onto the pelvic 
urethra by a process that also emplaces the openings of the ureters on the 
bladder wall (Larsen 2001). This concept was recently challeneged by 
Batourina et al (2005), who developed a mutant mouse model to show that 
the common nephritic duct does not differentiate into the trigone, but instead 
undergoes apoptosis, a crucial step for ureter transposition, controlled by 
Vitamin A signals from the primitive bladder. Furthermore, Vitamin A and the 
Ret proto-oncogene are required for the formation of proper connections 
between the bladder and ureter (Batourina et al. 2005). Oswald et al (2006) 
supported this finding when they investigated the ureterotrigonal units of 38 
human fetal specimens at nine to 40 weeks gestation. Bladder specimens 
were stained with a-smooth muscle actin in order to visualize detrusor 
smooth muscle. The authors found that as early as week 12, the intravesical 
ureter exhibited only longitudinal muscle fibres arranged in a single muscular 
layer. A thin layer of connective tissue separated the detrusor muscle from 
the muscle layer of the intramural ureter. No longitudinal continuation of the 
ureteral muscle sheath to the bladder neck was present at any gestational 
stage. The single muscle layer of the ureters crossed the midline to form the
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interureteral fold. The trigone is now thought to develop from the urogenital 
sinus, as a continuous single circular muscular layer corresponding to the 
posterior part of the vesical sphincter muscle (Oswald et al. 2006).
The adult human urinary bladder is composed of two main components: the 
bladder body, which is located above the ureteric orifices, and the base, 
consisting of the trigone, urethrovesical junction, deep detrusor, and anterior 
bladder wall. It is a hollow smooth muscle organ lined by urothelium, which 
is composed of a transitional type epithelium and underlying lamina propria. 
Its muscular wall is composed of detrusor smooth muscle cells orientated in 
three layers (Andersson & Arner 2004). The cells of the outer and inner 
layers tend to be orientated longitudinally, and those of the middle layer 
circularly. Detrusor cells are surrounded by connective tissue rich in 
collagen. (Andersson & Arner 2004). In adults, the trigone is a triangular­
shaped region located at the base of the bladder composed of muscle that 
helps to prevent backflow of urine to the ureters. The trigonal base, which is 
in the bladder neck, is bounded by the muscular sheath surrounding the 
intravesicular ureter; the trigonal apex, which is in the urethra, is the site 
where the sex ducts join the urogenital sinus (Tanagho 1981).
The pelvic part of the urogenital sinus is a narrow canal which extends to the 
surface of the genital tubercle, and will give rise to the urethra (Krishnan et 
al. 2006). This endodermal derived groove becomes a solid plate of cells, 
the urethral plate, which eventually tubularises in a proximal to distal fashion 
to form the phallic urethra. The appearance is identical in male and female
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fetuses until week nine, and by week 14 the male urethra is complete in its 
development. The urethra is then divided into four distinct regions: the 
prostatic and membranous parts are derived from the urogenital sinus and 
are lined by transitional epithelium (like the bladder); the bulbar and 
pendulous parts are derived from the urethral plate, and are lined by 
transitional epithelium proximally and squamous epithelium distally -  the 
latter parts are androgen dependent and are only present in the male 
(Krishnan et al. 2006). Haraguchi et al (2007) showed that the coordination 
of urogenital organ formation is orchestrated by Shh signals. They showed 
that Shh mutant mouse embryos display hypoplasia of external genitalia, 
internal (pelvic) urethra and bladder, and concluded that mesenchymal 
precursors for multiple urogenital structures derive from peri-cloacal 
mesenchyme (Haraguchi et al. 2007).
Even though the fetal kidneys produce urine from the tenth week of 
gestation onwards, their main function is not to clear waste products from 
the blood, a task handled by the placenta. Instead, fetal urine supplements 
the production of amniotic fluid. Lee et al. (2007) used three-dimensional 
ultrasound and VOCAL technology to estimate bladder volume and hence 
fetal urine output. They showed that the mean fetal bladder cycle lasts 25 
minutes, and that fetal urine output increases from a mean of 7.3 ml/hr at 24 
weeks gestation, to 71.4 ml/hr at 38 weeks.
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1.2.2 Pathogenesis of congenital anomalies of the kidney and urinary 
tract (CAKUT)
Urinary tract maldevelopment may result in a spectrum of abnormalities 
known as ‘congenital anomalies of the kidney and urinary tract’ or CAKUT 
(Woolf et al 2004). The spectrum of diseases encompassed by the term 
CAKUT is wide, including kidney anomalies such as agenesis (absent 
kidney), dysplasia (incomplete and metaplastic development), renal 
hypoplasia (reduced number of nephrons), duplex kidneys (containing two 
renal pelves each with its own ureter); ureteric anomalies such as 
megaureter (abnormally dilated and tortuous ureter), pelviureteric junction 
obstruction (PUJO) or vesicoureteric junction obstruction (VUJO); primary 
vesicoureteric reflux (VUR) and anomalies of the bladder and urethra (Woolf 
et al 2004). CAKUT is the underlying diagnosis in 40% of children in ESRF; 
approximately half of these children have an obstructive nephropathy, 
mainly PUV and other causes of congenital BOO (Lewis & Shaw 2002). It is 
thought that the primary "hit" in CAKUT is a developmental one: the trigger 
event could be genetic (i.e. mutation of a gene expressed by the developing 
kidney); teratogenic (e.g. ACE inhibitor ingestion in pregnancy or fetal 
alcohol syndrome); ‘disruption’ (i.e. dysplasia secondary to urinary flow 
impairment); or a combination of all three events. The renal damage may 
then be exacerbated by external factors, such as bladder dysfunction, reflux 
and infection in the case of PUV (Woolf et al 2004).
Potter (1972) classified cystic renal malformation into four categories on the 
basis of microdissection studies. Types I (autosomal recessive polycystic
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kidney disease (PKD)) and III (autosomal dominant PKD) do not feature 
renal dysplasia. Type II kidneys include subtypes A (very small ‘aplastic’ 
kidneys) and B (multicystic dysplastic kidneys). Potter type IV malformations 
were invariably associated with urinary tract obstruction, usually BOO. 
Kidneys contained subcapsular cysts, each comprising a dilated Bowman’s 
capsule and a primitive proximal tubule; hence cysts derived from forming 
nephrons (“S-shaped bodies”). Potter postulated that ureteric bud branching 
is initially normal in type IV malformations. Only nascent nephrons become 
cystic because they were nearest to ampullae and experienced “pressure 
(that) extends in a retrograde manner” from the obstructed lower tract; 
earlier nephrons located at the other end of arcades faced less 
“backpressure” and remained intact. Potter reasoned that a sudden, severe, 
obstructive event would rapidly ablate the renal mesenchyme, resulting in 
one layer of cysts, whereas mild obstruction might allow the renal 
mesenchyme to generate several generations of cysts (Potter 1972).
It is important to note that type IV kidneys seem to develop following 
antenatal, rather than postnatal, BOO, correlating with the greater length 
and limited compliance of a mature versus an immature nephron tubule. 
Models of fetal urinary tract obstruction in sheep and monkeys emphasise 
that formation of subcapsular cysts, some of which contain tufts of 
podocytes, are an early event after obstruction (Attar et al. 1998,Tarantal et 
al. 2001,Nyirady et al. 2002). These animal studies confirm that urinary flow 
impairment can generate type IV kidneys and also leave open the possibility
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that more profound grades of malformation (e.g. Potter IIA and B) might 
result from early BOO.
Although most cases of CAKUT are sporadic, kindreds have been described 
with more than one affected family member. Sometimes, these families have 
multi-organ syndromes, whereas others have CAKUT anomalies alone. 
Examples of such syndromes are:
• Fraser syndrome (FRAS1 mutation, putative cell adhesion molecule 
expressed by the ureteric bud): renal agenesis and dysplasia, digit 
and ocular malformations (McGregor et al. 2003,Jadeja et al. 2005)
• Townes-Brockes Syndrome (SALL1 mutation, transcription factor): 
renal dysplasia and lower urinary tract malformations (Woolf et al. 
2003)
• Orofacial (Ochoa) syndrome (locus on 10q, gene undefined): 
congenital obstructive bladder and kidney malformation with 
abnormal facial expression (Ochoa & Gorlin 1987)
Hydronephrosis per se may also be due to a primary genetic event, such as 
mutations in Uroplakin Ilia (UPllla) and Sonic hedgehog (Shh) (Yu et al.
2002, Jenkins et al. 2005). UPllla was found to be expressed in nascent 
urothelia in the ureter and renal pelvis of human embryos, suggesting that 
perturbed urothelial differentiation may generate human kidney 
malformations, perhaps by altering differentiation of adjacent smooth muscle 
cells such that the metanephros is exposed to a functional obstruction of 
urine flow (Jenkins et al. 2005). Shh, a Drosophila Hedgehog (Hh) homolog,
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is also expressed in the urothelium; its deletion in a genetic mouse model 
has been associated with kidney defects such as hypoplasia, hydroureter 
and hydronephrosis (Yu et al. 2002). The role of genetic factors in the 
aetiology of PUV is yet unclear, although a familial or genetic basis has been 
suggested on the basis of an association of PUV with specific syndromes 
(trisomy 21, deletion of chromosome 10q) and reports of rare familial or twin 
cases (Hanlon-Lundberg et al. 1994,Maruotti et al. 2006). Weber et al 
reported a consanguineous family with four male descendants affected by 
PUV and a healthy girl, suggestive of autosomal recessive inheritance 
(Weber et al. 2005).
1.2.3 Posterior urethral valves: developmental anatomy
Morgagni, and Langenbeck, are reported to have described the existence of 
posterior urethral valves (PUV) as far back as 1717 and 1805, respectively 
(reviewed by Krishnan et al. 2006). However, it was Young et al, in 1919, 
who first classified “valves” into the three classical types, after reviewing 36 
cases of PUV. Type I valves, the most common, were composed of a ridge 
coursing anterior from the distal verumontanum (the mucosal elevation at 
the site of insertion of the ejaculatory ducts) and attaching to the anterior 
urethra. Although type I valves are usually represented in line sketches as 
two distinct folds, they actually are a single membranous structure with the 
opening in the membrane positioned posteriorly near the verumontanum. 
During voiding, the fused anterior portion of the membrane bulges into the 
membranous urethra, leaving only a narrow opening along the posterior wall 
of the urethra. Type II valves, the rarest, extended from the proximal
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verumontanum toward the internal sphincter and bladder neck. Type III 
valves consisted of a discoid valve attached to the entire circumference of 
the urethra with a central opening. They are thought to represent incomplete 
dissolution of the urogenital membrane (Krishnan et al. 2006). Overall, type I 
valves make up 95% of lesions and type III make up the remainder; it is 
doubtful whether type II valves actually exist as a clinical entity (Dewan & 
Goh 1995).
Lowsley (1914) was the first to offer a theory of PUV development based on 
microscopic examination of an autopsy specimen. In his study of normal 
prostate development, he described how the ejaculatory ducts continued 
distally after opening up into the prostatic lumen, their fibres dissipating 
laterally. In babies with PUV, however, these fibres attached to the entire 
circumference of the urethra, creating an almost total obstruction of the 
urethra. Lowsley also noted that the membrane had squamous epithelium, 
differentiating it from the normally transitional epithelium of that region, 
leading him to suggest PUV was due to an anomaly of Mullerian duct origin 
(reviewed by Krishnan et al. 2006). In a study of 22 urinary tracts from 12 
children who died following obstruction due to PUV, Henneberry and 
Stephens (1980) showed that the degree of renal dysplasia associated with 
PUV was dependent on the position of the ureteric orifice in the bladder. 
Kidneys with a normal ureteric orifice had the potential for excellent renal 
function; kidneys with ureteral orifices located in diverticula were severely 
dysplastic; whereas those with their ureteral orifices located laterally in the 
bladder had a thin cortex, with low glomerular counts. The authors attributed
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these differences to ectopic origins of the ureteral buds from the most caudal 
part of the mesonephric duct. This could lead to induction of defective or 
sparse mesenchyme of the tail end of the nephrogenic cord with resultant 
dysplasia and hypoplasia, respectively (Henneberry & Stephens 1980).
The nomenclature of PUV remained wholly unchallenged until the series of 
Dewan et al. (1994). They thought that the term ‘valves’ was incorrect 
because the condition reflected obstruction by a single membrane. They 
coined the term COPUM (congenital obstructing posterior urethral 
membrane) to replace PUV (Dewan et al. 1994). They also claimed that 
types I and III valves were the same, with either being mistaken for the other 
during endoscopy based on the angle of visualisation and prior urethral 
instrumentation. The only other lesion they recognised which could obstruct 
the posterior urethra was Cobb’s Collar or congenital urethral stricture 
(Dewan et al. 1994). Other mechanical causes of fetal BOO, such as 
urethral hypoplasia or aplasia, did not fall under the same classification.
1.2.4 Other causes of congenital BOO
Although the focus of this introduction is PUV, it is important to review the 
features and outcome of the less common causes of fetal BOO. Urethral 
atresia is a congenital, complete obstruction of the urethra caused by a 
membrane that is usually located at the distal end of the prostatic urethra. 
The urethra distal to this point is usually hypoplastic, presumably from lack 
of fetal voiding (Gonzalez et al. 2001). This anomaly is incompatible with life 
unless an alternative communication develops between the bladder and
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amniotic cavity in the form of a patent urachus, a vesico-amniotic fistula or a 
fistula to the rectum (Gonzalez et al. 2001). The possibility of survival with 
prenatal decompression by vesico-amniotic shunting was reported by 
Steindhardt et al. in 1990. The fetus was shunted at 30 weeks gestation and 
although pulmonary function was acceptable, peritoneal dialysis was 
required in the neonatal period and he eventually received a renal transplant 
(Steinhardt et al. 1990). Freedman et al. included a case of urethral atresia 
among a series of long-term survivors of prenatal vesico-amniotic shunting 
(Freedman et al. 1999); Gonzalez et al reported the long-term survival of six 
cases of urethral atresia (all males): three survived following vesico-amniotic 
shunting in-utero, whereas the remaining three had developed a vesico- 
cutaneous fistula or patent urachus. Interestingly, five of the patients had a 
prune-belly phenotype. Ultimately four patients required transplantation and 
the remaining two are in renal failure (Gonzalez et al. 2001).
The Prune Belly Syndrome (PBS) is characterized by a triad of abnormalities 
including a loose, wrinkled abdominal wall with hypoplastic musculature, 
urinary tract abnormalities and undescended testicles (Fig. 5) (Reinberg et 
al. 1991). As a consequence, the full syndrome is limited to males; girls 
presenting with abdominal wall and urinary tract anomalies are rare 
(Reinberg et al. 1991). The condition has an incidence of 1:30,000, and 
although reports of multiple cases of PBS in the same family have 
suggested a genetic contribution, no clear mode of inheritance has emerged 
(Weber et al. 2005). The aetiology of abdominal musculature 
maldevelopment is unknown. It was suggested that the abdominal wall was
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deformed by pressure form a distended bladder due to BOO in-utero. 
However the condition could also arise from a primary defect in mesodermal 
development (Weber et al. 2005).
1.3 Congenital bladder outlet obstruction (BOO): clinical aspects
1.3.1 Congenital BOO: antenatal diagnosis and causes
Antenatal detection of congenital BOO is on the rise, and is reported to have 
improved from 33% between 1984 and 1990, to 62% between 1991 and 
1997, in the north of England (Anumba et al. 2005). In fact, a significant 
prenatal uropathy is found in 1:600 pregnancies (Hutton 2004). Ultrasound 
findings at the 18 to 20 week anomaly scan may include unilateral or 
bilateral hydroureteronephrosis and a thick-walled, poorly emptying or 
persistently full bladder, which may be associated with sonographically 
echogenic kidneys. The appearance of a full bladder together with a dilated 
posterior urethra in PUV is reminiscent of a keyhole and is termed the 
‘keyhole sign’ (Fig. 6A). The commonest cause of fetal BOO is PUV in 64% 
of cases, followed by urethral atresia (39%) and Prune Belly Syndrome 
associated with obstruction (4%) (Anumba et al. 2005). Montemarano et al. 
(1998) evaluated 21 cases by antenatal ultrasound for the presence of 
oligohydramnios, posterior urethral dilation, bladder wall thickening, urachal 
patency, cortical thinning, cortical cysts, and increased renal echogenicity. 
The postnatal diagnosis turned out to be PUV in only ten cases, the 
remainder being prune belly syndrome (four cases), primary VUR (four 
cases), left VUJO (one case), and non-refluxing, non-obstructive 
megacystis-megaureter (two cases). Oligohydramnios was present in eight
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of ten cases of PUV and in one of four cases of prune belly syndrome 
(Montemarano et al. 1998).
There is evidence to suggest that detection of PUV before birth predicts a 
worse prognosis: Anumba et al. showed that compared to undetected cases, 
those detected prenatally had higher mortality and a higher rate of chronic 
renal failure (CRF) at 24 months (17% vs 57%, p < 0.01) (Anumba et al.
2005). However, more recently other groups have disputed this finding. 
Thomas (2007) followed up a cohort of PUV patients for a mean often years 
and found no difference in the onset of renal failure in the first ten years of 
life. However, he suggested that the incidence of late-onset renal 
deterioration post-puberty may be prevented by antenatal diagnosis and 
hence close fllow-up and preventive treatment in childhood (Thomas 2007). 
The likelihood of early-onset renal failure can be largely predicted from the 
ultrasound appearances of the urinary tract in the second trimester. A study 
by Hutton et al. (1994) revealed that of 17 infants whose urinary tracts had 
demonstrated the characteristic ultrasound features of severe urethral 
obstruction before 24 weeks gestation, 24% subsequently died in infancy 
from pulmonary and/or renal failure and 35% went on to develop late-onset 
renal failure. By contrast, all infants with a prenatal diagnosis after 24 weeks 
survived, and 93% maintained normal renal function in early childhood 
(Hutton et al. 1994).
Cases of PUV not detected antenatally may present in infancy or childhood. 
Presenting features in the neonatal period are variable. The most severe
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cases may present with respiratory difficulties as a consequence of 
pulmonary hypoplasia, which is thought to be consequent on diaphragmatic 
compression by the grossly dilated urinary tract, combined with 
oligohydramnios due to reduced fetal urine output (Nakayama et al. 1986). 
Other modes of presentation include urinary tract infection (UTI) (74%), 
septicaemia (11%), incontinence (8%), failure to thrive (4%) and abdominal 
pain and haematuria (3%) (Parkhouse & Woodhouse 1990).
1.3.2 Congenital BOO: in-utero intervention
Management of the distended bladder diagnosed antenatally depends on 
the underlying aetiology and associated features. In 1994, an algorithm was 
introduced for the prenatal evaluation and selection of fetal candidates for 
prenatal intervention and has greatly improved the ability to predict which 
fetuses might benefit from intervention and those in whom intervention 
would not improve the clinical outcome (Johnson et al. 1994). Three major 
steps are advised:
1. a fetal karyotype (determination of fetal sex is important as with a 
female fetus the issue being dealt with may be more complex as in 
the case of cloacal abnormalities)
2. a detailed sonographic evaluation to rule out other structural 
anomalies that might impact on the prognosis for the fetus
3. serial urine evaluations to determine the extent of the underlying renal 
damage present.
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A candidate for prenatal intervention would have a normal male karyotype in 
the absence of other fetal anomalies that would adversely affect prognosis, 
and maternal oligo/anhydramnios or decreasing amniotic fluid volumes 
(Johnson et al. 1994). The sonographic appearance of the fetal kidneys 
must also be taken into account, since if these are ‘bright’ and small then 
dysplasia is likely and the long-term prognosis is poor. In a study of BOO 
presenting in the first and second trimester, hyperechogenic kidneys were 
predictive of renal dysplasia in 95% of cases (Robyr et al. 2005). The 
association of a sagittal diameter of the bladder of at least 40 mm with 
hydronephrosis before 28 weeks was predictive of PUV with a positive and 
negative predictive value of 44.4% and 66.6%, respectively (Robyr et al.
2005). Three serial vesicocenteses taken at 48-72 hour intervals and 
showing a pattern of decreasing hypertonicity indicate potential salvage and 
identify fetuses that hold the greatest potential benefit from in-utero surgical 
intervention (Johnson et al. 1994). Nicolini et al (1992) showed that the 
highest sensitivity for the detection of renal dysplasia was shown by urinary 
calcium (100%), whereas urinary sodium showed the best specificity (80%) 
(Nicolini et al. 1992). Muller et al. (2004) proposed that fetal blood levels of 
(32-microglobulin and cystatin C are significantly higher in cases of bilateral 
kidney hypoplasia and cystic dysplasia when compared to normal and 
hyperechogenic, but not dysplastic, fetal kidneys (Muller et al. 2004).
Clark et al. (2003) carried out a meta-analysis of studies analysing the effect 
of prenatal bladder drainage on perinatal survival in fetuses with BOO. 
Sixteen observational studies that included 9 case series (147 fetuses) and
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seven controlled series (195 fetuses) were identified. Among controlled 
studies, bladder drainage appeared to improve perinatal survival relative to 
no drainage (Clark et al. 2003). However, sub-group analysis indicated that 
improved survival was predominantly in fetuses with a defined ‘poor 
prognosis’ where there appeared to be marked improvement. The authors 
were unable to comment upon indication or timing of vesico-amniotic 
shunting due to heterogeneity and shortage of reporting. Also, no outcome 
data was available regarding the rate of progression to ESRF. Freedman et 
al (1999) carried out a retrospective study of 34 fetuses with BOO who 
underwent vesico-amniotic shunt placement. Of the 21 fetuses (62%) that 
survived the procedure, 57% progressed to CRF or ESRF at a mean follow- 
up of 54 months (Freedman et al. 1999). In a previous controlled study, the 
same group reported the perinatal survival of prenatally versus postnatally 
treated infants with PUV to be 60% versus 93% respectively (Freedman et 
al. 1996). However, again the critical factor was the lack of any alteration in 
the ultimate progression to ESRF in the prenatally treated group in 
comparison to the postnatally treated infants (31 versus 33%). More 
recently, Holmes et al (2001) reported outcomes of intervention on 36 
fetuses with bilateral hydronephrosis and oligohydramnios at a mean 
gestational age of 22 weeks. The mean age of the children at follow-up was
54.3 months. Of 14 fetuses who turned out to have PUV, 8 boys survived 
(43% mortality), of whom five (63%) were in ESRF before puberty (Holmes 
et al. 2001). The rate of progression to ESRF is therefore not different from 
that quoted in historical studies following postnatal management (Roth et al. 
2001).
36
The long-term benefit of antenatal decompression is therefore still 
questioned- hence the PLUTO (Percutaneous Shunting for Lower Urinary 
Tract Obstruction) trial (http://www.pluto.bham.ac.uk/) (Kilby et al. 2006). 
This randomised controlled trial is currently recruiting and is being 
coordinated by Professors Kilby and Khan at the Birmingham Women’s 
Hospital. The plan is to randomise 200 singleton pregnancies with 
ultrasound evidence of fetal BOO up to 28 weeks gestation (Morris et al.
2005). Eligibility for the trial will primarily be based on the “Uncertainty 
Principle” whereby the fetal medicine specialist is uncertain as to whether 
decompression would be appropriate. If the fetus is randomized to 
decompression, a V-A shunt is inserted and the fetus monitored with regular 
documentation of shunt location, liquor volume, bladder wall thickness and 
renal pelvic dilatation. The primary outcome measures will be perinatal 
mortality and serum creatinine at 6 weeks of age, followed by a paediatric 
nephrology work-up at one year of age (Morris et al. 2005). Long-term 
follow-up, though not mentioned in the study protocol, will be imperative in 
order to assess outcome in terms of renal and bladder function. Critics of the 
“uncertainty principle” have argued that because poor prognosis fetuses are 
the ones likely to benefit from decompression, it is the good prognosis group 
that need randomization.
Although vesico-amniotic shunting, whereby a catheter drains the fetal 
bladder into the maternal amniotic cavity, is the most commonly used 
technique for prenatal bladder decompression (Agarwal & Fisk 2001), other
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techniques have been described. Quintero et al. (1995) reported the use of 
in-utero percutaneous cystoscopy. The advantage of this technique is that it 
allows distinction between the different causes of fetal BOO. Welsh et al. 
(2003) published their experience with fetal cystoscopy. The procedure was 
carried out under local anaesthesia at 14-28 weeks’ gestation. A semi-rigid 
fetoscope was inserted into the fetal bladder via the maternal abdominal 
wall, and the bladder neck visualised. An attempt was then made to enter 
the posterior urethra under combined ultrasound guidance and direct vision 
(Welsh et al. 2003). Therapy for valvular obstruction was carried out in 10 of 
13 cases by means of hydro-ablation (utilising normal saline flushed at 
supra-physiological pressure) or by passage of a blunt-ended guide-wire in 
order to disrupt the valve leaflets. There were no immediate or long-term 
maternal complications. There were two fetal losses within 2 weeks of the 
procedure; a third intra-uterine death was related to maternal diabetes. Five 
cases were complicated by urinary ascites. One infant with urethral atresia 
died of pulmonary hypoplasia following delivery (Welsh et al. 2003). Of the 
remaining six fetuses, four turned out to have PUV, of whom only two had 
normal renal function at 16-34 months follow-up. Cystoscopy may therefore 
have a role in the diagnostic evaluation of fetal obstructive uropathy in-utero, 
but requires further evaluation, in particular, with equipment modifications to 
facilitate entry into the posterior urethra. Overcoming current technical 
limitations seems a prerequisite to definite evaluation of cystoscopic therapy 
(Welsh etal. 2003).
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1.4 Posterior urethral valves (PUV)
1.4.1 Postnatal management of PUV
An early treatment priority is to achieve adequate urine drainage by inserting 
either a fine urethral or suprapubic catheter (Dinneen & Duffy 1996). 
Attention is paid to the fluid, electrolyte and acid-base balance, and 
intravenous broad spectrum antibiotics are administered to treat or prevent 
sepsis. Hyperkalaemic acidosis is a common serious disturbance. In 
newborns, the initial serum creatinine is related to maternal renal function 
(because fetal blood is dialysed against the maternal circulation) and will rise 
over the next 48 hours to reflect the baby's native renal function. Once the 
baby is in a stable condition, an ultrasound scan is performed followed by a 
micturating cystourethrogram (MCUG), which may be performed via a 
urethral or suprapubic catheter (Fig. 6B). The MCUG confirms the diagnosis 
and permits assessment of bladder size, shape and outline, the presence of 
unilateral or bilateral vesicoureteric reflux (VUR). Radioisotope renography 
with MAG3 (mercaptoacetylglycine labelled with 99mTechnetiurn) can be 
performed after one month of age to provide information about renal function 
and drainage (Dinneen & Duffy 1996). " mTc-dimercaptosuccinic acid 
(DMSA) renography and glomerular filtration rate (GFR) estimation are 
useful in assessment of renal scarring and function. Surgical management is 
normally by endoscopic valve ablation. However, in the presence of a rising 
creatinine, recurrent urinary infection or doubts over the efficacy of bladder 
drainage, diversion, usually vesicostomy, may be a safe alternative 
(Dinneen & Duffy 1996).
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1.4.2 PUV and renal impairment
The most common renal diagnosis in children with ESRF is bilateral renal 
dysplasia, a term that describes organs containing undifferentiated and 
metaplastic tissues, such as smooth muscle and cartilage (Ikha-Dahmane et 
al. 1997). Just under half the cases of all childhood ESRF in the United 
Kingdom caused by renal dysplasia are associated with urinary tract 
obstruction, PUV being overwhelmingly the most common specific 
diagnosis, accounting for one half of all boys with ESRF (Lewis 1999). Renal 
impairment in boys with congenital BOO could theoretically be explained by:
1. Primary renal dysplasia/ hypoplasia and/ or
2. Renal dysplasia secondary to:
antenatal BOO (which is hypothesised to be associated with bladder 
dysfunction and high-pressure VUR) and
postnatal bladder dysfunction, high-pressure VUR, hyperfiltration 
injury and UTI’s
Primary renal dysplasia may be consequent on ectopic ureteric budding and 
abnormal implantation of the ureteric bud into the metanephric blastema, as 
proposed by Hennebury and Stephens (1980), on the basis of post-mortem 
findings of a more lateral ureteric orifice position in 22 renal units from boys 
with PUV (Henneberry & Stephens 1980). Various studies in animal models 
have documented a deregulation of cell turnover in dysplastic kidneys, with 
both enhanced proliferation in cystic structures as well as apoptosis in both 
epithelia and stroma; the latter might represent a loss of precursor cells that
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might otherwise form nephrons (Attar et al. 1998). The renal expression of 
diverse cytokines, growth/ survival factors and transcription factors is also 
deregulated in these organs, including B-cell lymphoma/ leukaemia (BCL2), 
hepatocyte growth factor, insulin-like growth factor-1 (IGF-1), paired-box 
(PAX2), tumour necrosis factor a (TNF-a) and transforming growth factor-p1 
(TGF-P1) (Winyard et al. 1996,Yang et al. 2000).
The mechanism of renal injury due to antenatal BOO as yet not known. 
Cussen (1971) carried out post-mortem examination of 30 children with 
congenital urethral obstruction (27 PUV and three urethral atresias). 
Dysplasia was confirmed histologically in 37%, and it was always associated 
with ipsilateral reflux, suggesting that antenatal high-pressure VUR may be a 
contributing factor (Cussen 1971). In addition, VUR is found in 37-67% of 
boys at the time of diagnosis of PUV (Churchill et al. 1983). Prenatal bladder 
dysfunction is difficult to document, but its presence is suggested by the 
finding of urodynamic abnormalities in infants born with PUV (Holmdahl et 
al. 1995). Holmdahl et al (1995) were able to document bladder dysfunction 
in neonates and infants up to five months of age, suggesting that the onset 
of this dysfunction must occur prenatally.
Postnatal progression of renal impairment after valve ablation may be due to 
a combination of factors including persistent dilatation, VUR, break-through 
infection, bladder dysfunction and hyperfiltration injury (Cuckow 2006). 
Holmdahl’s (1995) study showed that early renal dysfunction occurs in a 
significant number of cases: out of 16 infants born with PUV, 11 had a
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glomerular filtration rate (GFR) of 80% or less of expected value for age; in 
seven infants, the GFR was below 60% of expected value. Five patients had 
elevated creatinine levels between 60 and 90pmol/l (normal less than 
60pmol/l). In fact, infants may initially require acute renal replacement 
therapy until adequate renal function returns. Some patients will experience 
enough recovery of renal function and compensatory function of the 
remaining nephrons to come off dialysis once stabilized (Becker & Baum
2006). However, patients who do not require renal replacement therapy, or 
who come off dialysis, are still at risk of developing renal insufficiency in later 
life. Scott et al (1985) showed that after their initial management, 60% of 
patients recovered normal biochemical renal function on short term follow- 
up. Woodhouse (2001) reported that the proportion of children with PUV and 
renal dysfunction increased from 6.5% at 5 years of age to 25% at 10 years 
to 50% at 15 years.
Long-term renal outcome is variable and depends on a number of factors. 
Roth et al (2001) reported the outcome 10 consecutive, antenatally- 
diagnosed patients treated for PUV in one centre over a period of 21 years. 
Seven patients (70%) progressed to ESRF over a period of 9 to 13 years, all 
received maintenance dialysis and four subsequently received kidney 
transplantation (Roth et al. 2001). Older studies reported less dismal figures; 
however, patient follow-up was over a shorter period of time, and a greater 
proportion of patients were diagnosed postnatally. Smith et al (1996) 
reported a 13% progression to ESRF over 11 years (100 patients, of whom 
56% were diagnosed before one year of age), which is the same figure
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quoted by Merguerian et al (1992) at ten-year follow-up of 102 patients, of 
whom only 10% were diagnosed before one year of age (Merguerian et al. 
1992, Smith et al. 1996). It is uncertain at what level of GFR in childhood, 
renal failure becomes inevitable in adult life. As a clinical guide, Woodhouse 
(2003) reported that adolescents with a GFR of 20ml/min/1.73m2 are 
unlikely to avoid dialysis and transplantation in the long-term; those with a 
GFR of 20-40 are a serious concern (Woodhouse 2003).
Factors thought to influence this rate of progression of renal dysfunction 
include bladder dysfunction and persistent high-pressure VUR hyperfiltration 
injury. Parkhouse and Woodhouse (1990) showed that 58% of boys with 
bilateral reflux developed ESRF, compared with 22% and 20% for unilateral 
and no reflux respectively. Dinneen et al (1995) studied urinary 
concentrating ability, urine production and glomerular filtration rates in 51 
boys born with PUV between 5 and 10 years of age. Urine concentrating 
ability was impaired in 75%, the urine being <800mosm/kg in 59% and <300 
mosm/kg in 16%. There were significant correlations between concentrating 
ability and GFR and concentrating capacity and 24-hour urine volumes or 
overnight urine production. With an increased daily volume of urine there are 
more cycles of bladder filling and emptying, and so it is hypothesised that 
more time is spent with the bladder at a high storage pressure, leading to 
progressive renal injury (Dinneen et al. 1995). Neild et al (2004), however, 
challenged this concept by comparing the renal outcome of 44 patients with 
primary VUR and renal dysplasia with 24 patients with congenital BOO and 
bladder dysfunction and a GFR <60ml/min/1.73m2. They found no significant
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difference in renal outcome or median survival, and proposed that the main 
cause of progression to ESRF is nephrological rather than urological (Neild 
et al. 2004).
1.4.3 PUV and bladder dysfunction
A normal paediatric bladder would be expected to hold a volume of 
30+(agex30) ml, up to 12 years of age, after which estimated bladder 
capacity is 390ml. It would have a wall thickness of less than 3mm on 
ultrasound scanning, and would be expected to empty at last 90% of its 
volume on voiding (Neveus et al. 2006). Bladder function may be assessed 
using urodynamic (cystometric) techniques. Cystometry is used to study 
both the storage and voiding phase of micturition and is the method by 
which the pressure-volume relationship of the bladder is measured (Neveus 
et al. 2006). This study involves the insertion of a double-lumen catheter into 
the bladder (either urethrally or suprapubically) in order to simultaneously 
permit filling and intravesical pressure recording. A rectal balloon catheter 
allows the measurement of intra-abdominal pressure. Electronic subtraction 
of these two pressures gives true detrusor pressure. In normal bladder 
function there should be little change in intravesical pressure from empty to 
full. Bladder compliance describes the relationship between bladder volume 
and bladder pressure (AV/AP). In the normal adult bladder with a capacity of 
400ml, the change in pressure from empty to full should be less than 
10cmH2O (Abrams 2002). In theory, bladder compliance has a passive and 
active component. The passive component is dependent on bladder wall 
composition, and if there are significant quantities of fibrous tissue within the
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bladder wall, then compliance may be reduced. Detrusor overactivity exists 
when, during the filling phase, there are involuntary detrusor contractions 
that the patient cannot suppress, characterised by phasic contractions in 
which the detrusor pressure rises and then falls (Abrams 2002).
Ghanem et al. (2004) evaluated the urodynamics of 116 patients born with 
PUV at a mean follow-up of 10 years post-valve ablation. They found 
evidence of bladder dysfunction in 80% of cases, namely detrusor 
overactivity in 38%, poor compliance in 26%, and a combination of the two 
in 15% (Ghanem et al. 2004). Bladder dysfunction may become manifest in 
the form of incontinence or UTI’s; however, as many as 75% of 
asymptomatic patients can have urodynamic abnormalities, usually 
hypocontactility (De Gennaro et al. 2000). Careful urodynamic evaluation 
showed that incontinence in boys with PUV was not due to sphincter 
damage following valve resection, but due to abnormal bladder contractility 
(Parkhouse et al. 1988, Pfister et al. 1996, Holmdahl 1997).
The evolution in urodynamic abnormality with age was shown by Holmdahl 
et al (1996) who compared findings in pre- and postpubertal boys. The 
detrusor overactivity and reduced compliance noted in infancy improved with 
age as did the strength of voiding contractions while bladder capacity and 
residual urine increased. Unstable, poorly compliant, overdistended bladders 
changed towards decompensation with time, and increased capacity after 
puberty was attributed to increased prostatic/urethral resistance (Holmdahl 
et al. 1996). De Gennaro et al. (1996) showed that the prevalence of
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hypocontractility in boys aged 4 to 7 years was 37%, whereas it was more 
than 60% in boys older than 12 years. Furthermore, in a study of 30 boys 
born with PUV and followed up from infancy, the authors showed that 
bladder dysfunction, mainly hypercontractility, was detected in 21 boys 
(70%) at the first evaluation and in 18 (60%) at the last (De Gennaro et al. 
2000). Fifteen boys went on to develop impairment of contractility while 
voiding at final follow-up. Results suggested that the urodynamic pattern of 
hypercontractility generally found soon after valve ablation gradually 
changes to hypocontractility and in many boys this pattern predominates 
after puberty (De Gennaro et al. 2000).
1.4.4 Bladder dysfunction and end-stage renal failure (ESRF)
Parkhouse and Woodhouse (1990) reported an association between 
continence, which is a marker of bladder dysfunction, and renal outcome. In 
their series, 45% of 5-year-old boys were incontinent by day, and 46% of 
these had a bad long-term outcome (death in renal failure, end-stage or 
chronic renal failure), compared with continent patients of whom only 4% 
had bad outcomes (follow-up between 11 and 22 years). Ghanem’s (2004) 
study of 116 patients treated for PUV showed that although a combination of 
loss of compliance and detrusor overactivity was present in only 15% of 
cases, 53% of this group went on to develop ESRF, suggesting that this 
combination may be detrimental to the kidneys. Reduced compliance alone 
also correlated unfavourably with renal function: 40% of patients with loss of 
compliance developed ESRF (Ghanem et al. 2004). A combination of loss of 
compliance and detrusor overactivity may result in raised intravesical
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pressures, which are found in up to 60% of adolescent boys born with PUV 
(Peters et al. 1990). The critical value appears to be a leak-point pressure of 
40 cmH20, measured during urodynamic evaluation (Woodhouse 2003). For 
patients with salvageable renal function, management with anticholinergics, 
or clean intermittent self-catheterisation (CISC) is essential (Woodhouse 
2003).
1.4.5 Summary
• In spite of early surgical management of PUV, the secondary effects 
on the bladder and kidneys are permanent and may be progressive.
• Antenatal diagnosis is associated with a worse prognosis in terms of 
fetal and perinatal mortality, as well as long-term renal outcome.
• In-utero bladder decompression is feasible and may improve perinatal 
survival in neonates with an otherwise poor prognosis, but long-term 
renal outcome is not significantly affected.
• Post-mortem studies suggest that renal dysplasia in PUV may be a 
primary event, but it is not known whether in-utero bladder 
dysfunction compounds this damage.
No studies of human fetal bladder function and dysfunction have been 
reported, yet this seems to be a key piece in this as yet confounding puzzle. 
Our understanding of the pathophysiology of fetal urinary tract to obstruction 
has been acquired mainly from the research literature, which will be 
summarised in the following section.
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1.5 Congenital bladder outflow obstruction: research background
1.5.1 Animal models: overview
The use of animal models is expensive, complex and fraught with potential 
misinterpretation, and raises ethical issues: so why do we continue to use 
them? The principle goal of all animal research is to improve our 
understanding of a disease process so that we may treat humans more 
efficiently. In the field of BOO, it is important to understand the principles of 
the pathophysiology of the obstructed developing kidney and urinary tract, 
identify markers of the progression of that natural history, and ultimately to 
develop more specific treatments for this condition. Treatment should be 
based more on the impact of obstruction on renal and bladder development 
rather than the simple ‘plumbing’ problem producing the obstruction. There 
are two types of experimental model system in use to examine fetal renal 
diseases:
1. genetic models, based on spontaneous mutations in isolated animals 
(in which a specific trait is then propagated) or induced through gene 
knockout technology; and
2. surgical models of induced disease.
1.5.2 Genetic models of fetal urinary tract obstruction
Spontaneous BOO in animal species is unusual, although recently Singh et 
al (2007) reported a unique mutant mouse model that develps in-utero 
megabladder, and variable hydroureteronephrosis and renal insufficiency, 
secondary to obstructive uropathy. Bladder smooth muscle defects were
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evident as early as embryonic day 15 in both genders of affected mice, with 
male mice exhibiting a more severe phenotype as development proceeds 
(Singh et al. 2007).
Gene knockout technology has presented a new opportunity to study urinary 
tract obstruction in the developing fetus. Versus the kidney itself, rather less 
is known about the genes which control the development of the ureter, 
urinary bladder and urethra. Recent studies have shown that, as the 
urothelium differentiates, it expresses specialized proteins such as the 
Uroplakins, which coat the apical surface of cells: part of their function is to 
make the urinary tract ‘water-tight’ but they also may be important in 
directing lower tract growth, possibly even transducing yet-to-be-defined 
differentiation signals triggered by urinary constituents (Jenkins et al. 2005, 
Jenkins & Woolf 2006). Mice which lack specific Uroplakins have either 
severe VUR (due to a ‘golf-ball’ vesicoureteric junction) or anatomical 
obstruction of the ureter (due to overgrowth of the urothelium). Moreover, 
rare individuals with vesicoureteric reflux and kidney dysplasia have been 
shown to have mutations of Uroplakin genes (UPIIIA) (Jenkins & Woolf
2006).
The embryonic urothelium is also remarkable in acting as a ‘signalling- 
centre’ because it secretes sonic hedgehog (Shh), a growth factor which 
diffuses into the surrounding mesenchyme and triggers production of 
detrusor and ureteric smooth muscle (Yu et al. 2002). The signal is mediated 
by a series of other proteins, such as the patched and smoothened
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receptors and the Gl family of transcription factors. Mutations of these genes 
in humans cause holoprosencephaly as well as the Pallister-Hall syndrome, 
and these individuals can sometimes have urogenital sinus defects, absent 
or small kidneys and vesicoureteric reflux. Mice which are engineered to 
lack Shh in the developing renal tract have small kidneys, probably resulting 
from poor muscularisation of the ureter and subsequent ‘functional’ urinary 
obstruction (Haraguchi et al. 2007).
It was recently shown that a transcription factor gene called Teashirt-3 is 
expressed in the smooth muscle of the ureter: when mice are engineered to 
have no teashirt gene activity, animals are born with severe hydronephrosis 
and mimic human PUJO (Gannon et al. 2006). Again, there is no overt 
anatomical blockage of urine flow but the mutant embryonic ureters can be 
shown to have a very irregular type of spontaneous peristalsis. This type of 
gene is therefore a candidate for human PUJO, and this disorder may in fact 
be inherited. Finally, a normal variant (polymorphism) of the Angiotensin II 
type 2 receptor (AT2) gene appears to predispose individuals to a range of 
lower urinary tract anomalies: this gene may control programmed cell death 
and hence modulate the final shape of the lower urinary tract (Nishimura et 
al. 1999). Unfortunately to date there are no genetic mouse models which 
have PUV, although the megabladder model described above my yet prove 
informative for understanding the human disease (Singh et al. 2007).
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1.5.3 Surgical models of fetal urinary tract obstruction
Fetal models of urinary tract obstruction have the advantage of reliably 
reproducing the pathologic condition of choice at a specified time and to a 
specified degree. This has been successfully accomplished in the mouse, 
rat, guinea-pig, rabbit, opossum, dog, pig, monkey, and most commonly, the 
fetal sheep. The larger mammalian models, including the sheep and 
monkey, exhibit nephrogenesis exclusively during intra-uterine life and have 
the advantage of longer gestational periods similar to the human condition.
In other animals such as rodents, rabbits and pigs, nephrogenesis continues 
for a variable period postnatally, and therefore neonatal animals may also be 
used to study the developing kidneys (Matsell & Tarantal 2002). A 
comparison of periods of gestation and nephrogenesis in these models is 
presented in Figure 7. Table 1.0 displays periods of nephrogenesis as a 
percentage of gestation, and hence shows the similarity in the timing of 
mesonephric and metanephric development in the sheep and human. This 
implies that, for example, the stage of nephrogenesis at mid-gestation in the 
ovine model is equivalent to the stage of nephrogenesis at mid-gestation in 
the human, which is not the case with other animal models (Moritz and 
Wintour 1999). Tables 1.1 to 1.5 summarise the major fetal/ neonatal BOO 
studies published in the five most prevalent animal models, namely the 
lamb, rabbit, rodent, monkey and pig.
1.5.3.1 The fetal lamb BOO model
Prior to reviewing the studies performed on the fetal lamb model, it is useful 
to review the basics of ovine urinary tract development. Ovine gestation
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lasts for 145 days. The urogenital sinus in the fetal sheep is formed by the 
division of the cloaca and later forms the primitive bladder and urethra (Ward 
et al. 2006). The bladder extends to the umbilicus and opens directly into the 
allantois. At mid-gestation, the fetal urethra is well-formed but is probably not 
used as an outflow tract from the bladder as the lumen contains 
desquamated cells and debris (Ward et al. 2006). At this time-point, the 
urine from the fetal kidneys passes from the bladder in to the allantoic cavity 
via the urachus until approximately 90 days gestation, when the bladder 
begins to recede caudally, pulling on the allantoic stalk. Urine progressively 
passes directly into the amniotic cavity via the urethra until the urachus fully 
obliterates (the exact time this occurs is unknown but it may remain patent 
up to term). The delayed closure of thr urachus in the fetal lamb is a key 
difference from the situation in the human, where the urachus is reported to 
close between the fourth and fifth months of gestation (Zeiger et al. 1998). 
Ovine fetal allantoic and amniotic sacs remain separate cavities with the 
former eventually rupturing into the amniotic cavity to form one sac (Ward et 
al. 2006).
During kidney development, the ovine fetus does not develop a pronephros, 
but forms a “giant glomerulus”, consisting of approximately 15 fused 
glomeruli, at the cranial end of the future mesonephros (Moritz & Wintour
1999). The ovine mesonephros forms around day 17, reaching a peak 
nephron number by day 30, and then regresses from day 40 to 57. The fetal 
lamb mesonephros is able to produce hypotonic urine from day 18 of 
gestation. This urine passes into the allantoic cavity, which increases in
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volume from 3ml at day 20 to 20 ml by day 24. Ovine metanephric 
development begins at day 27. By mid-gestation (75 days), urine production 
is an impressive 5-6ml pr hour which equates to 0.5 litres of urine/kg body 
weight per day (Moritz & Wintour 1999). Normal ovine fetal urine is 
hypotonic, its osmolality being 179 mOsm/ kg (Nijland & Ross 2000). 
Metanephric formation of new nephrons is complete by day 135 of gestation 
and therefore complete before birth (Wintour et al. 1996).
The first description of ureteric ligation on the fetal sheep was reported by 
Beck in 1971. He showed that whereas ureteric ligation before mid-gestation 
results in dysplastic kidney changes, obstruction after mid-gestation results 
in hydronephrosis but not dysplasia (Beck 1971). Harrison et a.I (1983) later 
performed urethral ligation on the fetal lamb, and showed that ligation of the 
urachus is essential in addition to the obstructing the urethra, because the 
urachus in the fetal lamb, unlike in humans, remains patent throughout 
gestation (Harrison et al. 1983). A comparison of the key studies performed 
on the fetal lamb BOO model is presented in figures 8 (which summarises 
the effects of BOO on the kidney) and 9 (effects of BOO on the bladder). 
Details of these papers may be found in Table 1.1 at the end of the chapter.
Peters et al (1992a) highlighted the profound histopathological effects that 
BOO in early gestation (before 75 days) had on nephrogenesis, including 
cystic transformation of the elements of the nephron, abnormal glomerular 
development, and medullary hypoplasia. They showed that the features of 
obstructive nephropathy depend on the timing of obstruction. Most notably,
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the cystic dysplastic changes and architectural disorganization evident 
following early obstruction were not noticeable following BOO after 90 days, 
which was usually associated with cortical thinning but not cystic dysplasia 
(Peters et al. 1992a). Kitagawa et al. (1999) confirmed these findings by 
performing urachal and urethral ligation on fetal lambs at 60 and 90 days 
gestation. Most, but not all, obstructed systems were found to have dilated 
bladders and ureters, as well as vesico-ureteric reflux, on post-mortem 
cystograms. Obstruction at 90 days was not associated with cystic 
dysplastic changes, and kidneys were found to have a normal glomerular 
number (Kitagawa et al. 1999). In contrast, obstruction at 60 days was 
associated with the formation of multiple small cysts and a reduction in 
glomerular number. The subcapsular cysts seen were thought to reflect 
damage to the nephrogenic zone, and suggested that in the 60 day model, 
damage to the developing nephrons occurred while the latter were still in the 
S-stage of development (Kitagawa et al. 1999). The reduction in glomerular 
number was proposed to be due to a disruption of ureteric duct branching in 
the developing kidney associated altered glomerular vascularisation and 
podocyte apoptosis: features also noted in human histological studies 
(Poucell-Hatton et al. 2000).
Further studies on the fetal lamb model have focussed on upper tract 
obstruction. Attar et al. (1998) and Yang et al. (2001) performed complete 
unilateral ureteric obstruction in the fetal lamb at 90 days, for a duration of 
ten days, which resulted in cystic kidneys with a disorganized nephrogenic 
cortex, with cells separated by oedema and vascular spaces. Cortical
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histology was dominated by cysts associated with malformed glomerular 
tufts. This process was associated with a deregulation of cell turnover, due 
to a disruption in the balance of genes that promote and inhibit apoptosis. 
Apoptosis is regulated by an extrinsic pathway and an intrinsic pathway, 
both of which result in the activation of caspases, which induce apoptosis 
(Green & Reed 1998). The intrinsic pathway is in turn regulated by BAX, a 
pro-apoptotic gene, and BCL-2, and anti-apoptotic gene: the relative ratios 
of pro- and anti-apoptotic proteins determines the sensitivity of the cell to 
apoptotic stimuli (Reed 2000). The dysregulated tubular epithelial cell cycle 
observed in the ureteric obstruction model was associated with the 
sustained expression of PAX2, a cell-prolferation gene, and the over­
expression of BCL2, the anti-apoptotic gene (Attar et al. 1998). Hence the 
initiating obstructive event altered the expression of genes necessary for 
normal tubular epithelial cell differentiation, proliferation, and survival, and 
was thought to trigger the proliferation of cystic structures, as well as 
heighten apoptosis in both epithelia and stroma (Attar et al. 1998, Yang et 
al. 2001)
Samnakay et al. (2006) published similar findings in a fetal lamb BOO 
model at 70 days gestation in which the renal status was examined between 
two and thirty days post-obstruction. Changes in renal morphology were 
present as early as two days post-obstruction, and progressed over 20-30 
days to cystic renal dysplasia. BOO increased the renal cortical expression 
of BAX relative to BCL-X, a member of the BCL-2 family (Samnakay et al.
2006). Gobet et al. (1999) showed that partial BOO at 95 days for two to five
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weeks in the fetal lamb resulted in heavier kidneys with increased interstitial 
fibrosis, as measured by increased extracellular matrix volume fraction. 
They suggested that a possible mechanism for this process is a shift in the 
proteolytic activity to reduce matrix degradation associated with increased 
apoptosis in obstructed kidney (Gobet et al. 1999a). Mure et al. (2006) later 
supported this finding in a fetal lamb study of unilateral ureteral obstruction 
at 90 days gestation (Mure et al. 2006a). They also found increased renal 
interstitial fibrosis associated with increased type IV collagen deposition 
(Mure et al. 2006b). Peters et al. (1997) showed that increased collagen 
deposition was also a feature of obstructed fetal bladders (Peters 1997). 
Since a reduction in collagen degradation could account for the increased 
content, the authors demonstrated that matrix metalloproteinase-2 (MMP-2) 
activity, important in collagen degradation, was present in normal, but not 
obstructed, bladders. This was associated with increased tissue inhibitors of 
metalloproteinases (TIMP) (Peters 1997).
1.5.3.2 Rabbit BOO models
Details of the studies performed on the rabbit BOO model are presented in 
Table 1.2. Rabbit nephrogenesis continues during the neonatal period, 
therefore the neonatal rabbit model may also be employed in order to study 
the effects of obstruction on the developing kidney. Levin et al. (2002) 
investigated the effect of BOO on the mature rabbit bladder. Their findings 
are relevant as they define the terms ‘compensation’ and ‘decompensation’, 
phases of BOO which have not been defined or studied in developmental 
BOO models. Levin et al. (2002) showed similarities between partial BOO in
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mature rabbits and obstructive dysfunction in man, including increased 
bladder mass, increased fibrosis, reduced compliance, increased incidence 
of detrusor instability and decreased contractile ability. Gosling et al. (2002) 
showed that obstructed bladder function in the adult rabbit can remain 
relatively normal for prolonged periods of time, even though bladder mass is 
increased, and this defined the compensated stage of BOO (Gosling et al.
2000). Bladder mass increased rapidly in the first seven days post­
obstruction, was constant for the next seven days, then continued to 
increase gradually. This growth was attributed to bladder wall remodelling 
with marked urothelial and fibroblast hyperplasia (1 day) and smooth muscle 
hypertrophy (3-5 days) resulting in a 4-5 fold increase in bladder mass within 
seven days (Gosling et al. 2000). This weight increase could also have been 
caused by a four-fold increase in blood flow to the mucosa for the first three 
days post-obstruction, as shown by Lieb et al. (2000).
Levin et al. (1997) defined the decompensated stage of BOO in the mature 
rabbit model, when with prolonged obstruction, bladder function destabilizes 
and is characterized by progressive deterioration in contractility and function 
(i.e. ability to empty), a slower increase in mass, and a progressive decrease 
in the volume fraction of smooth muscle elements in the bladder wall. The 
end result was either an organ with a thick fibrous wall, low capacity, poor 
compliance and little or no contractile function; or a dilated bladder with a 
thin fibrous wall, high capacity, and little or no contractile function (Levin et 
al. 1997). It was hypothesised that the shift from the compensated to the 
decompensated stage is related to cyclical periods of ischemia followed by
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reperfusion (Levin et al. 2002). Relative blood flow to the rabbit bladder is 
increased at one day post-obstruction, due to vasodilatation induced by 
increased nitric oxide (NO) synthesis and release, then returns to control 
levels, i.e. blood flow increases with the increase in bladder mass. Using 
antibodies to the vascular endothelium marker CD31, Levin showed that 
partial BOO induces a rapid increase and redistribution to small or mid-size 
blood vessels in the bladder wall. Most notable was the marked 
neovascularisation of the obstruction-induced proliferated serosal 
compartment. The end of the compensation stage, Levin argues, is marked 
by areas of hypoxia revealed using hypoxyprobe-1 (pimidazole), a small 
molecular weight compound that freely diffuses through tissues and forms 
protein adducts in hypoxic cells only. The hypoxyprobe-1 adducts can be 
detected in tissue sections immuno-histochemically (Levin et al. 2002). This 
initiates degenerative membrane effects, which supports the process of 
bladder decompensation. It seems that relief of obstruction during the 
compensated phase, at least in animals, can induce a rapid and full 
restoration of the bladder function. However, if the obstruction is relieved 
during the decompensated stage, bladder function only partially recovers 
(Levin et al. 2002).
Rohrmann et al. (1997) developed the fetal rabbit BOO model, and 
evaluated the storage and emptying functions of the fetal bladder obstructed 
for the last eight days of gestation. Histologically, there was smooth muscle 
cell hypertrophy and increased connective tissue in obstructed bladders. In 
whole bladder preparations, the obstructed bladder had increased
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compliance. Removing calcium form the organ bath, thus eliminating the 
active component of compliance, did not affect compliance. This finding 
suggested that increased compliance was due to the passive properties of 
the bladder wall rather than smooth muscle tone (Rohrmann et al. 1997).
Contractility in the unobstructed bladder was examined by subjecting 
newborn rabbit bladder strips to various neurotransmitter agonists and 
antagonists (Levin et al. 1981). There was a poor contractile response to 
methoxamine, an alpha-adrenergic agonist, and isoproterenol, a beta- 
adrenergic agonist. In contrast, these bladder strips had a normal contractile 
response to bethanechol, a muscarinic cholinergic agonist, and ATP, a 
purinergic agonist (Levin et al. 1981). As with compliance, contractile 
function increased as development progressed (Levin et al. 1981). Following 
obstruction, however, Rohrmann et al. (1997) found a greater contractile 
response to bethanecol, in spite of an apparent denervation. These findings 
led the authors to suggest that this may represent a denervation 
supersensitivity as a result of obstruction. It appeared likely that with 
prolonged obstruction, the fetal bladder would begin to decompensate, 
losing both its compliance and contractility (Rohrmann et al. 1997).
1.5.3.3 Other developmental BOO models
Table 1.3 summarises BOO studies in the rodent model. Mouse and rat 
kidneys also continue to develop postnatally and therefore neonatal animals 
may be used in developmental studies. Lemack et al. (1999) hypothesised 
that inceased iNOS expression may improve oxygenation during
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obstruction-induced ischaemia: they reported that iNOS was non- 
significantly increased following BOO (Lemack et al. 1999). Felsen et al. 
(2003) went on to show that iNOS inhibition reduced the obstructive effect 
on bladder growth and spontaneous contractions.
Studies of unilateral ureteric obstruction (UUO) in the neonatal rat have 
provided many insights in the renal response to obstruction. Thornhill et al. 
(2005) reported a model of precisely controlled variable partial UOO in the 
neonatal rat, in which renal growth was impaired in a non-linear fashion, and 
found that tubular atrophy and interstitial fibrosis develop before significant 
renal pelvic dilatation. In addition, following a critical partial obstruction of the 
ureter (70% reduction in ureteral diameter), renal growth was reduced by 
60% and the number of glomeruli reduced by 50% (Thornhill et al. 2005).
Primate studies are presented in Table 1.4. No primate work has been 
published in the field of developmental BOO, but considerable work 
investigating UUO has been performed in this model. Matsell et al. (2002) 
mimicked pelvi-ureteric junction obstruction (PUJO) by injecting alginate 
beds into the pelvi-ureteric junction; the beads expand to produce the 
required partial obstruction. They reported that, as in the sheep model, early 
kidney obstruction results in disrupted glomerular development, reduced 
glomerular number, cystic dysplasia, deficient cortical ureteric duct 
development and branching, and altered glomerular basement membrane 
formation (Matsell et al. 2002a).
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The pig model (Table 1.5) was successfully used to test the feasibility of 
studying pressure-flow changes in unobstructed bladders using dual 
pressure radiotelemtry devices. Traces were also validated by conventional 
cystometry (Olsen et al. 2001). Olsen et al. (2001) were able to perform 
conventional urodynamics on unobstructed fetuses in the second and third 
trimester, accessing the fetal bladder via the urachus. They noted that in 
early gestation the fetus dribbled continuously but was able to attain 
significant voiding pressures, by the third trimester, when it voided 2-6 times 
per minute (Olsen et al. 2001). No urodynamic studies on obstructed 
fetuses have however been documented in the literature.
Bladder compliance has also been studied in the unobstructed fetal calf 
(Coplen et al. 1994, Dean et al. 1997). In an isolated whole fetal bovine 
bladder preparation, total bladder compliance was shown to increase with 
fetal development (Coplen et al. 1994). Compliance with active smooth 
muscle tone (“active compliance”), however, decreases with fetal age, 
whereas surgical removal of the detrusor smooth muscle (“passive 
compliance”), results in an increase in compliance with age (Dean et al. 
1997). Overall, smooth muscle tension is greater in the youngest fetuses, 
which therefore have the stiffest bladders. Active smooth muscle tension is a 
major factor in the compliance of the youngest bladder and decreases as 
gestation progresses (Dean et al. 1997). Connective tissue plays a variable 
role in compliance during development, and this may be indicative of 
ongoing remodelling of the extracellular matrix during bladder development 
(Coplen et al. 1994).
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Liapis et al (2001) performed UUO in the North American opossum, which 
resulted in medullary and tubular disruption and a decrease in glomerular 
number associated with an aberrant increase in fibronectin and collagen I 
and IV, with a further increase in synthesis with the duration of obstruction.
1.5.4 Models of in-utero bladder decompression
The next step in the investigation of the effect of obstruction on the 
developing urinary tract is to elucidate to what extent, if any, these changes 
are reversible following decompression. Kitagawa et al. (2006) created BOO 
in the fetal lamb at 60 days gestation, and a vesicostomy (female) or 
urethrostomy (male) fashioned 21 days later. Fetuses were delivered at 
term, and bladder compliance measured before the lambs were killed. Half 
the shunted lambs were found to have cystic kidneys, which were not 
different from the non-shunted ones. Shunted bladder walls were thickened 
and fibrous, with a thickened muscular layer compared to the obstructed 
group, and were found to have a poor compliance. The authors concluded 
that shunting at this gestation was partially effective and would need to be 
performed earlier to be more effective (Kitagawa et al. 2006).
In order to establish the effect that a V-A shint had on the fetal bladder, 
Kitagawa et al. (2007) studied the effect of shunting on the normal 
(unobstructed) fetal lamb bladder, carried out from mid-gestation to term. 
Shunted bladders were noted to have a poor compliance and increased 
fibrosis, with a mean volume of 4 ml compared to 60 ml in non-shunted
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unobstructed bladders. The authors suggested that bladder collapse and 
lack of cycling due to the shunt could result in damage and consequent 
fibrotic changes. This led them to experiment with the use of a pressure- 
limited vesicoamniotic shunt, which, they hypothesised, may preserve the 
filling and emptying cycle of the fetal bladder (Nagae et al. 2006). Both 
standard and pressure-limiting shunts were found to result in bladder 
fibrosis; however the latter resulted in a lesser degree of damage.
Edouga et al. (2001) utilised a fetal sheep model to study the effect of de­
obstruction on renal development. BOO was performed at 60 days; relief by 
vesicoamniotic shunting was performed at 90 days gestation. Animals were 
evaluated at 120 days gestation. Fetal BOO resulted in hydronephrosis 
(64%) or dysplasia (36%); dysplasia was associated with a reduction in the 
number of glomeruli. In shunted fetuses, the number of glomeruli increased 
at 120 days compared with non-diverted fetuses, and the temporal pattern of 
PAX2, disrupted after obstruction, restored. The authors concluded that in- 
utero diversion performed before the end of nephrogenesis may allow 
reversal of the glomerulogenesis arrest observed (Edouga et al. 2001).
Duncomb et al. (2002) utilised a similar ovine model of fetal BOO whereby 
obstruction was performed at 75 days and released at 94 days; animals 
were studied at 110 days gesatation. BOO resulted in increasing cortical 
thickness and decreasing glomerular numbers with cystic dysmorphic 
change. De-obstruction partially reversed these changes although final 
glomerular counts were in-between but not significantly different from counts
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in the obstructed-only or control groups. BOO resulted in both thick and thin- 
walled bladders but there was no comment about how de-obstruction 
affected this observation. The authors concluded that there may be at least 
some renal recovery when diagnosis and intervention occurs in mid­
pregnancy (Duncomb et al. 2002). Decompression in mid-gestation 
therefore appears to result in partial reversal of renal, but not bladder, 
changes.
Lindner et al. (1988) performed short (ten days) and long (six weeks) term 
BOO in the adult rat. Both models resulted in a rapid increase in bladder 
weight and DNA and RNA content; after removal of the obstructing ligature, 
detrusor weight, DNA and RNA content decreased significantly and were 
almost back at control levels in both groups, within four weeks (Lindner et al. 
1988).
1.5.5 Summary
• Numerous large and small animal models investigating the effect of 
BOO on various aspects of kidney and bladder morphology and 
physiology exist, but results are difficult to assimilate as studies have 
been performed on different models at different time-points and 
variable durations.
• Similarly, the effect of obstruction on the bladder and kidney were 
often performed on separate models, therefore the relationship 
between findings cannot be commented on.
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• The concept of bladder compensation and decompensation, which 
may be of utmost importance when selecting a time-frame for bladder 
decompensation, has been defined and studied in the mature, but not 
fetal, animal model.
• Bladder urodynamics, which are key to precise management of the 
human PUV bladder, have never been studied on a model of the 
obstructed fetal bladder.
• Therefore a unifying model which encompasses the above points is 
essential.
Before moving on to designing this model, a review of relevant bladder 
physiology, in particular the active role of the urothelium, and the key players 
in detrusor contractility, is presented.
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1.6 Current advances in bladder physiology
1.6.1 The urothelium: “not just a passive barrier”
The urothelium is not merely a passive permeability barrier but an active 
player in bladder dilatation, responsible for communication of intravesical 
pressure changes to the underlying nervous system (Apodaca 2004). The 
epithelium is composed of three cell layers: a single basal cell layer, an 
intermediate cell layer which may be between one and several cell layers 
thick, and an umbrella cell layer. The apical surface of umbrella cells 
contains unique structural and biochemical features (Apodaca 2004). When 
examined by scanning electron microscopy, the surface of this layer appears 
pleated and the cells are separated by a tight junction. Higher magnification 
views show that the surface is covered by raised ridges, also called hinges, 
or microplicae, and intervening areas called plaques. The membrane 
associated with the hinge and plaque region is known as the asymmetric 
unit membrane (AUM) due to the fact that the outer leaflet appears to be 
twice as thick as the inner leaflet (Apodaca 2004). The AUM is composed of 
a family of at least five proteins called uroplakins (UPs): UPla, UPlb, UPII, 
UPllla and UPlllb. UPla, UPII and UPllla and b are only expressed in the 
urothelium and are concentrated in the umbrella cell layer. UPlb is also 
expressed in the cornea and conjunctiva. It is thought that UPs help 
maintain the permeability barrier associated with the apical membrane of the 
umbrella cell layer (Apodaca 2004). Lack of UPIII expression in a knockout 
model resulted in increased permeability to methelene blue, and has been 
associated with increased cell turnover of the urothelium, vesicoureteric 
reflux and hydroureter (Hu et al. 2001).
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Another function ascribed to urothelial plaques is that they may modulate the 
apical surface area of the umbrella cell during bladder filling and emptying 
(Truschel et al. 2002). UPs are found within fusiform vesicles which occupy 
the cytoplasm of umbrella cells. These vesicles respond to cyclical changes 
in hydrostatic pressure as the bladder fills and empties. In the classical 
model of vesicle dynamics, as the bladder fills, it initially distends by 
unfolding of its “wrinkled” mucosa, then by a “flattening” of the initially 
cuboidal umbrella cells. It is hypothesized that this change of shape is 
associated with exocytosis of the fusiform vesicles, thus increasing the 
apical surface area of the umbrella cell (Truschel et al. 2002). Upon voiding, 
it is hypothesized that apical membrane added during filling is rapidly 
internalised, replenishing the pool of discoidal vesicles (Truschel et al.
2002). Studies have shown that the volume fraction and numerical density of 
fusiform vesicles are significantly decreased in filled versus voided bladders 
and that they acquire a position just underneath the apical plasma 
membrane in response to increased intravesical pressures (Minsky & 
Chlapowski 1978). Increased amounts of UPIII are found at the cell surface 
of umbrella cells exposed to hydrostatic pressure (Truschel et al. 2002). A 
revised model suggests that bladder filling stimulates both endocytosis and 
exocytosis; endocytosed membrane is delivered to lysosomes whereupon 
contents are degraded (Truschel et al. 2002).
The uroepithelium may communicate bladder fullness to the underlying 
nervous system through a paracrine system involving ATP release (Knight et
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al. 2002). Bladder filling increases hydrostatic pressure, stimulating ATP 
release through an unknown mechanism (Knight et al. 2002). The released 
ATP binds to purinergic P2X3 receptors on afferent nerve processes, 
increasing nerve firing and relaying bladder filling to the central nervous 
system (Burnstock 2001). ATP may also bind to purinergic receptors present 
on the basal/intermediate cells, which stimulate release of ‘secretagogues’ 
that act upon umbrella cells to stimulate vesicle exocytosis (Burnstock
2001).
Very little is known about how BOO affects AUM structure, vesicle dynamics 
and pressure signalling. Studies of obstructed adult human bladders have 
shown an inverse correlation between the expression of UPs and inducible 
nitric oxide synthase (iNOS) (Romih et al. 2003). A study of bladder neck 
specimens form adults with benign prostatic hyperplasia has shown that 
iNOS uptake was localized to areas devoid of an intact AUM. iNOS was not 
expressed in unobstructed bladder urothelium. As nitric oxide (NO), the 
product of iNOS, is a vasodilator, NO may regulate bladder mucosal and 
muscle perfusion, which appears to be inversely related to intravesical 
pressure. An increase in iNOS may be an initial compensatory response to 
overcome the effects of ischaemia generated by BOO (Romih et al. 2003).
In the long term, however, NO could also result in ischaemic damage 
caused by the formation of peroxynitrite and oxygen free radicals (Romih et 
al. 2003).
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Chertin et al. (2004) noted the over-experssion of all forms of nitric oxide 
synthase (iNOS, eNOS and nNOS) in the early phase of bladder obstruction 
(2 weeks in an adult guinea pig model), but whereas iNOS was not 
associated with increased apoptosis, the other two seemed to appear later 
in obstruction (8 weeks) and where more likely to be associated with areas 
of apoptosis (Chertin et al. 2004).
1.6.2 Bladder contractility and the role of the purinergic nervous 
system
The fact that autonomic nonadrenergic, noncholinergic (NANC) nerves may 
play a role in bladder contractility has been known for several years 
(Ambache & Zar 1970, Taira 1972). A NANC component was recognised in 
the autonomic nervous system of smooth muscles from a wide range of 
vertebrate species, and preliminary studies identified purine compounds as 
transmitter candidates (Burnstock 1977). This led to the view that adenosine 
and ATP may be released from NANC nerves, and hence the concept of 
purinergic neurotransmission was proposed (Burnstock 2002). Figure 10 
shows how cholinergic and purinergic nerve stimulation results in detrusor 
contractility. It is widely accepted that there are two major types of purinergic 
receptor: the P1 receptor, which is more responsive to adenosine, and the 
P2 receptor, which is more responsive to ATP. Subsequently, the 
development and use of specific purine nucleotide and nucleoside agonists 
and antagonists helped to characterise two families of P2 purinoreceptors, 
namely P2X ionotropic ligand-gated ion-channel receptors, and P2Y 
metabotropic G-protein-couples receptors (Burnstock 2002). The P2X
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receptor is prominent in contractile smooth muscle cells but is not detectable 
in proliferating smooth muscle cells, in which P2Y receptor expression is 
substantially increased. Stimulation of purinergic nerves with single pulses 
produces hyperpolarisations of up to 25 mV (inhibitory junction potentials) in 
smooth muscle cells. These potentials are unaffected by atropine, 
adrenergic neuron blocking agents or sympathetic denervation, but are 
abolished by tetrodotoxin (Burnstock 2002).
In the normal human bladder, atropine will block at least 95% of 
parasympathetic nerve-mediated contraction, indicating that its innervation is 
predominantly cholinergic: purinergic signalling is responsible for the 
atropine-resistant component of contraction (Burnstock 2002). There are a 
number of examples of the purinergic component of co-transmission 
increasing in pathological conditions. One is that purinergic nerve-mediated 
contraction of the human bladder is increased to 40% in the 
pathophysiological conditions such as interstitial cystitis, BOO, idiopathic 
instability and possibly neurogenic bladder (Burnstock 2002). Purinergic 
signalling also appears to play a role in afferent sensation from the bladder. 
ATP is released from urothelial cells when the bladder is distended. 
Sensory-nerve recording has indicated that P2X receptors are involved in 
mediating the nerve responses to bladder distension, providing 
mechanosensory feedback involving both the micturition reflex and pain. It is 
not yet known whether these findings are also present in the fetal bladder 
(Burnstock 2002).
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1.7 The unifying model of fetal BOO
1.7.2 The long-term (30 days) fetal BOO model
Nyirady et al. (2002) investigated the effect of urethral and urachal 
obstruction initiated at mid-gestation (75 days) and lasting 30 days. This 
long-term fetal BOO resulted in marked hydroureteronephrosis and a floppy, 
hypocontractile bladder (Fig. 11). There was marked growth of the bladder 
(both wet and dry weight were significantly increased) compared to 
unobstructed controls, and a significant increase in both protein and DNA 
content. Obstructed bladders were characterized by a flattened, single cell- 
layer urothelium, an attenuated lamina propria, and a significant 
predominance of connective tissue. Obstructed kidneys showed a 
morphological disruption of the nephrogenic cortex and subcortical cysts 
(Nyirady et al. 2002). An in-situ end-labelling technique (TUNEL) was used 
to assess apoptosis, which was noted to be up-regulated in the obstructed 
detrusor and lamina propria. This was accompanied by a down-regulation of 
the anti-death protein BCL2 and an up-regulation of the pro-death protein 
BAX (Thiruchelvam et al. 2003a). Moreover, activated caspase-3, an 
effector of apoptotic death, was increased in obstructed bladders (Nyirady et 
al. 2002).
Ex-vivo cystometry revealed increased compliance and reduced elasticity in 
the obstructed bladders. Tension-frequency contractility studies showed that 
obstructed bladder strips were significantly hypocontractile in response to 
electrical field stimulation (EFS) and to the carbachol, an acetylcholine 
agonist, a-p methylene-adenosine triphosphate (ABMA), a purinergic
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receptor antagonist and KCI, suggesting that both nerve-induced contractility 
and direct muscle stimulation were reduced. Hypocontractility was more 
pronounced on nerve-stimulation than on direct muscle stimulation, 
suggesting that denervation had a greater role to play than detrusor failure 
per se. This was confirmed on S100 and protein gene product 9.5 (PGP9.5) 
staining. A greater atropine resistance was noted, suggesting that a 
purinergic component may be more prominent as cholinergic nerves are 
failing (Thiruchelvam et al. 2003b).
In summary, 30 days of in-utero BOO resulted in an over-compliant, 
hypocontractile, denervated bladder undergoing active apoptosis of its 
detrusor and lamina propria layers. Kidneys were cystic and nephrogenesis 
disrupted. This picture is very similar to the concept bladder 
decompensation described by Levin et al. (2002) in the mature rabbit model,
i.e. “progressive deterioration in contractility and function (i.e. ability to 
empty), a rapid increase in mass, and a progressive decrease in the volume 
fraction of smooth muscle elements in the bladder wall” giving an end result 
of a “dilated bladder with a thin fibrous wall, high capacity, and little or no 
contractile function” (Levin et al. 2002). This type of bladder is more often 
found in some boys born with PUV who develop a hypocontractile organ 
around puberty (Holmdahl et al. 1996, De Gennaro et al. 2000). The next 
step was to create a model of compensating fetal BOO, i.e. the type of 
bladder found in younger boys born with PUV, then establish a way of 
recognizing the transition between the two states.
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1.7.3 In-utero urodynamics
In-utero urodynamics could potentially be a way of identifying the transition 
from a compensating to a decompensating bladder. De Tayrac et al. (2003) 
carried out “traditional” urodynamics using filling cystometrography, on fetal 
lambs between 87 and 133 days gestation. However, the high fetal death 
rate (87%) and rate of catheter dislodgement and chorioamnionitis 
suggested that this model was less than ideal. Some traces were obtainable 
and revealed a mean resting fetal bladder pressure of 17cm H20  in both 
BOO and control fetuses. Mean voiding pressures were 21cm H20  in control 
and 20cm H20  with BOO. Voids occurred every 16 minutes and lasted for 4 
minutes in control bladders, and every 25 minutes lasting 5 minutes 
following obstruction. There was no significant difference between these 
urodynamic parameters, although instability at end-fill only occurred 
following BOO (de Tayrac et al. 2003). It must be stressed, however, that 
the “control” fetuses in this study were catheterised via their urachus, which 
Gobet et al. (1998) have suggested causes BOO at this gestation.
Ghoniem et al. (1997) published the use of telemetry to monitor 
urodynamics in awake rhesus monkeys, by adapting a system which was 
originally described for monitoring left ventricular diameter and pressure in 
dogs (Patrick et al. 1974). The advantage of radiotelemetered urodynamics 
over ‘traditional’ urodynamics is that it allows bladder pressures to be 
monitored without the use of external catheters so that dislodgement and 
infection, and hence fetal death, may be reduced. Transducers were 
implanted into the primate bladder and abdominal cavity, with all lines
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terminating in a subcutaneous transmitter. Conventional urodynamics were 
performed for comparison and revealed excellent reproducibility (Ghoniem 
et al. 1997). Mills et al. (2000) published the use of radiotelemetered 
cystometry in adult pigs. Radiotelemetered pressure data were validated by 
comparison with filling pressures during bladder distension and 
simultaneous conventional cystometry, and showed a good correlation (Mills 
et al. 2000).
Thiruchelvam et al. (2004) were the first to successfully perform natural-fill 
radiotelemetered cystometry in a fetal model. The radiotelemetry set-up 
involved the use of gel-tipped intravesical and intra-abdominal catheters 
attached to a subcutaneous transmitter. Pressure changes were transmitted 
to a receiver in the sheep pen in the form of radiowaves; the receiver 
digitalises the data, which is then stored in a data acquisition system. Four 
fetal lambs (three at 105 days gestation and one at 75 days gestation) were 
monitored for four weeks, and the findings validated by ex-vivo cystometry. 
Insertion of the intra-abdominal and intravesical catheters was performed via 
an abdominal incision: the tip of the intra-abdominal catheter was 
intraperitoneal in all fetuses. In two of the 105 day fetuses (one male and 
one female), the intravesical catheter was inserted through an incision in the 
bladder wall, whereas in the other two fetuses (both male) the intravesical 
catheter was inserted into the bladder via the urachus. Traces were obtained 
from three animals (one trans-urachal catheter displaced before term). 
Detrusor pressures were derived by calculating the intra-abdominal 
pressure/ intravesical pressure difference. A normal fetal void was
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characterised by a sustained increase in pressure to 10mmHg with 
superimposed high-frequency, low amplitude activity occurring up to three 
times per minute at a maximum voiding pressure of 40mmHg, and lasting 
between 60 and 180 seconds. Discreet detrusor contractions up to 5mmHg, 
labelled “staccato” activity, were also noted in the unobstructed bladder 
(Thiruchelvam et al. 2004). This study confirmed the resilience of the fetal 
ovine model, and the feasibility of this set-up for monitoring in-utero 
cystometry in the ovine model.
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1.8 Hypotheses and aims
My hypotheses were that:
1. Short-term (nine days) partial urethral obstruction and urachal ligation 
in the fetal lamb, initiated at mid-gestation (75 days), would result in a 
thick-walled bladder with preserved compliance and contractility. In 
order to clarify the role of the urachus at this gestation, I also 
hypothesised that urachal ligation alone would result in features of 
BOO. This hypothesis was tested in Protocol 1.
2. In-vivo radiotelemetered cystometry could be performed in the fetal 
ovine model of BOO initiated at 94 days gestation for nine days and 
would identify early-onset bladder dysfunction in the form of high- 
pressure voiding and detrusor overactivity. This hypothesis was 
tested in Protocol 2.
Thus the aim of this project was to:
1. develop the ovine model of short-term BOO (as opposed to the long­
term BOO model investigated by Thiruchelvam et al. (2003)) at an 
early stage of the obstructive pathophysiology, such that it could be 
suitable for subsequent experiments testing a hypothesis of 
reversibility
2. adapt this model to characterise in-utero bladder dysfunction by 
means of in-vivo radiotelemetered cystometry
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Table 1.0. Mesonephric and metanephric development as a percentage of 
gestation.
(Adapted from Moritz and Wintour 1999).
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Figure 1. Post-mortem appearance of urinary tract associated with 
posterior urethral valves.
Note bilateral hydroureteronephrosis and thick-walled bladder associated 
with dilated posterior urethra.
(http://medic.med.uth.tmc.edu)
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Figure 2 A. Schematic transverse section through the 50 hour chick 
embryo showing the pronephric tubule.
Note that the coelom opens into the pronephric tubule via a nephrostome 
(literally "kidney mouth").
Developmental Biology Online (www.uoguelph.ca)
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Figure 2 B. Schematic representation of the mesonephric duct in the 
chick embryo.
The medial end of the mesonephric duct has expanded and invaginated into 
itself to form Bowman's capsule.
Developmental Biology Online (www.uoguelph.ca)
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Figure 3 A. Schematic representation showing the location of 
mesonephros and metanephros. B. Metanephric diverticulum (ureteric 
bud), coming off the mesonephric duct, and the developing 
metanephros.
Developmental Biology Online (www.uoguelph.ca)
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Figure 4. Development of the metanephros into the adult kidney.
(Top right) The dotted outline represents the embryo's body. The ureter 
elongates and becomes separate from the mesonephric tubule. (Anti­
clockwise) Note the increasing branching and complexity of the ureteric bud 
as it forms the collecting ducts within the medulla of the kidney. 
Developmental Biology Online (www.uoguelph.ca)
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Figure 5. Infant with prune-belly syndrome: note lax abdominal wall 
and undescended testicles.
(http://www.emedicine.com/)
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Figure 6A. Ultrasound appearance of dilated bladder and posterior 
urethra (arrow), giving a “key-hole” appearance 
(www.thefetus.net/)
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Figure 6B. Micturating cysrourethrogram performed via a supra-pubic 
catheter (SPC).
Note dilated bladder (B) and ureter (U), and posterior urethra (PU) proximal 
to the site of obstruction (O). Distal to the valvular obstruction, the anterior 
urethra (AU) is of normal calibre. (Image courtesy of Mr P Cuckow).
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Figure 7. Comparison of periods of gestation and nephrogenesis in 
various animal models and the human.
(Adapted from Matsell & Tarantal 2002)
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Figure 10. Signal pathways involved in activation of detrusor 
contraction via the cholinergic (left pathway) and purinergic (right 
pathway) nervous systems. Acetylcholine (Ach) released at the 
neuromuscular junction activates the muscarinic M3 receptor wich is 
coupled to a G-protein; in turn the activated phospholipase C (PLC) triggers 
inositol triphsphate (IP3) to release calcium from the sarcoplasmic reticulum 
and hence precipitate contractile coupling. PLC may also activate 
diacylglycerol (DAG) which results in the opening of non-specific ion 
channels, allowing influx of calcium into the cell. Alternatively, adenosine 
triphosphate (ATP) may activate the purinergic P2x receptor, a ligand-gated 
cation channel that promotes influx of extracellular calcium and hence 
calmodulin activation as before. Adapted from Fry and Wu 1998.
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Figure 11. Comparison of sham and obstructed fetal lamb urinary 
tracts after 30 days urethral and urachal occlusion initiated at 75 days 
gestation.
Inset shows a cross-section through the hydronephrotic kidneys. Key: K, 
kidney; Ur, ureter; Ura, urachus; B, bladder; U, urethra.
(Thiruchelvam et al. 2003)
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TABLE 1.1 
FETAL SHEEP 
BOO MODEL 
(145 days 
gestation)
Publica
tion
year
Location Number
studied
Gestational 
age at BOO
Method of BOO Gestatio 
nal age 
at
analysis
Bladder findings Kidney/Lung findings
Tanagho
(Tanagho
1972a,
Tanagho
1972b)
1972 San
Francisco,
USA
N/A 70-75 days Silastic tubing 
occluding urethra 
(partial)
Term Urethral obstruction 
became complete as 
the fetus grew but 
bladder decompressed 
via a urachal fistula
Harrison,
Ross, Noail, de 
Lorim ier 
(Harrison et al. 
1983)
1983 San
Francisco,
USA
5 complete 
BOO, 8 partial 
BOO
99-108 days Urethra was either 
ligated, or partially 
occluded with 3mm 
ameroid constrictor or 
intermittently occluded 
with balloon-cuff 
occluder. Urachus 
ligated.
Term Complete BOO: 
massive
hydroureteronephrosis 
and pulmonary 
hypoplasia, all died 
Kidneys showed 
thinning of cortex and 
medulla with fibrosis; no 
cyst formation or 
parenchymal 
disorganization 
Partial BOO: 
hydroureteronephrosis 
and pulmonary 
hypoplasia, 4 survived 
Intermittent BOO: 
model failed due to 
inconsistent degree of 
obstruction
Harrison, 
Nakayama, 
Noall, de 
Lorim ier 
(Harrison et al. 
1982)
1982 San
Francisco,
USA
17 BOO of 
which 9 were 
decompressed
93-107 days Urethra occluded with 
ameroid constrictor 
(partial) and urachus 
ligated;
decompression via 
suprapubic cutaneous
Term 4 BOO survived to term 
with respiratory 
insufficiency and severe 
hydroureteronephrosis 
but no cystic dysplastic 
changes
cystostomy 7 diverted lambs 
survived to term with 
less respiratory 
insufficiency; 
hydronephrosis had 
resolved significantly
Adzick, 
Harrison, 
Glick, Flake 
(Adzick et al. 
1985)
1985 San
Francisco,
USA
8 BOO, 9 BOO 
+ cystostomy 
and 8 controls
95-105 days, 
suprapubic 
cystostomy 3 
weeks later
Silastic tubing 
occluding urethra 
(partial) and urachus 
ligated
Term 4 BOO stillborn, other 
4 had respiratory 
insufficiency due to 
hypoplastic lungs, only 
1 survived
7 decompressed lambs 
survived, lung weight 
significantly better 
Bilateral
hydroureteronephrosis 
but no cystic dysplastic 
changes in BOO lambs; 
hydronephrosis had 
resolved in 
decompressed lambs
Peters, Carr, 
Lais, Retik, 
Mandell 
(Peters et al. 
1992a)
1992 Boston,
USA
11 BOO, 4 
bilateral and 8 
unilateral 
ureteral 
obstruction
55-60 days Ureter or urethra and 
urachus occluded with 
surgical clip
Term All kidneys were 
hydronephrotic; most 
kidneys did not show 
gross cystic changes 
but diffuse thinning with 
normal glomeruli and 
tubular dilatation on 
section. Inc urine 
sodium and normal 
osmolality in BOO 
group, no change in 
ureteral obstruction 
group
2 BOO, 2 bilateral
92
ureteral and 1 unilateral 
ureteral obstruction 
kidneys showed cystic 
changes with distortion 
of renal parenchyma 
Dysgenetic kidneys with 
structural
disorganization was 
only seen in ureteral 
obstruction groups; 
urine chemistry 
significantly altered
Peters, 
Vasavada, 
Dator, Carr, 
Shapiro, 
Lepor, 
McDonnell, 
Retik, Mandell 
(Peters et al. 
1992b)
1992 Boston,
USA
Unclear as not 
all animals 
were analysed
60 days Surgical clip occluding 
urethra (complete), 
urachus ligated
Term Distended thick-walled 
bladders, intact muscle 
bundles,
Bladder weight 
increased x4.6 and 
muscle mass x5.8 due 
to hypertrophy (inc 
protein:DNA ratio) 
Muscurinic receptor 
increase x3.2 
Reduced compliance
Hydroureteronephrosis
Karim,
Cendron,
Mostwin,
Gearhart
(Karim et al.
1993)
1993 Baltimore,
USA
9 BOO and 6 
controls
90-100 days 6mm silver ring 
(partial), urachus 
ligated
Term Thickened bladder wall 
Significant increase in 
bladder weigh (x2.7), 
DNA content (x2.0), 
and cholinergic nerve 
density; no change in 
protein:DNA ratio
No hydronephrosis
Bogaert,
Gluckman,
Mevorach,
Kogan
(Bogaert et al.
1995 San
Francisco,
USA
10 BOO and 8 
controls
BOO at 90 
days, 
vascular 
catheters and 
left renal
Urethra ligated and 
urachus catheterised, 
allowing urine 
drainage into amniotic 
cavity
120-125
days
Bilateral
hydroureteronephrosis 
in all lambs
Higher renal blood flow, 
increase GFR and urine
93
1995) artery flow 
transducer at 
108 days
volume after BOO, no 
change in sodium 
excretion
Normal architecture but 
thinned cortex
Gobet, 
Bleakley, 
Peters (Gobet 
etal. 1998)
1998 Boston,
USA
8 male and 4 
female BOO
95 days Urachus only clipped 109
days (3 
male), 
116 
days (1 
male) 
and term 
(4 male, 
4
female)
7/8 males but no 
females developed 
hydroureteronephrosis 
Significant increase in 
bladder weight in males 
only
Cortical thinning and 
loss of medullary tissue 
in males, overall renal 
architecture preserved
Gobet, Park, 
Nguyen, 
Chang, Cisek, 
Peters (Gobet 
etal. 1999)
1999 Boston,
USA
12 BOO, 19 
controls
95 days Urethra occluded by 
surgical clip 
(complete) and 
urachus ligated
109 
days 
(n=6) 
and term 
(n=6)
Increased rennin mRNA 
(x2.5), angiotensin-2 
mRNA (x4.0) and 
tumour necrosis factor­
ial expression at 109 
days
Gobet, 
Bleakley 
Cisek, Kaefer, 
Moses, 
Fernandez, 
Peters (Gobet 
etal. 1999)
1999 Boston,
USA
33 BOO, 24 
controls
95 days 2mm gold ring 
(partial) and urachus 
ligated
109
days,
116 
days 
and term
Hydronephrosis, 
distorted nephrogenic 
blastema
Interstitial fibrosis noted 
2 weeks post BOO: 
increased extracellular 
matrix volume fraction, 
increased total collagen 
content and 
collagen:DNA content 
Altered proteolytic 
balance (increased 
metalloproteinase-1 
activity which degrades
94
tissue)
Increased urine sodium 
but no change in urine 
osmolality
Kitagawa, 
Pringle, Stone, 
Nakada, 
Kawaguchi, 
Nakada, 
Wakisaka, 
Furuta, Koike, 
Seki (Kitagawa 
et al. 1999)
1999 Kawasaki, 
Japan and 
Wellington, 
New 
Zealand
10 female BOO 60 (n=3) and 
90 (n=7) 
days
Silastic tubing tied 
around urethra and 
urachus ligated
Term 7/10 hydronephrosis 
90 day model: renal 
architecture maintained, 
thinned cortex, no 
cysts, no change in 
glomerular count 
60 day model: multiple 
small cortical cysts, 
tubular cysts with 
fibromuscular cuffing 
Inc urinary sodium and 
chloride at 90 days
Kitagawa, 
Pringle, 
Zuccollo, 
Koike, Nakada 
(Kitagawa et 
al. 2001)
2001 Kawasaki, 
Japan and 
Wellington, 
New 
Zealand
2 BOO and 1 
VUJO at 50 
days; and 9 
BOO and 9 
VUJO at 60 
days
50-60 days Urethra and urachus 
or ureter ligated with 
silastic tubing 
(complete)
Term Three types of renal 
dysplasia identified: 
Type A following any 
obstruction at 50 days: 
small kidneys, no cysts, 
paucity of nephrons 
(arrested 
nephrogenesis)
Type B following BOO 
at 60 days: large 
kidneys with large 
cysts, fibromuscular 
cuffing -  positive 
keratin staining 
suggesting distal 
tubular/ collecting duct 
origin
Type C following VUJO 
at 60 days: multiple
95
small cysts, keratin 
negative, proximal 
tubular origin
Levin, 
Macarak, 
Howard, 
Horan, Kogan 
(Levin ef al. 
2001)
2001 New York 
and
Philadelphi 
a, USA
Not mentioned 90 days 3mm ring around 
urethra (partial) and 
8Fr feeding tube via 
urachus
93-95
days
Bladder strips 
subjected to EFS 
showed biphasic 
contraction with 
reduced response at 5 
days; no significant 
difference in response 
to carbachol, ATP and 
KCL
Edouga,
Hugueny,
Gasser,
Brussieres,
Laborde
(Edouga et al.
2001)
2001 Paris,
France
11 BOO only, 5 
BOO and V-A 
shunting, 37 
controls
BOO at 60 
days, V-A 
shunting at 
90 days
Urethra and urachus 
occluded by surgical 
clip (complete)
120
days
Control fetal histology 
at 50 days showed 
cortical comma- and S- 
shaped bodies 
surrounded by 
undifferentiated 
mesenchymal tissue; 
renal cortex became 
organized in three 
layers from 60 days. 
Following BOO, tubular 
and glomerular 
microcysts seen in 7 
cases, renal dysplasia 
in 4 cases, subcapsular 
cysts with distortion in 3 
cases.
Significant reduction in 
glomerular number 
(20% less at 90 days 
and 25% at 120 days) 
No change in plasma 
sodium, potassium,
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creatinine, urea; 
creatinine clearance 
significantly lower and 
sodium excretion higher 
following BOO 
Renal morphology in 
shunted fetuses nearly 
normal, only residual 
hydronephrosis but no 
cysts seen 
Glomerular count 
higher than non­
shunted group (5% less 
at 120 days)
No significant difference 
in plasma values or 
creatinine clearance 
and sodium excretion
De Tayrac, 
Cuckow, 
Devlieger, 
Deprest, 
Bogaert, Ville 
(de Tayrac ef 
al. 2003)
2002 London,
UK;
Leuven, 
Belgium 
and Poissy, 
France
9 urachal 
occlusion and 2 
BOO
87 days 11 with 5 Fr urachal 
catheter only; 3 also 
had urethral ring 
(partial)
133
days
Fetal urodynamic 
studies via natural fill 
cystometry were 
performed weekly 
under ultrasound 
monitoring 
Resting bladder 
pressure was 
14.5cmH20
Mean voiding pressure 
was 23.0cmH20 
Voiding occurred every 
19mins and lasted 
4.2mins
Voiding pattern was 
biphasic and 
superimposed by 
regular low-level
Hydroureteronephrosis 
and post-void residuals 
noted in all fetuses 
(mild in 7 
“unobstructed”)
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contractions 
There was no 
difference between 
groups
Nyirady, 
Thiruchelvam, 
Fry, Godley, 
Winyard, 
Peebles,
Woolf, Cuckow 
(Nyirady et al. 
2002)
2002 London,
UK
8 BOO and 8 
controls
75 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
ligated
105
days
Dilated, thin-walled 
bladder; increased 
bladder weight (x4.0) 
Hypocontractile bladder 
strips in response to 
EFS, carbachol, KCL 
and apMADP 
Reduced innervation on 
PGP 9.5 and S100 
staining
Increased compliance 
and capacity on ex-vivo 
cystometry
Progressive 
hydroureteronephrosis 
on ultrasonography 
Disruption of 
nephrogenic zone, 
cystic, dilated tubules 
and loss of normal 
glomerular formation
Thiruchelvam, 
Wu, David, 
2003Woolf, 
Cuckow, Fry 
(Thiruchelvam 
ef al. 2003c)
2003 London,
UK
5 BOO and 5 
controls
75 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
ligated
105
days
Increased bladder 
compliance and 
reduced wall stress 
Muscarinic, purinergic 
and nitrergic 
mechanisms present 
Greater
hypocontractility with 
EFS versus carbachol, 
suggesting denervation 
Greater atropine 
resistance suggesting 
purinergic component
Thiruchelvam, 
Nyirady, 
Peebles, Fry, 
Cuckow, W oolf 
(Thiruchelvam
2003 London,
UK
11 BOO and 11 
controls
75 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
ligated
105
days
Increased bladder 
weight, protein and 
DNA content 
Upregulation of 
apoptosis in detrusor
Progressive 
hydroureteronephrosis 
on ultrasonography
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et al. 2003a) and lamina propria; 
downregulation of anti­
death protein Bcl-2 and 
upregulation of pro­
death protein Bax 
Inc in caspase-3, 
effector of apoptosis 
No difference in 
proliferative index 
between groups on 
PCNA staining
Kitagawa, 
Pringle, Koike, 
Zuccollo, Seki, 
Fugiwaki,
Sato, Nagae, 
Nakada
2003 Kawasaki, 
Japan and 
Wellington 
New 
Zealand
31 BOO and 8 
controls
60 days Urethra and urachus 
ligated with silastic 
tubing (complete)
80-90
days
Kidneys had large cysts 
in 8 lambs, small cysts 
in 17 and no cysts in 6; 
25 kidneys showed 
early dysplastic 
changes
Thiruchelvam,
Godley,
Farrugia,
Cuckow
(Thiruchelvam
et al. 2004)
2004 London,
UK
2 urachal 
catheterization, 
2 trans-vesical 
catheterization
105 days 
(n=3) and 75 
days (n=1)
Urodynamic catheter 
through urachus or 
bladder wall
Term Voiding pattern 
recognized as 
sustained increase in 
intravesical pressure 
with superimpose high 
frequency low 
amplitude activity; 
“staccato” activity; short 
phasic increase in 
pressure before and 
after voiding 
Urachal catheter at 75 
days: voids per hour 
decreased from 4.0 to 
2.0 and duration 
increased from 25 to 
135s
Transvesical group:
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Voids per hour 
decreased from 3.0 to 
1.5, duration of voids 
increased from 60 to 
100s
Sato, 
Kitagawa, 
Pringle, Koike, 
Zuccollo, 
Robinson, 
Wakisaka, 
Seki, Nakada 
(Sato ef al. 
2004)
2004 Kawasaki, 
Japan and 
Wellington 
New 
Zealand
15 BOO of 
which 13 
shunted but 
only 3 
successful
BOO at 60 
days,
vesicostomy 
at 81 days
Urethra and urachus 
ligated with silastic 
tubing (complete)
Term Control BOO bladders 
had dense subepithelial 
fibrosis and muscular 
thickening which were 
not improved by 
shunting
Kitagawa, 
Pringle, Koike, 
Zuccollo, Sato, 
Sato, Fujiwaki, 
Odanaka, 
Nakada 
(Kitagawa et 
al. 2004)
2004 Kawasaki, 
Japan and 
Wellington 
New 
Zealand
15 BOO 60 days Urethra and urachus 
ligated with silastic 
tubing (complete)
62/63/65
/
67 days
Hydronephrosis noted 
from 2 days post-BOO 
Kidneys showed 
extensive acute tubular 
necrosis (ATN)-like 
tubular damage; 
glomerular cysts were 
noted in 13 kidneys. 
Dysplastic changes not 
seen.
No glomerular cysts 
noted at 2 days, cystic 
changes in glomeruli 
and tubules noted at 5 
days and glomerular 
dilatation evident at 7 
days
Kitagawa, 
Pringle, Koike, 
Zuccollo, Seki, 
Wakisaka,
2006 Kawasaki, 
Japan and 
Wellington 
New
11 BOO and 
shunt, 5 BOO 
controls
BOO at 60 
days;
Vesicostomy
or
Urethra and urachus 
ligated with silastic 
tubing (complete)
Term Shunted bladders had 
reduced compliance 
compared to BOO 
alone; shunted bladder
2 shunted kidneys were 
small with reduced 
glomeruli and normal 
tubules; 3 had cystic
100
Sato, Sato, 
Nagae, Nakada 
(Kitagawa et 
al. 2006)
Zealand urethrostomy 
at 81 days
walls were thickened 
with dense fibrosis 
extending from the 
submucosal to 
muscular layers, a 
feature not present in 
BOO bladders
dysplastic kidneys; 6 
had normal fetal renal 
histology with 
macroscopic pelvic 
dilatation. BOO kidneys 
were cystic dysplastic.
Samnakay, 
Orford, Barker, 
Charles, terry, 
Newham, Moss 
(Samnakay N 
etal. 2006)
2006 Subiaco,
Australia
33 BOO, 29 
controls
70 days Urethra and urachus 
ligated with prolene tie 
(complete)
Fetal 
kidneys 
sampled 
at 72,
75, 80, 
90 and 
100 
days
Hydronephrosis in all 
BOO animals 
Glomerular cysts were 
evident from day 2 
post-BOO and 
progressed to cystic 
renal dysplasia with 
disordered architecture 
by day 20
Upregulation of pro­
death Bax relative to 
anti-death Bcl-2 
Tubular apoptosis 
peaked at 2 days; 
glomerular apoptosis 
was rare
Farrugia,
Long, Godley, 
Peebles, Fry, 
Cuckow, Woolf 
(Farrugia et al. 
2006a)
2006 London,
UK
4 urachal 
ligation only, 6 
BOO and 4 
controls
75 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
ligated
84 days Increase in bladder 
weight (x5 in urachal 
group and x3 in BOO 
group) and bladder wall 
thickness, no change in 
protein:DNA ratio 
Bladder wall 
architecture preserved 
Increased urothelial 
apoptosis in urachal 
ligation and BOO 
groups
Hydroureteronephrosis 
in both urachal alone 
and complete bladder 
obstruction. No change 
in urine sodium and 
osmolality 
2 kidneys in urachal 
ligation group and 2 in 
BOO group showed 
cortical cysts and 
medullary tubular 
dilatation
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Farrugia, 
Godley, Woolf, 
Peebles, 
Cuckow, Fry 
(Farrugia et al. 
2006b)
2006 London,
UK
4 urachal 
ligation only, 6 
BOO and 4 
controls
75 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
ligated
84 days Increase in bladder 
weight, wall thickness 
and capacity in both 
obstructed groups 
No significant 
difference in 
compliance and wall 
stress
Contractions blocked 
by TTX hence nerve- 
mediated
Bladder overgrowth did 
not result in contractile 
failure
No difference in 
innervation
Hydroureteronephrosis 
in both obstructed 
groups
Wu,
Thiruchelvam, 
Sui, Woolf, 
Cuckow, Fry 
(Wu et al. 
2007)
2007 London,
UK
7 BOO and 11 
controls
75 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
ligated
105
days
Looked into intracellular 
calcium regulation by 
examining the Ca2+ 
response to agonists in 
detrusor
No difference between 
resting intracellular 
calcium but role in 
down-regulation of 
muscarinic and 
purinergic pathways 
following BOO
Farrugia, 
Woolf, Fry, 
Peebles, 
Cuckow, 
Godley
(Farrugia et al. 
2007)
2007 London,
UK
4 BOO and 5 
controls
94 days 3mm silver ring 
occluding urethra 
(partial) and urachus 
occluded by 
urodynamics catheter
103
days
In-vivo fetal 
urodynamics showed 
resting bladder 
pressure of 5-10mmHg 
with initial voiding 
pressure of lOmmHg 
rising to 25mmHg by 3
Hydroureteronephrosis 
in BOO group 
V* obstructed pairs of 
kidneys showed cortical 
cysts but renal 
architecture well 
preserved
102
days post BOO 
Voids characterised by 
sustained rise in 
pressure with 
superimposed high 
frequency low 
amplitude contractions, 
and became more 
frequent and prolonged 
with time
Detrusor overactivity 
became more prevalent 
with length of 
obstruction 
No significant 
difference in 
compliance__________
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TABLE 1.2 
RABBIT BOO 
MODEL (31 
days
gestation)
Publicati 
on year
Location Number
studied
Age at 
BOO
Method of BOO Age at 
analysis
Bladder findings Kidney/Lung findings
Rohrmann,
Levin,
Duckett,
Zderic
(Rohrmann et 
al. 1996)
1996 Philadelphia,
USA
4 animals per 
group and 4 
controls
Mature Urethra catheterized 
with 8Fr catheter and 
tied with silk ligature
1, 7, 14 
and 28 
days post­
obstruction
Increased bladder 
weight, reduced 
maximal cholinergic 
response 
Contractility at 28 
days significantly 
reduced, 
suggesting 
decompensation
Rohrmann,
Zderic,
Duckett,
Levin,
Damaser
(Rohrmann et
al. 1997)
1997 Philadelphia,
USA
8 BOO and 7 
controls
23 days 
gestation
Urethra ligated with 
silk ligature
30 days 
gestation
Increased bladder 
weight and capacity 
after BOO, no 
difference in 
stretch-strain 
patterns, increased 
compliance in BOO 
bladders
Spontaneous slow, 
large amplitude 
contractions on 
filling in both 
groups
Removal of calcium 
from organ bath 
abolished 
spontaneous 
contractions during 
filling but did not 
change baseline
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pressures or force 
values
Geloso, Levin 
(Geloso & 
Levin 1998)
1998 Albany, USA 12 BOO and 12 
controls
Mature Urethra catheterized 
then ligated with silk
14 days 
post-BOO
Significantly 
reduced response 
to EFS after BOO, 
but increased 
response in the 
presence of TTX, 
unaffected by 
addition of atropine 
or ATP suggesting 
that BOO 
decreased 
neurogenic 
response but 
increased
myogenic response
Gotoh,
Masuzaki,
Taguri,
Yoshimura,
Ishimaru
(Gotoh et al.
1998)
1998 Nagasaki,
Japan
36 BOO and 10 
controls; 3 
fetuses
decompressed 
on days 1 and 
3
25 days 
gestation
Urethra ligated with 
nylon
Fetuses 
studied on 
days
1,2,3,4 and 
5 post- 
BOO or 5 
days post- 
decompres 
sion
Bilateral
hydroureteronephrosis 
from day 1
Flypoplastic cortex and 
medulla but no 
dysplasia
Renal nephrogenic and 
glomerular counts 
lower after 2 days BOO 
Significant increase in 
urine microalbumin on 
day 1 vs day 3 post- 
BOO; no change in 
urine (32 microglobulin,
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Na, Cl and osmolality 
Mild tubular dilatation 
but less cortical and 
medullary hypoplasia 
and better glomerular 
counts seen in 
decompressed kidneys
Gosling, 
Kung, Dixon, 
Horan, 
Whitbeck, 
Levin
(Gosling et al. 
2000)
2000 Albany, USA 28 BOO and 4 
controls
Mature Urethra catheterized 
then ligated with silk
7,14,28 
and 70 
days post- 
BOO
Bladder mass 
increased rapidly 
during first 7 days, 
was constant for 
next 7 days then 
gradually increased 
Decrease in 
contractile 
response to EFS 
greater than 
decreased 
response to 
carbachol
Smooth muscle cell 
hypertrophy and 
axonal
degeneration at 7 
days, becoming 
more extensive 
with BOO
Lieb,
Chichester, 
Kogan, Das, 
Leggett, 
Schroder, 
Levin (Lieb et 
al. 2000)
2000 Albany, USA 20 BOO and 10 
controls
Mature Silk ligature tied 
loosely around 
vesical outlet and 
catheter removed
Left
femoral
artery and
right
carotid
artery
cannulated
and rabbits
Rapid increase in 
bladder weight and 
capacity post-BOO 
Mucosal blood flow 
4x greater than that 
of detrusor, more 
so following BOO 
with a peak 1 day
No difference in renal 
blood flow
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studied at 4 
hours, 1, 3 
and 7 days 
post-BOO
post-BOO 
Blood flow in BOO 
bladders returned 
to control values at 
3 days remaining 
constant for 7 days
Schroder, 
Uvelius, 
Capello, 
Longhurst 
(Schroder et 
al. 2002)
2002 Albany, USA 10 BOO and 4 
controls
Mature Urethra ligated with 
silk
Cystometry 
performed 
pre- and 
post­
obstruction 
for 2 weeks
Increased bladder 
weight and post­
void residual, no 
change in 
compliance 
After BOO, bladder 
elongated in long 
axis
Reduced
contractile respose 
to EFS, ATP, 
carbachol and KCI
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TABLE 1.3 
RODENT BOO 
MODEL 
(Mouse 18 
day gestation, 
rat 22 day 
gestation)
Publicat 
ion year
Location Number
studied
Age at BOO Method of BOO Age at 
analysis
Bladder findings Kidney/Lu
ng
findings
Uvelius, 
Persson, 
Mattiasson 
(Uvelius etal. 
1984)
1984 Lund,
Sweden
Not
mentioned
Mature 
Sprague- 
Dawley rats
Urethra ligated 6 weeks 
and 4 
months 
post-BOO
Bladder muscle mass increased 
up to 6 weeks post-BOO but 
stabilizes thereafter, due to 
both hypertrophy and 
hyperplasia
Increased total collagen
Lindner,
Mattiasson,
Persson,
Uvelius
(Lindner et al.
1988)
1988 Lund,
Sweden
Not
mentioned
Mature 
Sprague- 
Dawley rats
Urethra ligated 10 days
and 6
weeks
post-BOO,
or 2,4 or 6
weeks
post-
decompres
sion
Increase in detrusor weight 
after 10 days and 6 weeks BOO 
Decompression caused 
reduction in weight up to 4 
weeks post-decompression but 
not thereafter, weight did not 
return to control values 
DNA and RNA concentration 
increased in both BOO groups 
and decreased post­
decompression up to 2 weeks 
Muscle cell hypertrophy 
reversed post-decompression
Sutherland,
Baskin,
Kogan, Cunha 
(Sutherland et 
al. 1998)
1998 San
Francisco,
USA
48 BOO and 
18 controls
Mature 
Fischer rats
Urethra occluded by 
ligating over 20G 
angiocatheter
1,2 and 4
weeks
post-BOO
6-7x increase in bladder volume 
and weight, smooth muscle 
hypertrophy
Increased bladder capacity and 
voiding pressures post-BOO 
Diminished AChE-positive 
fibres within muscle bundles 
and adrenergic staining in the 
bladder neck after BOO
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PGP nerve staining inc 
minimally after BOO 
NADPH staining was similar in 
both groups
Lemack, 
Burkhard, 
Zimmern, 
McConnell, 
Lin (Lemack 
et al. 1999)
1999 Dallas, USA Mature wild 
type mice
Urethra occluded by 
ligating over 22G 
angiocatheter
1,3 and 5
weeks
post-BOO
Increased bladder weight and 
capacity, decreased cholinergic 
response at 5 weeks 
iNOS present in 70% of 
bladders obstructed for 1 and 3 
weeks but in 50% of controls 
Enhanced iNOS expression 
may improve oxygenation 
during obstruction-induced 
ischaemia
Kim, Seo, 
Park, Hwang 
(Chul etal. 
2001)
2001 Seoul, Korea 15 mild BOO, 
15 severe 
BOO and 10 
controls
Mature 
Sprague- 
Dawley rats
Severe: ligature tied 
loosely around 
catheter in urethra; 
Mild: ligature 
surrounding two 
catheters and one 
removed
2 weeks 
post-BOO
Bladder weight increased in 
both BOO groups 
Contractility to EFS inc after 
mild BOO and decreased after 
severe BOO
Inc in TGF-j31 expression after 
severe BOO only
Felsen, 
Dardashti, 
Ostad, Lemer, 
Gross, Chen, 
Vaughan, 
Poppas 
(Felsen ef al. 
2003)
2003 New York, 
USA
21 BOO and
22 controls
Mature 
Sprague- 
Dawley rats
2mm jeweller jump 
ring around urethra
2 weeks 
post-BOO
BOO induced iNOS mRNA 
expression
iNOS-/- mice showed reduced 
volume at 3weeks 
iNOS inhibition attenuated 
increase in bladder size, 
spontaneous contractions and 
bladder fibrosis after BOO
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TABLE 1.4 
PRIMATE BOO 
MODEL (165 
days
gestation)
Publica
tion
year
Location Number
studied
Gestation at 
BOO
Method o f BOO Gestation 
at analysis
Bladder
findings
Kidney/Lung findings
Tarantal, Han, 
Cochrum, 
Mok, DaSilva, 
Matsell
(Tarantal etal. 
2001)
2001 California, 
USA and 
Ontario, 
Canada
13 unilateral 
PUJO
(contralateral 
kidney control)
Early: 70, 80 
or 90 
(second 
trimester) 
and late: 100 
or 120 (third 
trimester) 
days 
gestation
Ultrasound-guided 
injection of alginate 
spheres
90, 120, 
140 or 150 
days 
gestation
Obstructed kidneys smaller 
than contralateral side 
Cortical cysts derived from 
glomeruli and collecting ducts 
with disruption of normal 
glomerular development worse 
with early than late PUJO but 
no dysplasia after 120 days 
obstruction
Cortical and medullary 
interstitial expansion with 
pericystic and peritubular 
fibromuscular cuff formation 
Apoptosis in obstructed kidneys 
present in cystic glomeruli; 
tubular apoptosis more 
pronounced after PUJO
Matsell, Mok, 
Tarantal 
(Matsell et al. 
2002)
2002 California, 
USA and 
Ontario, 
Canada
13 unilateral 
PUJO
(contralateral 
kidney control)
75 days Ultrasound-guided 
injection of alginate 
spheres
90, 120, 
140 or 150 
days 
gestation
Ureteric duct branching 
evaluated with CK-IR and DB 
lectin staining -  reduced 
expression in outer cortex 
following PUJO 
Significant reduction in 
glomerular number at 150 days; 
contralateral kidneys displayed 
fewer glomeruli and ureteric 
duct area than controls
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TABLE 1.5 
PIG BOO 
MODEL (113 
days gestation)
Public
ation
year
Location Number
studied
Age at 
BOO
Method of 
BOO
Age at 
analysis
Bladder findings Kidney/
Lung
findings
Speakman, 
Brading, Gilpin, 
Dixon, Gilpin, 
Gosling 
(Speakman et 
al. 1987)
1987 Oxford, UK 22 BOO, 8 
controls
"Recently
weaned"
6mm Q- 
shaped silver 
ring
occluding
urethra
Urodynamic 
studies ad 
bladder biopsy 
performed at 6 
weeks, 3,6 and 
12 months
Increased voiding pressures and bladder 
instability after BOO, controls did not have 
instability
Increased contractile responsiveness to 
carbachol and acetylcholine after BOO, 
suggesting supersensitvity
Nielsen,
Andersen,
Petersen,
Oxlund,
Nordling
(Nielsen et al.
1995)
1995 Aarhus,
Denmark
9 BOO, 2 
controls
156 days 6mm Q- 
shaped teflon 
ring
occluding 
urethra after 
bladder wall 
biopsy
Ring removed 
60 days post- 
BOO
6x increase in bladder weight, 3x increase 
in smooth muscle number, 2.5x increase 
in smooth muscle cell size, no difference 
in muscle and connective tissue 
proportions, 8x increaes in collage 
content, increase in collagen l.lll ratio 
All changes incompletely reversed after 
recovery, except smooth muscle cell 
number and collagen l:lll ratio
Kok,
Wolffenbuttel, 
Minekus, 
Mastrigt, 
Nijman (Kok et 
al. 2000)
2000 Rotterdam,
the
Netherlands
34 BOO 
and 6 
controls
3-4 weeks 6mm Q- 
shaped silver 
ring
occluding
urethra
Pressure flow 
studies 
performed 
before BOO 
and weekly; 
animals studied 
at weeks 
1,2,3,4,5,6,8,10 
post-BOO
Bladder contractility increased strongly 
during first 3 weeks, reached plateau 
weeks 4-7, then decreased 
Compliance decreased progressively from 
week 1
Mills, Noble, 
Brading (Mills 
et al. 2000)
2000 Oxford, UK 22
unobstruct
ed
Mature Dual pressure 
radiotelemetry 
device
implanted for 3 
months
Pressure data validated by comparison 
with conventional cystometry
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Olsen, 2001 Aarhus, 11 second 61 days Urachus Conventional At mid-term, fetuses dribbled continuously
Dalmose, Denmark trimester, and 80 catheterized urodynamics with 1-5 detrusor contractions per minute
Swindle, 11 third days with double­ performed for and maximum flow 1.2ml/min, fill pressure
Jorgensen, trimester lumen 241 minutes 2-6cmH20
Djurhuus urodynamics Third trimester pressure increased to
(Olsen et al. catheter, mean 5.5cmH20 up to 21cmH20
2001) urethra
unoccluded
“staccato” flows 0.2ml/min 
2-6 voids per minute
112
2. MATERIALS AND METHODS
The aim of Protocol 1 was to develop the ovine model of short-term BOO at 
an early stage of the obstructive pathophysiology, such that it could be 
suitable for subsequent experiments testing a hypothesis of reversibility. My 
hypothesis was that short-term (nine days) partial urethral obstruction and 
urachal ligation in the fetal lamb, initiated at mid-gestation (75 days), would 
result in a thick-walled bladder with preserved compliance and contractility, 
suggesting a stage of bladder compensation. In order to clarify the role of 
the urachus at this gestation, I also hypothesised that urachal ligation alone 
would result in features of BOO.
The aim of Protocol 2 was to adapt this model in order to study in-utero 
radiotelemetered urodynamics on the obstructed fetal bladder. I 
hypothesised that in-vivo radiotelemetered cystometry could be performed in 
the fetal ovine model of BOO initiated at 94 days gestation for nine days and 
would identify early-onset bladder dysfunction in the form of high-pressure 
voiding and detrusor overactivity.
2.1 Study design
Experiments were conducted in accordance with the Home Office Animals 
Act (Scientific Procedures) 1986. Protocols 1 and 2 are summarised in 
Figures 12 A and B. In the section that follows, autopsy, ex-vivo cystometry, 
in-vitro contractility studies and histology were performed in both protocols 
and hence only described once. Protein and DNA estimation was only
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carried out in Protocol 1, whereas in-vivo radiotelemetered cystometry was 
only performed in Protocol 2.
2.2 Protocol 1: Fetal BOO from 75 days gestation
2.2.1 Animals
Nineteen pregnant Romney-Marsh ewes (Royal Veterinary College, Potters 
Bar, UK) were purchased. Ewes were scanned prior to surgery to confirm a 
viable pregnancy. Establishment of fetal sex was very difficult even in the 
hands of an experienced obstetrician, therefore all ewes were operated but 
only male fetuses were included in the study (PUV being a male-limited 
human disease). When female fetuses were found at laparotomy, these 
were utilized by our fetal medicine colleagues for a separate gene therapy 
study.
Animal surgery was performed at the Biological Services Unit, Royal 
Veterinary College, Camden. The ewes operated in Protocol 1 were the 
following (numbers are the ewe ID):
Control animals: 2895 (twin 2), 4002, 4007 (twin 1), 4039 
Urachal ligation only: 2881 (twin 1), 2891, 4007 (twin 1), 4030 
Urachal and urethral ligation: 2881 (twin 2), 2889 (twin 2), 4011, 4084, 4085 
(twin 1), 4085 (twin 2)
Female fetuses (excluded): 2886, 2895 (twin 1), 4007 (twin 2), 2889 (twin 1), 
4023, 4033
Intra-uterine deaths: 2887 (twins), 4021 (twins), 4023 (twins)
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2.2.2 Fetal surgery
Pregnant ewes underwent surgery between 75 and 82 days gestation. They 
were premedicated with 1 mg/kg sodium thiopentone (Rhone Merieux, 
Dublin, Ireland) and intubated with a 14Fr endotracheal tube. Anaesthesia 
was maintained with 2-3% halothane (Fluothane, Mallinckrodt Veterinans, 
Phillipsburg, New Jersey) in a N20 /0 2 mixture. After induction, 1 g 
streptomycin/penicillin (Streptopen, Schering-Plough Animal Health, Omaha, 
Nebraska) was administered intramuscularly. Laparotomy was performed 
via a paramedian incision and the peritoneum entered. The pregnant uterus 
was delivered and single ortwin pregnancy confirmed. The uterus was 
opened using cutting diathermy, carefully preserving all amniotic fluid. Fetal 
hind-quarters were delivered, and male fetuses were allocated to: a sham 
control group (n = 4) or one of two groups in which either both urachus and 
urethra (n = 6) or the urachus-only (n = 4) were obstructed. The urachus, at 
its confluence with the apex of the bladder, was approached via a para­
umbilical incision (Fig. 13), and was ligated with a 3/0 silk ligature (Fig. 14). In 
the urethral and urachal ligation group, the urethra was identified as it ran 
subcutaneously over the abdominal wall in the suprapubic region. A 
segment was isolated and partially occluded using a standardized 3 mm Q- 
shaped silver ring (Fig. 15). While the urachal ligation was complete, the 
urethral ring was expected to constrict but not, at least initially, completely 
occlude the urethral lumen to produce an incomplete urinary flow 
impairment. The controls underwent urethral and urachal exposure only. The 
fetal abdomen was closed using 6/0 prolene interrupted sutures and the 
fetus returned to the amniotic cavity. Benzylpenicillin sodium (600 mg,
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Brittania Pharmaceuticals, Redhill, Surrey, UK) and gentamicin (80 mg, 
Cidomycin Adult Injectable, Hoechst Marrion Roussel, Strasbourg,
Germany) were instilled into the amniotic cavity prior to closure. The uterus 
was closed with a continuous 2-layer 3/0 silk stitch, and the maternal 
abdomen was closed in layers, using umbilical tape to secure the fascia, and 
0 prolene to skin. Intramuscular buprenorphine (Vetergesic; Alstoe Animal 
Health, Melton Mowbray, UK) was used for postoperative analgesia. 
Ultrasonography with a Vingmed CFM 800 device (Vingmed Sound, Horten, 
Norway) was performed on post-operative days one and seven to confirm 
fetal viability and monitor urinary tract dilatatation.
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2.3 Protocol 2: Fetal BOO model and radiotelemetered urodynamics 
from 94 days gestation
2.3.1 Animals
Thirteen pregnant Romney-Marsh ewes were operated in the second of our 
study, with the following ID numbers:
Control animals: 4127, 4132, 4121 (no implants); 4089, 4093 (with implants); 
Obstructed animals: 4088, 4091, 4137, 4141;
Animals excluded from study (female fetuses): 4095, 4098, 4105, 4136.
2.3.2 Fetal surgery and radiotelemetry implant insertion
The radiotelemetry set-up used was that employed in our pilot study 
(Thiruchelvam et al. 2004) (Fig. 16 and 17). Anaesthesia and surgical 
approach were carried out as described in section 2.2.2. Pregnant ewes 
underwent laparotomy and hysterotomy at 94 days gestation. Fetal hind­
quarters were delivered, with careful preservation of amniotic fluid, and male 
fetuses allocated to obstructed (n=4) or sham (n=5) groups. In fetuses 
assigned to the obstructed group, the intravesical catheter was passed into 
the bladder via the urachus and secured with a 3/0 silk ligature, while the 
intra-abdominal catheter was tunnelled beneath the fetal abdominal wall and 
into the abdominal cavity (Fig. 18). The urethra was partially occluded with a 
standardized 3 mm O-shaped silver ring, also seen in Figure 18. The 
catheters were brought out of the uterus and the implant body was secured 
on its exterior surface by means of two 2/0 prolene sutures. The uterus was 
approximated to the inside of the maternal abdominal wall to facilitate 
switching the implant on and off, performed with a 25T magnet swiped over
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the maternal abdomen. In two sham fetuses, the urachus was left patent and 
the intravesical catheter was inserted via a stab incision on the anterior 
surface of the bladder, and kept in place by a 6/0 prolene purse-string 
suture.The intra-abdominal catheter was inserted as described above. The 
remaining three fetuses underwent exposure only without insertion of a 
radiotelemetry device. Pregnancy was allowed to proceed for nine days.
2.3.3 In-vivo cystometry
Cystometry traces were recorded continuously for the first 24 hours post- 
operatively (Day 0), then for two hours daily up to the eighth post-operative 
day (Days 1 to 8). Traces were stored using the Dataquest software, then 
analysed at the end of the experiment. ‘Voiding’ patterns and ‘filling’ patterns 
were identified: voids were defined as sustained elevations in detrusor 
pressure without a concurrent abdominal pressure rise; the filling patterns 
were traces recorded between voids. The ‘voiding’ pattern was recognized 
due to its similarity to that reported in a previous study where fetal voids 
were visualised by ultrasonography at the same time that direct cystometry 
measurements were recorded (de Tayrac et al. 2003). The same pattern 
was recognized during the pilot study, performed on unobstructed fetuses at 
105 days gestation (Thiruchelvam et al. 2004). More than three consecutive 
acute rises in pressure lasting less than 0.1 of a minute were defined as 
‘detrusor overactivity’. Representative episodes of good quality recordings 
devoid of movement artefacts were then copied onto a Microsoft Excel® 
database for further analyses. An Excel worksheet was created for each 
animal. Three baseline intra-abdominal and intra-vesical pressure readings
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per two minutes of sampled trace were measured and documented. The 
median detrusor pressure over a six minute period was then calculated by 
subtracting the median intra-abdominal pressure from median intravesical 
pressure for that period. The voiding pressure per void was calculated by 
subtracting the baseline bladder pressure from the peak intra-vesical 
pressure. The duration of the void was defined as the time taken for the 
voiding pressure to return to baseline. The interval between the start of one 
void and that of the subsequent void was measured in order to derive the 
frequency of voids. Where clearly distinct voiding patterns were identified but 
no time at baseline was identifiable between voids, the voids were described 
as “successive”. Pressures and duration of episodes of detrusor overactivity 
were also measured.
2.4 Autopsy
Ewes in both protocols were sacrificed after nine days by means of 1 ml/kg 
intravenous pentobarbitone sodium injection (Euthatal; Rhone Merieux, 
Athens, Georgia). Ewes were sectioned and the uterus incised, taking note 
of, but not formally measuring, amniotic fluid volume. Fetuses were 
removed, weighed, and their occipito-snout length (OSL) and crown-rump 
length (CRL) measured. A mid-line para-umbilical incision was then 
performed and the bladder identified. Both ureters were then ligated at the 
vesico-ureteric junction and bladder urine was aspirated and its volume 
noted, then stored in dry ice (for later sodium content and osmolality 
estimation). After ex-vivo cystometry (see below), bladders were dry-blotted 
and weighed. Dome strips were used for in-vitro physiology while samples
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from bodies of the same organs (defined as the superior portion of the 
bladder excluding the trigone) were placed in 10% paraformaldehyde (BDH, 
Poole, UK) for histology or were weighed (after blotting) and frozen in liquid 
nitrogen pending biochemical analyses. Kidneys were weighed intact (i.e. 
containing urine in the pelvis) and then again with urine drained; kidney- 
related weights in Results are totals for the two kidneys of each fetus.
2.5 Ex-vivo cystometry
The fetal bladder was catheterised with a 5-French double-lumen tube, 
inserted through an incision in the proximal urethra, and connected to a 
PDCR 75 water-filled transducer (Druck Ltd, Groby, UK) placed level with 
the bladder (Fig. 19). One lumen filled the bladder and intravesical pressure 
was measured via the second lumen, using a Lectromed chart recorder 
(Letchworth, Hertfordshire, UK). Pressure was recorded at baseline and 
during intermittent filling with Ca-free Tyrode’s solution at room temperature, 
during stepwise increments of 0.1-0.5 ml. Filling was stopped when initial 
bladder volumes were reached or when the bladder became tense on visual 
observation.
Compliance (Avolume/Apressure) curves were constructed using raw 
pressure-volume data. However these curves were not comparable due to 
the different empty bladder intravesical volumes and variability in wall 
thickness. Therefore, standardisation of the curves was carried out by 
calculating wall stress (a; a measure of circumferential tension in the bladder 
wall). A modified Laplace relation <r = P.r^ l.d  was used, where P is luminal
120
pressure, r\ the bladder inner radius and d wall thickness; r\ was calculated 
from bladder volume (V) using the relationship V = (4 n / 3 ) . r Tissue volume 
{W) of the bladder wall (bladder weight/density, p; p = 1.05 g.ml'1) was used 
to calculate d, assuming that tissue formed a concentric sphere around the
bladder lumen, using the formula d  = f3W p 1— +r\ ■r. . Plots of wall stress, a,
versus bladder volume were linear and the slope was a measure of the 
physical properties of the bladder wall, a decreased slope indicated that for 
a given change of volume the consequent change of wall stress was 
smaller.
2.6 In-vitro contractility studies
Full-thickness bladder dome strips, less than 1mm in diameter, were 
mounted in a horizontal trough between a fixed hook and an isometric force 
transducer (Fig.20), and superfused at 4 ml.min'1 with Tyrode’s solution at 
37°C. Electrical field stimulation (EFS) used 3 second trains (1-60 Hz; 0.1 ms 
pulses) every 90 seconds. The effect of tetrodotoxin (TTX, 1 pM) and 
atropine (10 pM) in response to EFS, was recorded. Carbachol (10 pM) and 
a-(3 methylene-adenosine triphosphate (ABMA, 10 pM) were added to the 
Tyrode’s in the absence of EFS. A high-K (80 mM) solution was made by 
adding solid KCI to Tyrode’s solution, no osmotic correction was made. At 
the end of the experiments, the preparation diameter and weight were 
recorded. Tension values are expressed as mN per unit cross-section area 
(mm2) of muscle to enable the normalised level of contractility to be 
compared between specimens.
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2.6.1 Solutions
Tyrode’s solution contained (mM): NaCI, 118; KCI, 4.0; NaH2P0 4 .2 H2 0 , 0.4; 
NaHC03, 24, MgCI2.6H20, 1.0, CaCI2, 1.8; Na pyruvate, 5.0; glucose, 6.1; 
gassed with 95%02-5% C 02. Ca-free solution contained (mM): NaCI, 105; 
KCI, 3.6; NaH2P04.2H20, 0.4; HEPES, 19.5; NaHC03, 22.3; MgCI2.6H20, 
0.9; glucose, 5.4; Na pyruvate, 4.5, pH 7.1 adjusted with 1 M NaOH. All 
chemicals were from Sigma-Aldrich Co Ltd, Poole, Dorset, UK.
2.7 Histology
For light microscopy, fixed tissues were washed in PBS (1x30 minutes,
2x1 hour, 2x24 hours), dehydrated in alcohols of increasing concentration 
(30 minutes in each of 70%, 85%, 95% then 100% for 1 hour followed by 1 
hour in xylene at 56°C), left overnight in wax at 56°C, then embedded in 
blocks. Blocks were cooled in ice and sectioned at 5 pm using a microtome. 
Prior to staining, sections were dewaxed by placing in xylene (2x15 minutes) 
then rehydrated by placing in alcohols of decreasing concentration as 
follows: 100% alcohol for 5 minutes, 90% for 2 minutes, 80% for 2 minutes, 
then 70% for 10 minutes. A selection of slides was taken to the 
histopathology department (Great Ormond Street Hospital) for staining with 
Masson’s trichrome (which differentiates between collagen (blue), cytoplasm 
and smooth muscle (red) and nuclei (black)) and Elastic von Geison (stains 
elastin fibres and nuclei black, collagen red and other tissue elements 
yellow).
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2.7.1 Immunohistochemistry
Further sections were used for immunohistochemistry. Endogenous 
peroxide was quenched by immersing the slides in 3% H20 2 in methanol for 
30 minutes. After rinsing in buffer (0.1% triton in PBS) for 30 minutes, 10% 
fetal calf serum was used to block non-specific binding of immunoglobulin 
(30 minutes). When final staining was not intense enough, the sensitivity of 
the tissue to antigen binding was increased by microwaving the sections in 
6% citric acid at high power for 6 minutes, then rinsed in buffer solution. 
After excess buffer was allowed to drip off carefully from the slides, tissue 
sections were encircled using a wax pen, and each slide was placed on a 
humidified tray. Two hundred microlitres of antibody solution per specimen 
were required. Negative controls were also created by omitting primary 
antibodies or replacing them with pre-immune IgG. As a positive control, 
slides known to stain positively with antibody (courtesy of Nyriady (2002) 
and Thiruchelvam (2003)) were used.
Primary antibodies employed were:
• Mouse monoclonal anti-human a-smooth muscle actin (a SMA;
1:200; DAKO, High Wycombe, UK) -  labels smooth muscle 
cells, myofibroblasts and myoepithelial cells
• Rabbit anti-human inducible nitric oxide synthase (iNOS; 1:100;
Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) -  
identifies the enzymes responsible for NO synthesis
• Rabbit polyclonal anti-human PGP 9.5 (1:500; DAKO) -  
expressed in vertebrate neurons and neuroendocrine cells
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• Mouse anti-human uroplakin ill (UPIII; 1:50; courtesy of TT Sun,
NYU medical centre, New York), rabbit anti-human UPlb 
(1:1000) and rabbit anti-human asymmetric unit membrane 
(AUM; 1:1000) -  taken up by the respective uroplakin 
component of the AUM or by the entire AUM
Primary antibodies were detected with Envision + System-HRP (DAKO).
The system is based on an HRP-labelled polymer which is conjugated with 
secondary antibodies. Staining was completed by a 5-10 minute incubation 
with 3,3’-diaminobenzidine (DAB) substrate chromagen which results in a 
brown-coloured precipitate at the antigen site (DAB is a potential carcinogen 
and precautions were taken). Once stained, the reaction was stopped by 
rinsing in water twice for ten minutes. Slides were counterstained in 
Haematoxylin and rinsed in water for ten minutes. Slides were then 
dehydrated by placing in alcohols of increasing concentrations (70%-80%- 
90%-100%) followed by xylene twice for 15 minutes. The slides were 
transferred to a fume cupboard, and DPX adhesive used to fix the coverslip 
in place. Slides were allowed to dry overnight prior to microscopy. The 
intensity of the iNOS signals were graded as 0 (absent), 1 (weak) or 2 
(strong) by two ‘blinded’ observers.
2.7.2 TUNEL
\
Apoptosis (programmed cell death) was detected using an in-situ cell death 
detection kit based on labelling of DNA strand breaks (TUNEL - Roche 
Applied Science, Penzberg, Germany). Tissue sections were rehydrated as
124
described above and rinsed in buffer solution. Sections were then incubated 
with a solution of trypsin (one tablet per ml of water) (Sigma Aldrich, Dorset) 
for an hour at 37°C, then rinsed in PBS. Sections were then incubated with 
the TUNEL kit solution for one hour at 37°C and rinsed in PBS. Nuclei were 
counterstained with 1:10,000 propidium iodide (Invitrogen, Paisely) for 5 
minutes, rinsed and mounted using immunofluorescence mountant media 
(Citifluor, London). Fluorescein labels incorporated in nucleotide polymers 
were detected and quantified by fluorescence microscopy. In order to 
generate an ‘apoptotic index’, apoptotic and total number nuclei were 
counted in six high power fields per specimen, and the percentage of 
apoptotic cells (the ‘apoptotic index’) calculated. Numbers of ‘nuclear layers 
in urothelium’ were established by counting propidium iodide-labeled nuclei 
visualised in the shortest distance between lumen and lamina propria: 
counts quoted per bladder were averages of six separate measurements.
2.7.3 Transmission electron microscopy
For transmission electron microscopy (TEM), tissues were fixed in 3% 
glutaraldehyde and sections visualised with a JEOL 1200EX electron 
microscope.
2.8 Protein extraction and quantification
2.8.1 Protein extraction
Bladder samples were weighed and 100 mg of tissue added to 1 ml of 
radioimmunoprecipitation buffer (RIPA, 150 mM sodium chloride, 1.0% 
Nonidet P-40, 0.5% sodium deoxycholic acid, 0.1% sodium dodecyl sulphate
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(SDS), 50 mM Tris-HCI pH 8.0 and fresh inhibitors (30 pl/ml of 2.2 mg/ml 
aprotinin; 10 pl/ml of 10 pg/ml phenylmethyl-sulfonyl fluoride; 10 pl/ml of 
100mM sodium orthovandate)). The RIPA buffer enables efficient cell lysis 
and protein solubilisation while avoiding protein degradation and 
interference with the proteins’ immunoreactivity and biological activity. RIPA 
buffer also results in low background immunoprecipitation and molecular 
pull-down assays. The samples were homogenised for two minutes on ice in 
a falcon tube. After each sample, the homogeniser was wiped with tissue 
and washed in a series of tubes of distilled water. Samples were left to 
stand for 5 minutes on ice. The supernatant was transferred to 1.5 ml 
centrifuge tubes and centrifuged at 13,000 x g for 30 minutes at 4°C to 
remove any solid debris. The supernatant was transferred to fresh tubes and 
a further 10 pi of 10 pg/ml PMSF was added and the supernatant stored at - 
70°C.
2.8.2 Protein quantification
The concentration of protein was quantified using a bicinchoninic acid 
protein (BCA) assay (Pierce, Rockford, IL, USA). BCA is a highly sensitive 
and selective detection agent for the cuprous cation Cu+. This assay 
combines the reduction of Cu2+ by protein to Cu+ in an alkaline medium with 
the cuprous ion detecting property of BCA. For each sample, 50 pi of protein 
was incubated with 1 ml of working reagent (50 parts of BCA Reagent A and 
1 part of BCA reagent B). The mixture was incubated at 37° C for 30 minutes 
in a water bath and absorbance readings measured at 562 nm. 1 ml of 
sterile water was used as a negative control. A standard curve was
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generated using 2 mg/ml of bovine serum albumin (BSA) in serial dilutions 
and protein concentrations read from this graph.
2.9 DNA extraction
0.1 mg bladder samples were dissolved in 300 pi of extraction mix (20 mM 
Tris pH 7.4, 100 mM EDTA pH 8.0 and 0.3 mg/ml proteinase K) at 55 °C 
overnight. Samples were then vortexed to make sure the tissue had fully 
dissolved. 20 pi of 3M sodium chloride was added to each sample and then 
300 pi of phenol. Samples were vortexed and centrifuged at 13,000 x g for 
30 minutes. The top (aqueous) phase containing DNA was carefully 
removed using a 1000 pi pipettor and transferred to a new tube. DNA was 
precipitated by adding 1x volume of isopropanol. After vortexing and 
centrifuging at 13,000 x g for 30 minutes a pellet was formed at the bottom 
of the tube. The pellet was washed in 1 ml ice-cold 70% ethanol and then 
air-dried. The pellet was then re-suspended in 50 pi of TE buffer (10mM 
Tris-HCI pH 8.0, 1mM EDTA) and quantified at 260 nm using a 
spectrophotometer.
2.10 Statistics
Due to the small numbers in both experiments, measurements were 
expressed non-parametrically as medians (ranges) and groups compared 
using two-tailed Mann-Whitney U-tests. The null hypothesis was rejected at 
p<0.05. Correlation between different variables was assessed by calculation 
of a correlation coefficient, r, estimation of a f-value from
t = r^{n - 2 ) / { \ - r 2) , to allow estimation of p.
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2.11 Summary
• Short-term (nine days) BOO was carried out in the fetal lamb 
model at 75 days and at 94 days gestation
• Prenatal ultrasonography was performed on post-operative days 
one and seven
• Radiotelemetered urodynamics (in Protocol 2 only) were 
monitored at intervals throughout the experiment
• Following autopsy, gross fetal inspection, in-vivo cystometry, 
contractility studies and histological analyses were performed
• Results were analysed non-parametrically, and will be 
discussed in the following chapter.
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Sham (S) 
n=4
_L
Laparotomy and hysterotomy 
75 days’ gestation
Urachal ligation only 
(U) n=4
Post-operative ultrasound Days 1 and 7 
Autopsy Day 9
1 —  Urachal and urethral
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Cystometry with urinary tract
In-vitro physiology studies
Histology
Figure 12 A. Summary of Protocol 1 study design.
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Laparotomy and hysterotomy 
Radiotelemetry implant insertion 
94 days gestation
Sham (S) Obstructed (O)
n=5 n=4
Daily telemetry monitoring 
Post-operative ultrasound Days 1 and 7 
Autopsy after 9 days (104 days gestation)
Cystometry with urinary tract
In-vitro physiology studies
Histology
Figure 12 B. Summary of Protocol 2 study design.
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Umbilical cord Urachus
Figure 13. Exposure of urachus lateral to umbilical cord.
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Figure 14. Urachal ligation.
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Figure 15. Partial urethral occlusion with Q-shaped ring.
133
Receiver
ns • * * - ' j
/
Ambient pressure
recorder * D -m
*?• •
*1
Data quest 
ART svstem
Power supply Data
Exchange Matrix
Figure 16. Radiotelemetered urodynamics set-up.
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Figure 17. Radiotelemetry implant.
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Figure 18. Insertion of intravesical and intra-abdominal catheters. 
Implant body seen lying over uterus.
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Figure 20. In-vitro contractility set-up.
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3. RESULTS
The results presented in this chapter have been published (Farrugia et al. 
2006 a and b, Farrugia et al. 2007) and reprints are enclosed at the end of 
this thesis. Key results are discussed here and summarised in Tables 2 to 4 
and Figures 21 to 24. Raw data may be found in the appendix at the end of 
the thesis.
3.1 Protocol 1 results: Fetal BOO from 75 days gestation
3.1.1 Surgical and anaesthetic outcome
Nineteen pregnant ewes were operated on in Protocol 1 -  two (4021 (twins) 
and 4022 (twins)) arrested on the table due to difficulty with intubation and 
maintaining the airway -  giving a 10% anaesthetic mortality. Of the 24 
fetuses operated, one set of twins (2887 (one male)) was lost following a 
maternal chorio-amnionitis giving an 8% fetal mortality rate. Four fetuses 
formed part of a preliminary study leaving 20 fetuses for the actual study, of 
which 12 were female. Eleven male fetuses were therefore utilised in 
Protocol 1.
3.1.2 Ultrasonography
Ultrasound examinations were carried out on postoperative days one and 
seven by Boaz Weiss, research fellow in Fetal Medicine. On the first 
postoperative day, all fetal bladders were identifiable on ultrasonography 
(Fig.21); kidneys were also identifiable but not the renal pelves. An attempt 
was made to measure renal size, renal pelvic diameter and bladder volume,
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but measurements could not be made due to technical limitations of the 
ultrasound machine available at the Biological Services Unit and due to 
movement of the ewe, which was difficult to restrain. On the seventh post­
operative day, bladders in the urachal ligation only and in the urachal and 
urethral ligation group were noted to be comparatively larger than the sham 
bladders (Fig.22). Hydronephrosis was visible in both ligation groups 
(Fig.23) but not in shams. This appearance suggested that both 
interventions resulted in hydroureteronephrosis, henceforth the urachal 
ligation only and urachal and urethral ligation groups will be referred to as 
“BOO” groups.
3.1.3 Gross anatomy
At autopsy, fetal weight and size were not significantly different between the 
three groups (Table 2). Urine aspirated from all bladders was snap frozen 
and submitted to the biochemistry laboratory at the Institute of Child Health 
for analysis. There were no significant differences in urine osmolality and 
sodium content between the three groups. After removing urine, bladder 
weights (absolute and normalised for fetal weight) were significantly greater 
after BOO, with a significant response in the urachal-only group (Table 2).
Kidneys were weighed intact (with ureters), then bivalved in order to drain 
the urine retained in the renal pelvis, and re-weighed. We hypothesised that 
the difference in weight would reflect the volume of retained urine, and 
hence of that of the renal pelves. Amounts of renal pelvic urine were 
increased in both BOO groups, confirming the ultrasonographic impression
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of hydronephrosis. The weights of kidneys (after urine drainage) were 
increased in both BOO groups but, after normalising for body weight, this 
remained significant in only the urachal-only ligation group (Table 2).
3.1.4 Protein and DNA content
Absorbance and concentration data for bladder protein and DNA estimation 
are shown in Appendices 5 and 6 respectively. Total bladder protein was 
significantly greater in the double-ligation group compared with the urachal 
ligation only group. The median DNA content was increased in both BOO 
groups but this only attained significance in the urethral and urachal ligation 
group: BOO had no affect on the protein/DNA ratio in the BOO groups 
versus shams (Table 2).
Figure 24 shows scatter plots of each measurement, providing a visual 
guide to be considered along with Table 2, containing medians/ranges for all 
parameters. Unless otherwise stated, similar differences were recorded in 
both BOO groups versus sham controls.
3.1.5 Histology
Bladders from all three groups had distinct urothelial, lamina propria and 
detrusor smooth muscle (DSM) bundle layers, the latter expressing a- 
smooth muscle actin (aSMA) (Fig.25 A and B). DSM appeared similar in all 
specimens, as assessed by light microsopy (Fig.25 C and D). An attempt 
was made to quantify the amount of DSM in each specimen using Image-J 
software, but this method was deemed to be inaccurate as the programmed
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tended to pick up “background” SMA staining which did not correspond to 
DSM. On observation, however, DSM remained intact following nine days of 
BOO. Individual obstructed muscle bundles appeared to be wider and were 
separated by more connective tissue when visualised by TEM (Fig.25 E and 
F).
The urothelium, on the other hand, differed markedly between sham and 
BOO bladders. The nuclear layers in urothelium in obstructed groups were 
increased versus shams (Fig.26 A and B; Table 2). iNOS immunostaining 
was detectable in both the sham and BOO groups (Fig.26 C and D), with no 
difference in signal intensity on blind analysis. TUNEL staining revealed a 
striking difference in the number of apoptotic nuclei present in BOO 
urothelia, where apoptosis was pronounced particularly in the basal zone, 
compared to sham ones (Fig.27). Apoptotic cells were noted in the lamina 
propria and DSM layers of all samples but were too rare to quantify 
accurately.
A continuous asymmetric unit membrane expressing UPlb (Fig.28 A and B) 
and UPIII (not shown) was demonstrated in all bladders. Areas of 
denudation were occasionally present in some bladders (Fig.28 C) but this 
may have been due to fracturing during processing of the specimens. When 
viewed in greater detail under TEM, however, the asymmetric unit 
membrane appeared to be intact in obstructed specimens. Umbrella cells 
appeared to be larger, and contained a higher concentration of cytoplasmic 
vesicles, in BOO bladders (Fig.29).
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Nerve bundles were present in the detrusor from all three groups, as 
identified by PGP 9.5 immunostaining. These were situated mainly between 
the detrusor layer and the serosa, with some neurovascular bundles 
interspersed between muscle fascicles (Fig.30). Nerve bundle count in the 
double ligation group was significantly reduced compared with the other two 
groups.
Sham renal histology revealed a nephrogenic zone, a deeper cortex with 
formed glomeruli (Fig.31 A) and medullary collecting ducts (Fig.31 B). In six 
out of ten kidney pairs from the BOO groups, these appearances were 
maintained (Fig.31 C and D). In two sets of kidneys from the urachal-only 
ligation group and in two sets from the urachal and urethral ligation group, 
however, the cortex contained cysts, some with glomerular tufts, and 
medullary ducts were dilated (Fig.31 E and F). Kidneys with cysts tended 
occur in fetuses with the highest bladder weights and protein contents.
3.1.6 Compliance and wall stress
Bladder compliance was measured from ex-vivo filling cystometry data. End- 
fill volumes were determined by measuring the volume of urine aspirated 
from each bladder at post-mortem. Bladder volume was greater in the 
obstructed groups compared to control. Figure 32 A shows ex-vivo pressure- 
volume curves for bladders from the three groups. The curves from sham- 
operated bladders were similar and are shown as a single curve; pressures 
did not exceed 7 cm H20  at maximum volumes of 2 ml. Corresponding
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curves from obstructed bladders were variable: two bladders (one from each 
intervention group) had low compliance, and the remainder had a similar or 
greater compliance compared to the sham group. Part of this variability may 
be due not only to differences in the unit physical properties of the bladder 
wall, but also to its thickening in response to obstruction.
Estimated (empty) bladder wall thickness was significantly increased in both 
BOO groups compared to control. Wall stress, normalised to unit cross- 
section area, was calculated as a function of filling volume (see Methods) to 
compensate for any increase of wall thickness. Figure 32 B shows that the 
transformation linearised the curves; the shallower the line the smaller was 
the wall stress generated per unit change of volume, i.e. wall stiffness was 
reduced. Despite the standardized median wall stress values being smaller 
in the obstructed groups there was no statistical difference between them. 
However, the scatter of data may hide any trend that may develop with 
obstruction.
Morphology results showed a good correlation between bladder: fetal weight 
ratio (BFR) and bladder protein/DNA content, indicative of bladder 
overgrowth with obstruction. The question arises if normalised wall stiffness 
is a function of increasing bladder weight with obstruction. Figure 32 C plots 
this estimate of wall stiffness as a function of BFR, irrespective of the 
interventional group. The data show a significant negative correlation 
between BFR and wall stress, with the exception of a single datum point for 
one of the obstructed bladders, with a correlation coefficient of -0.76
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(p<0.01). It appears, therefore, that an increase of BFR, as occurred during 
this short-term BOO, is associated with a more compliant bladder wall.
3.1.7 Contractility
Dimensions and weights of detrusor strips from all groups were similar. 
Contractions elicited by electrical field stimulation (EFS) were completely 
blocked by the neurotoxin TTX, indicating they were nerve-mediated. 
Atropine completely abolished nerve-mediated contractions in detrusor strips 
from all groups. However, application of 1 pM ABMA generated transient 
contractures in all preparations, of similar magnitude in control and 
obstructed groups. The data from the two obstructed groups have been 
combined because of the relatively small data sets. In the presence of 
atropine, EFS generated small transient relaxations in nearly all preparations 
from both sham-operated and obstructed bladders.
Another important hypothesis to be tested was if bladder overgrowth was 
associated with contractile failure. Plots of BFR as a function of tension 
generated by various interventions did not show a significant correlation: 
nerve-mediated stimulation at 40 Hz (r =0.02, p>0.05), 10 pM carbachol 
(r=0.14, p>0.05) or an increase of extracellular [KCI] (r=-0.04, p>0.05).
Figure 33 A shows the median values (with the 25% and 75% interquartiles) 
of tension generated by carbachol, and in part B that by nerve-mediated 
stimulation at 40Hz, T40, and by high-KCI solution. Because of the similarity 
of data in the two obstructed groups, they have been combined to one 
experimental data set. With all three interventions the hypothesis was
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rejected, as the median values were not significantly different between the 
sham-operated and obstructed data sets. It should be noted that one 
preparation in the sham-operated group yielded a much larger value for the 
KCI contracture than the others and hence has generated a large 75% 
interquartile range. However, even if this individual value is removed from 
the statistical evaluation a similar conclusion is drawn, i.e. that the median 
values in the sham-operated and obstructed groups are statistically similar.
3.1.8 Innervation
In the morphology section, it was shown that nerve bundles were present in 
the detrusor from all three groups, as identified by PGP 9.5 immunostaining. 
Nerve bundles in the urachal and urethral occlusion group appeared to be 
smaller and were significantly reduced in number compared to the other two 
groups. However, there was no significant relationship between PGP nerve 
count and either BFR (r=-0.42, p>0.05) or tension generated by electrical 
field stimulation at 40 Hz (r=0.50, p>0.05). These correlations are consistent 
with the observation that bladder overgrowth at this period of obstruction is 
not associated with reduced contractility. Wall stress also showed no 
correlation with PGP counts (r=0.44, p>0.05). However, it is of interest to 
note that if the single point associated with the very high wall stress 
observed in Figure 32 C was omitted a strong positive correlation was 
observed (r=0.74, p>0.01).
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3.1.9 Protocol 1 results: summary
• Ultrasonography on the pregnant ewe revealed progressive 
hydronephrosis in both the combined urachal and urethral 
ligation and the urachal ligation only groups, hence the 
combined groups are henceforth referred to as “BOO” groups
• BOO bladders were significantly heavier and had a greater DNA 
content than controls, but there was no significant difference in 
protein: DNA ratio between groups
• BOO kidneys were hydronephrotic; histologically, some kidneys 
in both groups exhibited glomerular cystic change and medullary 
tubular dilatation
• BOO bladder histology revealed an intact detrusor with a 
reduced nerve bundle count in the double ligation group only; 
the urothelium appeared to have an increased number of 
nuclear layers, and exhibited marked apoptotic change
• Compliance was variable in both BOO groups and was 
standardised by calculating the circumferential bladder wall 
tension, or wall stress, which was not significantly different
• Detrusor contractility was not significantly affected following 
BOO
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3.2. Protocol 2 results: Fetal BOO and radiotelemetered urodynamics 
from 94 days gestation
3.2.1 Surgical and anaesthetic outcome
All BOO fetuses survived the full nine days of the experiment, as did the 
three sham fetuses which did not receive telemetry devices. The two sham 
fetuses implanted with radiotelemetry devices, however, died within 48 
hours. The cause of death was undetermined as autolysis was too advanced 
for analysis at the time of autopsy. Fetal demise was probably related to the 
fact that, at 94 days gestation, the fetuses were too small for direct insertion 
of the telemetry catheter through the delicate bladder wall. In-vivo 
cystometry was, therefore, only obtained in the BOO group, although three 
sham bladders were available for all other analyses. Operative mortality in 
this protocol was 22%.
3.2.2 Ultrasonography
On the first postoperative day, all fetal bladders were identifiable on 
ultrasonography as previously described; kidneys were also identifiable but 
not the renal pelves. On the seventh post-operative day, BOO bladders were 
comparatively larger than the sham bladders. Dilated renal pelves were 
visible in obstructed, but not in sham, fetuses (not shown).
3.2.3 Gross anatomy
On direct inspection, BOO fetuses were noted to have tortuous ureters and 
a dilated posterior urethra proximal to the occlusive ring. There was no 
significant difference in fetal weight and size (Table 3).
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3.2.4 Histology
As assessed by Masson’s trichome staining and aSMA immunostaining, all 
sham and BOO bladder cross-sections were clearly demarcated into 
urothelium, lamina propria and detrusor layers (Fig.34 A-C). Detrusor 
muscle bundles were well-preserved in three obstructed bladders; one BOO 
bladder, however, was found to have thinner bundles (Fig.34 B). 
Microscopically, sham kidneys contained a nephrogenic zone, directly below 
the kidney capsule, with several layers of glomeruli deeper in the cortex 
(Fig.34 D-F). One BOO kidney pair had a similar appearance as the shams 
(Fig.34 E), whereas the three other BOO bladders contained subcapsular 
cysts, often with glomerular tufts on their walls (Fig.34 F), and medullary 
tubular dilatation (not shown). The non-cystic set of kidneys (Fig.34 E) was 
associated with the bladder with the attenuated detrusor (Fig.34 B). There 
were no consistent differences between sham and BOO groups regarding 
fetal or bladder weights, bladder end-fill volumes, urothelial layers and 
incidence of apoptosis, or kidney weights (Table 3).
3.2.5 In-vivo radiotelemetered cystometry
A total of 36 urodynamic trace recordings were performed, of which 19 were 
amenable to accurate analyses. The remaining traces could not be analysed 
due to a software malfunction (which could not be repaired by the DSI 
Technical Support team, support@datasci.com 1-800-262-9687). Analysis of 
the available traces provided a composite picture of events that occurred
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during the period of observation. A summary of medians obtained per 
obstructed animal are summarized in Table 4.
The first 24 hours post-BOO (Day 0) were characterized by a filling pattern 
with stable, low baseline detrusor pressures of less than 10 mmHg. Voids 
occurred at intervals of one to two minutes at median voiding pressures of 
12 to 14mmHg (Fig.35 A), and resembled the voids documented in our 
preliminary study (Fig. 36) (Thiruchelvam et al. 2004). The ‘filling’ pattern 
between voids was either a flat trace or consisted of a series of low-pressure 
‘undulations’ (Fig.35 B). A gradual increase in voiding pressures occurred 
over the ensuing days, such that there was a significant difference between 
voiding pressures on days 0-1 versus days 6-7 (sheep 4137 and 4141 
compared), when voiding pressures up to 38 mm Hg were recorded. 
Meanwhile, baseline detrusor pressure did not differ significantly between 
days 0-1 and 6-7 (medians of 3 to 8 mmHg) (see Table 4). Voids also 
became significantly more prolonged with obstruction. By day five, voids 
typically lasted three minutes (Fig.35 C) and occasionally occurred in 
successive runs (Fig.35 D). Days 6-8 were characterized by ‘haphazard’ 
excursions of elevated detrusor pressure of varying amplitude and duration 
(Fig.35 E). It was thought this represented repeated efforts to void in view of 
the fact that “normal” voiding patterns became much less frequent.
Detrusor overactivity was characterised by runs of three or more detrusor 
pressure elevations lasting less than 0.1 of a minute (Fig.35 F). Detrusor 
overactivity was identified in all animals starting from day 0, apart from
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sheep 4091. There was no significant difference in the pressures reached or 
duration of instability between days 0 and 7.
Overall, there were marked changes in the patterns of bladder activity 
throughout the period of study. There was a significant progression in the 
frequency and duration of ‘voiding’ activity, such that more time was spent at 
higher pressures of emptying activity rather than at the baseline with a non­
contracting detrusor. The patterns between individual BOO animals were not 
substantially different, although, notably, the one animal with the non-cystic 
kidneys (see below) maintained a more moderate frequency and duration of 
voidings.
3.2.6 Ex-vivo compliance, contractility and innervation
Compliance curves for the obstructed and control bladders are shown in 
Figure 37 A; there was no significant difference between the two groups.
The least compliant bladder was the one which did not develop cystic 
kidneys. Derived wall stress values were plotted as a function of bladder 
volume and are shown in Fig.37 B. The median values of the slopes were 
not different between the two groups. As expected, the least compliant 
bladder from the animal without cystic kidneys had the greatest wall stress 
per unit volume. The most severe hydronephrosis was associated with least 
wall stress per unit volume. Contractions elicited by 1-60Hz EFS were 
blocked by the neurotoxin TTX, indicating they were nerve-mediated. 
Atropine, a muscarinic receptor antagonist, also abolished nerve-mediated 
contractions in all detrusor strips. The contractions elicited by 20Hz EFS and
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contractures generated by the acetylcholine analogue are shown in Figure 
38 A and B: although BOO bladders appeared to be hypercontractile, the 
difference did not reach significance. Nerve bundle (PGP 9.5 staining) count 
(per high power field) was not different in the two groups.
3.2.7 Protocol 2 results: summary
• BOO at 94 days did not result in a significant difference in 
bladder or kidney growth between obstructed and non­
obstructed groups
• Similarly, ex-vivo compliance and wall stress were not 
significantly different between the two groups
• In-utero fetal cystometry (via urachal catheterisation) was only 
feasible in the obstructed group
• Urodynamic changes were noted within hours of obstruction: 
these were characterised by voids at increasing pressures and 
frequency with a baseline disrupted by detrusor overactivity. The 
filling/storage pressure did not alter significantly throughout the 
nine days of obstruction
• Histologically, glomerular cysts were evident in three of four sets 
of kidneys; bladder wall architecture was well-maintained, 
although there was evidence of an apoptotic response
Thus Protocol 2 has raised further questions, which I will attempt to explain 
in the forthcoming discussion:
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• Why does obstruction at 94 days result in less growth than 
obstruction at 75 days?
• Why does ligation of the urachus with a patent urethra result in 
obstructive changes?
• How does short-term BOO for nine days compare with long-term 
BOO for 30 days?
• What is the clinical implication of the antenatal cystometry 
findings?
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Table 2. Effects of short-term fetal BOO at 75 days on renal tract 
morphology and biology. Measurements are median (range) * and ** 
respectively indicate P<0.05 and P<0.01 for each obstructed group versus 
sham controls; + and ++ respectively indicate P<0.05 and P<0.01 for the 
urachal and urethral obstruction group versus the urachal obstruction-only 
group. Gestation at surgery refers to the day when sham or obstruction
surgery was performed; all other measurements were taken at sacrifice.
Sham
operation
(n=4)
Urachal and 
urethral 
occlusion 
(n = 6)
Urachal ligation
only
(n = 4)
Fetal weight at sacrifice
(g)
Gestational at surgery 
(days)
450 (350-650) 
75 (75-82)
635 (400-850) 
79.7 (75-82)
500 (400-700) 
78.5 (75-82)
Bladder weight (g) 
Bladder/fetal weight (x10'3)
0.41 (0.34-0.46) 
0.9 (0.7-1.1)
"1.20 (0.85-2.60) 
"/++2.10 (1.4-3.1)
"2.04 (1.37-2.59) 
"3.8 (3.0-4.7)
Bladder protein (mg) 
Bladder DNA (mg) 
Protein/DNA
39.8 (30.3-42.7)
0. 40 (0.24- 
0.41)
104(101-128)
/+96.4 (33.2- 
144.3)
'1.0 (0.56-2.24) 
77 (30-239)
'159.5(136.0-
166.4)
'1.87 (0.69-2.56) 
73 (65-230)
Urothelial layers 
Urothelial apoptotic index 
(%)
1.4(1.3-2.6) 
0.09 (0.08-0.20)
*3.6 (2.4-8.3) 
"1.66 (0.81-4.59)
"6.4 (4.3-10.1) 
0.98 (0.09-2.27)
Kidney weight (both) (g)
Kidney/fetal weight (x10‘2) 
Renal pelvic urine weight
(g)
5.38 (4.29-6.14)
1.2 (0.9-1.3) 
0.30 (0.10-0.40)
*7.76 (5.10-10.00)
1.2 (1.0-1.9)
"1.05 (0.46-2.16)
"7.33 (6.90- 
13.04)
"1.6 (1.4-1.7) 
"0.68 (0.54-4.21)
Urine osmolality 
(mOsmol/kg water)
150(131-165) 157(139-257) 143 (113-294)
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Table 3. Effects of short-term fetal BOO at 94 days on renal tract 
morphology and biology. Values for sham and BOO groups at sacrifice, 
nine days after the experiments were initiated at 94 days gestation. Values 
are shown as median (ranges). The ‘apoptotic index’ is the percent of 
urothelial nuclei undergoing apoptosis.
Sham (n=3) BOO (n = 4)
Fetal weight (g) 1063(380-1860) 1319 (798-1472)
Bladder weight (g) 0.6(0.4-1.3) 1.0 (0.8-1.3)
Bladder/fetal weight (x1 O'3) 0.70 (0.56-1.1) 0.79 (0.54-1.5)
Bladder end-fill volume (ml) 2.8(1.0-11.0) 6.0 (1.1-10.5)
Urothelial layers 3.0 (-) 3.5 (3.0-4.0)
Urothelial apoptotic index (%) 0.79 (0.26-0.93) 0.72 (0.56-2.10)
Two-kidney weight (drained of urine
(g)
9.5(5.2-15.6) 10.7(8.3-16.6)
Total drained kidney/fetal weight 
(x10'2)
0.89 (0.84-1.37) 0.95 (0.71-1.21)
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Table 4. Radiotelemetered cystometry results. * signifies a significant 
difference between values.
Day Sheep ID Baseline Filling / Storage 
pressures (mmHg)
Detrusor
Overactivity
(mmHg)
Voiding Phase 
pressures (mmHg)
PAbd PVes Pdet Rise in 
PDet
Duration
(Mins)
Voiding
Pressure
PDet
Duration 
of void 
(mins)
0 4141 22 25 3 8 <0.1 12 1.1
4137 18 20 4 4 <0.1 12 0.8
4088 14 22 8 - - - -
1 4141 20 25 5 8 <0.1 17 1.4
4137 17 20 2 18 <0.1 16 1.8
4088 10 23 9 17 <0.1 42 2.4
2 4141 16 26 11 10 <0.1 5 5
4137 15 21 6 18 <0.1 19 5
3 4141 14 24 10 6 <0.1 14 2
4137 15 21 6 20 <0.1 23 3.6
4091 10 20 10 - - 25 2
4 4141 18 29 11 6 <0.1 17 3
4091 10 23 15 - - 25 2
5 4141 14 24 8 14 <0.1 18 3
4088 16 33 15 41 0.2 29 2.7
4091 15 28 10 - - 25 2
6 4141 16 21 5 16 <0.1 32 2.7
4137 18 24 8 20 <0.1 24 2.4
7 4141 18 24 7 18 <0.1 32 3.4
4137 16 24 8 - - 26 4
Day 0/1 and 6/7 differences
(Sheep 4137 and 4141 data only)
0.05 0.16 0.03* 0.03*
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Figure 21. Ultrasound appearance of a 75-day fetal bladder one day 
post-urachal ligation only.
Bladder diameter marked with yellow line (Scale 1:2).
Figure 22. Ultrasound appearance of a 75-day fetal bladder seven days 
post-urachal ligation only.
Bladder diameter marked with yellow line (Scale 1:2).
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Day 7 Kioney
Figure 23. Ultrasound appearance of a 75-day fetal renal pelvis seven 
days post-urachal ligation only.
Renal pelvic diameter marked with yellow line (Scale 1:2).
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Figure 24. 75-day BOO results: scatter plots.
Medians indicated by horizontal bars. Key: S = sham; U = urachal only 
ligation group; UU = urachal and urethral occlusion. The circled points 
represent fetuses in which the kidneys had cortical cysts and dilated 
medullary collecting ducts; non-circled points were from fetuses with 
preserved renal morphology. Note on numbers: for technical reasons, only 
three of the four bladder samples in the U group were available for analysis 
of protein and DNA. In the UU group, only five of the six bladders were 
available for analyses of the nuclear layers in urothelium and apoptosis.
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Sham Sham
Figure 25 A-F. Detrusor smooth muscle (DSM).
A and B were immunostained for a-smooth muscle actin (brown) and 
counterstained with hematoxylin (x12.5 original magnification); C and D 
were stained with Masson’s trichrome (original magnification x50); E and F 
are TEM images (original magnification x3000). A, C and E are from sham 
bladders and B, D and F are from bladders with urachal ligation and urethral 
rings. Note the generally-preserved DSM morphology in the BOO versus 
sham samples.
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Figure 26 A-D. Urothelium visualized by light microscopy: Masson’s 
trichrome and iNOS immunostaining.
A and B were stained with Masson’s trichrome (original magnification x50); 
C and D were immunostained for iNOS (brown) and counterstained with 
hematoxlin (original magnification x100). Note that BOO bladders appeared 
to have more nuclear layers (between lumen and lamina propria) and that 
iNOS protein could be immunolocalized to both sham and BOO urothelium.
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Figure 27 A-F. In-situ end-labelling for apoptosis in the urothelium.
All views are from a confocal microscope, original magnification x260. A-C 
represent sham bladder wall sections, whilst D-F are from a BOO bladder. 
The uppermost, dense layer of cells is the urothelium, while the lamina 
propria, with sparser cells, is below. A and D have a ‘wavelength window’ 
set to detect all nulcei (propidium iodide -  red), B and E have a window set 
to detect apoptotic nuclei (green), and C and F are merged images. Note the 
apparent increase in nuclear layers of BOO urothelium, which has many 
apoptotic nuclei in the basal zone (two examples are marked with arrows in 
D and F).
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Figure 28 A-C. Uroplakin lb immunostaining.
A and B show an intact asymmetric unit membrane (AUM) expressing 
Uroplakin lb in both control and obstructed bladders (original magnification 
x200). C shows an obstructed bladder with a potentially disrupted AUM, 
although this may be due to a processing artefact.
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Sham
Figure 29 A-B. TEM of urothelium.
TEM of sham (A and enlarged inset x2.7 magnification) and BOO (B and 
enlarged inset x2.7 - combined urachal and urethral ligation) bladders. Note 
the flat umbrella cell layer sitting on top of cuboidal-shaped urothelial cells in 
the sham bladder. In the BOO sample, the umbrella cell layer is very 
prominent and contains many vesicles.
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Figure 30 A-C. PGP 9.5 immunostaining.
Sham (A), urachal ligation (B) alone and with urethral occlusion (C) bladder 
cross-sections showing smaller nerve bundles in the double ligation group.
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Figure 31 A-F. Kidney histology.
All samples stained with Masson’s trichrome (original magnification x50). A 
and B are from a sham kidney, and C-F are from two fetuses with BOO. In 
the sham sample, note the nephrogenic zone surrounding the first layers of 
forming glomeruli (circled in A), with normal calibre ducts in the medulla (B); 
in six out of the ten fetuses with BOO, similar appearances were noted (C 
and D). In four of the fetuses with BOO, abnormal renal morphology was 
noted with a cysts in the outer cortex, many of which contained a glomerular 
tuft (indicated by * in E); in these kidneys, dilated ducts were always found in 
the renal medulla (F).
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Figure 32 A-C. Pressure-volume relationships.
The median [25, 75% interquartiles] data for the sham-operated animals are 
shown as closed squares. Data from the bladders undergoing urachal 
ligation (open circles) and urachal ligation with partial urethral occlusion 
(open squares) are shown for individual animals. A. Compliance curves 
constructed from raw data. B. Transformed data from part A showing 
calculated wall stress as a function of filling volume. C. The relationship 
between normalised wall stress (slope of lines in part B) and bladder-to-fetal 
weight ratio: symbols the same as in parts A and B.
170
Tension, mN.mm 
25 r-
obstructed
B
Tension, mN.mm'2
10.0
8.0
6.0
4.0
2.0
sham obstr
0.0
KC1T
40
Figure 33 A-B. Contractile function of isolated detrusor.
A. Contractions evoked by 10 pM carbachol in strips from sham-operated 
and obstructed bladders. Data from the two obstructed groups have been 
combined -  see text. B. Contractions evoked by electrical field-stimulation at 
40 Hz or raised superfusate [KCI]. Median values with 25% and 75% 
interquartiles.
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Figure 34. Bladder and kidney histology in the 94-day model.
Paired bladder (A-C) and kidney (D-F) sections stained with Masson’s 
trichrome (original magnification x50). Bladder architecture was generally 
similar in sham (A) and BOO (B and C) bladders, although apparently 
thinner detrusor bundles were found in B. Representative sham renal cortex 
(D). The kidneys (E) attached to one BOO bladder (B) appeared normal, 
whereas kidneys attached to the three other BOO bladders contained 
subcapsular cysts (F).
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Figure 35 A-F. Radiotelemetered cystometry traces in the obstructed 
94-day fetal model.
Intravesical pressures; (P.Ves.; black), abdominal pressures (P.Abd.; red). 
Note: detrusor pressure = P.Ves - P.Abd; the subtracted trace is not shown. 
Pressures: mmHg versus time in minutes. A: A typical voiding pattern seen 
within an hour of surgery and terminating in an ‘undulating’ baseline; the 
void was repeated after two minutes. B: The ‘undulating’ pattern seen in A 
was often seen preceding the onset of a void. C: Prolonged void; day six 
post-obstruction. D: A four minute excerpt from a prolonged ‘voiding’ 
episode with a sustained period of elevated bladder pressures, seen on the 
sixth post-operative day. E: An eight minute excerpt from a ‘haphazard’ 
series of elevated bladder pressures, with only brief returns to baseline; 
seven days post-obstruction. F: Detrusor overactivity.
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Figure 36. Example of a normal void (105 day fetus).
Pattern is typically that of a sustained rise in intravesical pressure (Pves) with 
superimposed high-frequency, low-amplitude activity with a gradual return to 
baseline filling pressure (Thiruchelvam e t  a l .  2004)
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Figure 37. Pressure-volume plots for ex-vivo fetal bladders.
Compliance curves shown in A, and corrected wall stress shown in B. 
Shams are shown in blue, and BOO data in red.
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Tension at 20Hz frequency
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Carbachol Contracture
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Figure 38. Fetal bladder contractility following nine days BOO at 94- 
days.
Bar charts illustrating muscle tension achieved by EFS at 20Hz (A) and by 
direct muscle stimulation with the acetylcholine agonist carbachol (B).
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4. DISCUSSION
4.1 Overview
My results have shown that:
• Nine days of urachal and urethral occlusion, in the fetal lamb, initiated 
at 75 days gestation resulted in bilateral hydronephrosis, a thick- 
walled bladder with well-maintained detrusor structure and function, 
and normal compliance and wall stress.
• Radiotelemetered fetal cystometry was feasible in the obstructed fetal 
ovine bladder from 94 days gestation (for nine days), and revealed a 
progression of urodynamic patterns within hours of obstruction. 
Patterns were characterised by voids at increasing pressures, 
occurring more frequently, and a baseline pressure disrupted by 
detrusor overactivity. In-utero cystometry in the unobstructed fetal 
ovine bladder was unsuccessful.
In addition:
• Urachal ligation alone from 75 days gestation resulted in the same 
urinary tract appearance and bladder physiology as in the double 
ligation group.
• Nine days of BOO initiated at 75 days caused marked growth of the 
obstructed fetal urinary tract compared with shams, a feature which 
was not noted when BOO was initiated at 94 days gestation.
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The appearance and function of the bladder obstructed for nine days 
from 75 days contrasted markedly with that found after 30 days of 
BOO
Protocols 1 and 2 confirm the reproducibility and resilience of the fetal ovine 
BOO model. This is the first time morphology, function and in-vivo 
cystometry have been studied in the same model. This work, together with 
that of Nyirady et al. (2002) and Thiruchelvam et al. (2003a and b), 
constitutes the first time that BOO at 75 days has been studied since 
Tanagho’s pioneering work in 1972 (Tanagho 1972). Samnakay et al (2006) 
published findings on a 70-day model but only renal, and not bladder, 
changes were described.
My findings are discussed in the following sections:
• BOO initiated at 75 days (bladder morphology and physiology 
followed by kidney morphology)
• BOO initiated at 94 days gestation (bladder morphology and 
physiology and comparison between short- and long-term fetal BOO)
• Interpretation of radiotelemetered urodynamics
• Clinical implications
• Future work
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4.2 Protocol 1 results: Fetal BOO from 75 days gestation
4.2.1 Bladder morphology
BOO initiated at mid-gestation, and maintained for just nine days, produced 
marked accelerated bladder growth, as assessed by weight, protein and 
DNA content. Bladder weights increased four-fold in spite of the fact that 
fetal growth was not significantly different between the normal and 
obstructed groups. Amounts of protein and DNA in the obstructed bladders 
reached levels expected of normal term organs. Considering the bladder as 
a whole, the growth response was predominantly hyperplasia, as judged by 
lack of increase in protein/DNA ratios. Detrusor smooth muscle (DSM) in 
BOO bladders appeared grossly normal on light microscopy, with no 
evidence of disruption. Ultrastructurally, individual detrusor muscle bundles, 
as well as intervening connective tissue, appeared greater than controls, 
though this difference was not formally quantified. These findings reflect 
work performed by other groups. Peters et al. (1992) described a significant 
increase in bladder mass following BOO in the fetal lamb at 60 until term -  
and showed the ratio of hyperplasia to hypertrophy to be 3.3:1. Buttyan and 
Levin (1997) used 3H-thymidine staining to show that hypertrophy and 
hyperplasia occur in different cellular compartments: the former in detrusor 
smooth muscle, and the latter in fibroblasts and mucosal cells.
When analysing the bladder in greater detail, my results revealed significant 
changes in the urothelium, whereby the “urothelial cell layers” increased 
almost three-fold in the obstructed bladders compared with shams. It is 
possible that the measured increase in urothelial nuclear layers was due to
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bladder collapse prior to fixation, rather than growth. However, Gosling et al. 
(2000) and Lieb et al. (2000) also noted this phenomenon: they described 
urothelial and fibroblast hyperplasia following BOO in the mature rabbit, 
which was later followed by detrusor hypertrophy. Monson et al. (1995), who 
also studied BOO in the rabbit, proved that the increase in urothelial nuclear 
layers was due to urothelial hyperplasia, by means of a thymidine-labelling 
technique. My urothelial studies also showed prominent apoptosis in the 
basal urothelial zone in BOO groups but not in sham urothelia, a feature not 
previously reported. The apoptotic count in the other layers of the fetal 
bladder, namely the lamina propria and DSM layers, was sparse. iNOS was 
immunolocalized in urothelia of sham fetal bladders with no change in signal 
intensity after BOO: hence, in this context, no correlation was noted 
between levels of iNOS and apoptotic index, as in the guinea-pig bladder 
(Chertin et al. 2004).
BOO at 75 days also resulted in the undisrupted expression of uroplakin 
(UPlb and III) proteins in urothelia from both sham and obstructed bladders: 
ultrastructural studies will be needed to establish whether these proteins are 
found in vesicles or apical membranes of the umbrella cells. Although 
Truschel et al. (2002) showed that UPIII expression is increased in apical 
membranes exposed to increased hydrostatic pressure, my work showed no 
difference between BOO and control UPIII.
When visualised by transmission electron microscopy, urothelial umbrella 
cells appeared larger than control cells, and contained a higher
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concentration of apical vesicles (Fig. 29 A-B). This finding is very interesting 
because although bladders would have been drained, and hence “un­
stretched” prior to fixation, they may have maintained their “stretched” 
appearance ultrastructurally. We know from previous work that bladder 
distension results in the accumulation of vesicles beneath the apical 
membrane (Minsky & Chlapowski 1978), and that exocytosis of vesicle 
contents occurs in order to increase the urothelial apical membrane surface 
area (Truschel et al. 2002) -  so it is possible that continuous distension 
results in an increased production of apical vesicles for this purpose.
4.2.2 Bladder physiology
Analysis of the data sets indicated that nine days of BOO from 75 days 
gestation generated an evolving pattern of changes in bladder physiology.
In terms of conrtactility, standardization of bladder data for initial intravesical 
volume and wall thickness suggested that there was no significant difference 
between the three groups (sham, urachal ligation only, urachal and urethral 
occlusion) - a finding which correlated with the well-preserved DSM. Since 
electrical field stimulation depends on an intact nerve supply, this finding 
suggests that the degree of BOO was not sufficient to cause a functional 
denervation. Variability of the raw data was generally greater in the 
obstructed groups than the control set. For example, the variance ratio of 
normalised wall stress values in the obstructed and control groups was, as 
indicated by Fisher’s test, highly significant. This indicated that there was an 
inherent variability in the extent of obstruction between animals and this led 
to a spectrum of responses. This made comparison of group data sets
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difficult, as the large inherent variability may have masked any trends. To 
minimise variability, different parameters were assessed as a function of the 
bladder-to-fetal-weight ratio (BFR). Furthermore, as no differences could be 
identified between the two obstruction groups, (urachal ligation only and 
urachal and urethral occlusion), the data from the two groups were 
amalgamated.
The change in the passive properties (compliance) of the bladder wall, as 
assessed by measurement of normalised wall stress per unit change of 
volume, precedes functional (contractility) changes: an increase of BFR was 
associated with a reduced wall stress per unit change of volume, i.e. the 
bladder wall was easier to extend per unit volume change as BFR 
increased. The implications are that an increase in bladder wall thickness 
appears to facilitate filling by reducing wall stress, and hence reduce the risk 
of a raised intravesical pressure. A reduced circumferential tension implies a 
reduction in the ability of detrusor tension to be transmitted through the 
tissue mass, and so again reduces the ability of the bladder to raise 
pressure during active contraction. This compensatory mechanism may not 
last throughout a more prolonged obstructive period, and hence intravesical 
pressures may be expected to rise in spite of a thickened bladder wall. 
Whether wall stress recovers after a period of de-obstruction remains a 
further question to address.
The hypothesis that a short period of obstruction would result in 
compensation, i.e. bladder overgrowth of the bladder without failure of
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function (Gosling et al. 2000) was confirmed by the lack of association of 
nerve counts or contractile function with increased BFR. Two modes of 
contractile activation were tested, i) via the cholinergic motor nerves, ii) by 
direct activation through depolarisation with elevated [KCI] or with 
muscarinic or purinergic agonists. Again, data from the two obstructed 
groups have been combined because of the relatively small data sets. 
Contractions elicited by EFS and by direct muscle stimulation with 
charbacol, confirmed that a cholinergic mechanism is active at this 
gestation. Contractions elicited by EFS were completely blocked by the 
neurotoxin TTX, indicating they were nerve-mediated. Atropine completely 
abolished nerve-mediated contractions in detrusor strips from all groups, 
and actually resulted in mild relaxation. This finding would suggest that no 
mechanism for detrusor contraction (e.g. purinergic) other than via 
cholinergic neurotransmission was in place (Burnstock 2002). However, 
application of ABMA, a purinergic agonist, generated transient contractures 
in all preparations, which were not significantly different between BOO and 
control bladders. This suggested that purinergic receptors may in fact be 
present at this gestation, although ATP-induced contraction is not 
necessarily active in normal or obstructed fetal bladders at this gestation. 
Studies in older fetal lamb models (90 days and above), on the other hand, 
have suggested a possible active purinergic component (Levin et al. 2001, 
Thiruchelvam et al. 2003c). Receptors may also develop in response to an 
increased amount of ATP, which is released by bladder distension 
(Burnstock 2002). The relaxation component may suggest that a nitrergic 
mechanism may also exist but was not studied in the current set-up. Plots of
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BFR as a function of tension did not show a significant correlation 
suggesting that bladder overgrowth was not associated with contractile 
failure.
4.2.3 Kidney morphology
BOO for nine days had variable effects on renal histology, even though 
hydronephrosis was uniformly documented. Sham renal histology revealed a 
nephrogenic zone with S-shaped bodies, a deeper cortex with formed 
glomeruli and medullary collecting ducts. In six out of ten kidney pairs from 
the BOO groups, these appearances were maintained. In two sets of 
kidneys from the urachal-only ligation group and in two sets from the urachal 
and urethral ligation group, however, the cortex contained cysts, some with 
glomerular tufts, and medullary ducts were dilated. These changes were 
typical of fetal renal obstruction early on in gestation in ovine and other 
models (Kitagawa et al. 1999, Matsell et al. 2002). Kidneys with cysts 
tended to occur in fetuses with the highest bladder weights and protein 
contents, although in this study I have not shown whether this relationship 
was due to a direct transmission of intravesical pressure due to reflux. In 
human congenital obstructive nephropathy, the observation that urine 
osmolality concentrations approach plasma values indicate a failure to dilute 
urine; however, this is a normal function of the sheep kidney in the second 
half of gestation (Nijland & Ross 2000). In this study, urine osmolality and 
sodium concentration were not significantly different between BOO and 
sham fetuses.
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4.2.4 Role of the urachus
An unexpected outcome of Protocol 1 was the revelation that urachal 
ligation with patent urethra produced similar changes in bladder growth, 
morphology, compliance and contractility as combined urachal and urethral 
obstruction. Gobet el al. (1998) had also suspected and investigated this 
finding. They performed urachal-only ligation in the fetal lamb at 95 days 
gestation: at term, only the male lambs had hydronephrosis and increased 
bladder weight. Collectively, Gobet’s and our current results strongly 
suggest that the male sheep fetal urethra is a high-resistance conduit in mid­
gestation. We found that some paramaters, such as bladder protein and 
bladder/fetal weight, had less variability in the urachal-only group, and this 
finding remains unexplained.
4.2.5 Comparison between BOO at 75 days maintained for nine days 
and BOO at 75 days maintained for 30 days
It is interesting to compare effects of short- versus longer-term fetal BOO 
induced by combined urachal and urethral obstruction (Table 5). Nine days 
BOO caused bladders to be 3-4 times heavier than controls, whereas 30 
days BOO led to an even greater increase versus time-matched shams 
(Nyirady et al. 2002): hence the accelerated growth response is sustained. 
Although bladders obstructed for either nine or 30 days were both 
overgrown, their histology differed markedly. More prolonged BOO led to a 
flattened urothelium, with DSM bundles separated by prominent matrix and 
increased apoptotic index in the DSM and lamina propria; short-term BOO 
generated a urothelium with more cell layers than normal, with a generally
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well-maintained detrusor layer and prominent urothelial apoptosis (Nyirady 
et al. 2002). The trajectory of morphological/cell biological changes is 
paralleled by physiological observations, with well-maintained contractility at 
nine days but hypocontractility after 30 days. Hence, there is an evolution 
from an overgrown but contractile (‘compensating’) bladder to a 
hypocontractile (’decompensated’) organ. These findings are again in 
parallel with Levin et al.’s (1997) definition of decompensation as the phase 
characterized by progressive deterioration in contractility and function (i.e. 
ability to empty), a slower increase in mass, and a progressive decrease in 
the volume fraction of smooth muscle elements in the bladder w a ll. Levin et 
al. (1997), however, describe two possible end-results: either an organ with 
a thick fibrous wall, low capacity, poor compliance and little or no contractile 
function; or a dilated bladder with a thin fibrous wall, high capacity, and little 
or no contractile function: the findings in the study by Nyriady et al. (2002) 
were consistent with the latter. Importantly for my future work, Levin et al. 
(2002) showed that relief of obstruction during the compensated phase, at 
least in animals, induced a rapid and full restoration of the bladder function. 
However, when the obstruction was relieved during the decompensated 
stage, bladder function only partially recovers (Levin et al. 2002).
4.2.6 Summary
In summary, the results from Protocol 1 proved the hypothesis that nine 
days urachal and urethral occlusion in the fetal lamb, initiated at mid­
gestation, result in a thick-walled, compliant, contractile bladder similar to 
the compensating obstructed bladders found in infants born with PUV
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(Holmdahl et al. 1995; see 4.4.2). These findings contrast with the 
decompensated features noted following BOO for 30 days.
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4.3 Protocol 2: Fetal BOO and radiotelemetered urodynamics from 94 
days gestation
4.3.1 Morphology and physiology
The most striking difference between the morphology and physiology 
outcomes of BOO initiated at 75 days and that initiated at 94 days is that 
although the same BOO methodology was used in both sets of experiments, 
early-onset BOO resulted in significant increases in bladder weights, 
urothelial layers and incidence of urothelial apoptosis, as well as profound 
renal cystic changes, while late-onset BOO, maintained for the same period 
of time, failed to elicit such pronounced responses. These findings are in 
keeping with previous experimental BOO studies: several groups have 
shown that fetal ovine BOO at 75 days gestation or earlier, results in 
kidneys with microcystic dysplastic changes, structural disorganization, a 
reduction in glomerular number and medullary tubular dilatation (Kitagawa et 
al. 1999,Kitagawa et al. 2001 .Edouga et al. 2001 ,Nyirady et al.
2002,Kitagawa et al. 2004), whereas fetal BOO later in gestation results in 
hydronephrosis with larger cyst formation and a normal glomerular count, 
but no parenchymal disorganization, although a thinned cortex was often 
observed (Harrison et al. 1982,Harrison et al. 1983,Adzick et al. 1985,Gobet 
etal. 1998,Kitagawa et al. 1999).
Although bladder morphology appeared rather resilient in the 94 day BOO 
group, three of the four sets of BOO kidneys had developed cysts in nascent 
glomeruli in the subcapsular area: the reason why these just-forming 
nephrons appear to be more easily distorted following fetal BOO versus
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more mature nephrons in the deeper cortex is unknown but may 
theoretically relate to less resilient basement membranes. In fact, the 
formation of similar cortical cysts has been shown to initiate after just a few 
days of experimental complete unilateral ureteric obstruction in sheep 
fetuses aged 90 days gestation (Attar et al. 1998), and is also a 
characteristic of experimental urinary flow impairment in primates (Matsell et 
al. 2002a). Protocol 2 showed that generation of cortical cysts correlated 
with episodes of raised detrusor pressure; however, it remains to be 
determined whether the underlying mechanism involves mechanical 
obstruction of the ureters by dilated bladders, or high pressure VUR 
secondary to BOO. Surprisingly, the obstructed fetus which did not develop 
cystic kidneys was found to have the least compliant bladder, which goes 
against VUR being the mechanism of transmission of pressure to the upper 
tracts.
4.3.2 Radiotelemetered natural-fill urodynamics
This model represents a fresh insight into the application of the fetal ovine 
model to antenatal urodynamic studies, and the characterization of fetal 
cystometry at various stages of obstruction. The major advantage of 
radiotelemetered natural-fill urodynamics versus traditional urodynamics 
utilising external catheters (de Tayrac et al. 2003) is that in the absence of 
external lines, the pregnant ewes are free to move around the pen without 
restraint, and there is also less risk of dislodgement and infection. The 
disadvantages of the radiotelemetry technique are the relatively large size of 
the implant body (6 by 6 cm, approximately the size of a 94-day fetal
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abdomen) and the diameter of the catheters (1.2 mm); factors which clearly 
limit the size of fetuses which can be realistically studied. Bladder 
catheterisation through an incision in the bladder wall was successful in the 
pilot study performed by Thiruchelvam et al. (2004) in the fetal lamb at 105 
days gestation, but failed in our 94 day-old fetuses, suggesting that the 
younger bladders were too delicate to sustain direct catheterisation.
Inserting catheters through the urachus is not an accurate way to study 
‘normal’ unobstructed bladders, as we now know that urachal occlusion per 
se causes a degree of BOO (Gobet et al. 1998,Farrugia et at. 2006a). Until 
radiotelemetry technology is able to provide smaller catheters, a substitute 
method of measuring intravesical pressure is required that is tolerated by 
animals of younger gestational age. Difficulties identified during an earlier 
pilot study were overcome in this study: intra-abdominal catheter 
dislodgement was prevented by tunnelling the intra-abdominal catheters, 
and a previous inability to activate the implant’s on/off switching mechanism 
was overcome by attaching the implant body to the internal surface of the 
maternal abdomen making it accessible to the required magnetic induction.
An inevitable limitation of monitoring in-vivo fetal urodynamics chronically in 
an ambulatory situation was that voiding could not be directly visualised. 
Thus ‘voids’ were recognised as sustained elevations in pressure, also 
characterised by a high frequency superimposed low-amplitude activity 
(thought to arise from the activity of a urethral pump mechanism in the long 
posterior urethra of sheep) (Fig. 35 and 36). The same pattern of voiding 
has been noted in a previous fetal sheep study with voiding observed during
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ultrasonograpy (de Tayrac et al. 2003) and in an acute study of normal fetal 
pigs in which synchronous voiding and urinary flow were observed (Olsen et 
al. 2001). Thiruchelvam at al. (2004) reported the same sustained normal 
voids in a study of in-vivo urodynamics in two unobstructed animals (one 
male, one female) using the same radiotelemetry technique in 105 day 
gestation sheep with bladder catheters inserted directly through the bladder 
wall. The voids had variable durations between 60 and 180 seconds and 
occurred about three times per hour. The maximum detrusor voiding 
pressures at 105 days gestation were 20 to 28 mmHg (27 to 38 cmH20) 
(Thiruchelvam et al. 2004).
4.3.3 Interpretation of in-vivo cystometry
Due to the unavailability of control traces in this study, the obstructed traces 
obtained were compared with the ‘normal’ traces reported by Thiruchelvam 
et al. (2004) at 105 days (which is close to the age at which my study was 
concluded). This comparison was not ideal, as only one of the two fetuses 
with trans-vesical catheterisation in that study, was male. My results showed 
that within 24 hours of obstruction, voids occurred at median voiding 
pressures of 12-14 mmHg (16-19 cmH20) and lasted for one minute, with a 
pattern similar to that seen by Thiruchelvam et al. (2004). Conversely, the 
low-pressure ‘undulations’ noted in-between voids had not been previously 
documented. The gradual increase in voiding pressures that occurred over 
the ensuing days, reaching a median of 24 to32mmHg at 101 days, was 
also a new finding, as Thiruchelvam’s work showed that the unobstructed 
male fetus at 105 days maintained stable voiding pressures of 27-28 mmHg
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throughout 30 days of observation (Thiruchelvam et al. 2004). Of course one 
cannot conclude, without directly comparable control animals, whether the 
increasing detrusor pressures seen in this study were actually a result of 
obstruction or a feature of normal intra-uterine development.
The frequency and duration of voids also differed markedly between the two 
studies. The frequency of voids in the unobstructed male fetus was 
observed to decrease from 3.0 to 1.5 voids per hour over a period of 30 
days (Thiruchelvam et al. 2004); mean duration of each void increased from 
1 to 1.5 minutes. Fetuses in Protocol 2 were attempting to void initially every 
1 to 2 minutes and even more frequently with prolonged obstruction; the 
duration of each void increased significantly to a median of 3.4 to 4 minutes 
after seven days of obstruction. Notably, only one obstructed fetus 
maintained a more regular voiding frequency (one void every two or three 
minutes), and this was the only BOO fetus which did not develop glomerular 
cysts, possibly because the bladder spent less time at raised intravesical 
pressures. The ‘haphazard’ contractile activity noted later in the obstructive 
period, is also a new finding. These excursions may represent frequent 
voiding attempts by the fetus. Overall, the obstructed bladders spent 
increasing amounts of time at sustained high pressures usually associated 
with bladder emptying activity.
Despite the heterogeneity of renal cystic changes and voiding patterns in the 
BOO group, it should be emphasised that all four BOO fetuses had dilated 
renal tracts on ultrasonography. Overall, the resting baseline detrusor
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pressure remained low throughout the nine day study period: this finding is 
consistent with the normal compliance found on ex-vivo cystometry and 
implies that the bladders were able to compensate by accommodating 
increasing intra-vesical volumes.
4.3.4 Summary
Protocol 2 results have proven the hypothesis that radiotelemetered fetal 
cystometry is feasible in the obstructed ovine bladder at 94 days gestation 
and suggest that bladder dysfunction associated with congenital BOO 
begins in-utero. In the fetal lamb, this occurs within hours of obstruction and 
is characterized by a pattern of more frequent and prolonged voids. Voiding 
pressures inceased during the period of obstruction; however, in the 
absence of any controls, it is unknown whether this was the effect of 
obstruction or response to fetal and bladder growth. Baseline storage 
pressure, however, does not change significantly throughout the nine days 
and is consistent with the normal bladder compliance noted following ex-vivo 
cystometry. Radiotelemetered cystometry failed in the 94-day gestation 
unobstructed fetus.
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4.4 Clinical implications
4.4.1 Human versus experimental fetal BOO
The morphological and physiological findings following fetal ovine BOO 
closely reflect the human scenario where, although the typical infant “valve” 
bladder is thick-walled and trabeculated with a variable compliance, the 
extent of renal dysplasia differs considerably. Cussen (1971) peformed post­
mortem studies of 30 renal units from children with congenital urethral 
obstruction, and demonstrated cystic renal dysplasia in only 37%. The 
nature of the dysplasia found experimentally is typical of prenatal 
obstruction, i.e. Potter type IV malformations (Potter 1972). Potter (1972) 
described the characteristic findings, which are subcapsular cysts, each 
derived from S-shaped bodies, and comprised of a dilated Bowman’s 
capsule and a primitive proximal tubule. She postulated that ureteric bud 
branching is initially normal in type IV malformations and that a sudden, 
severe, obstructive event would rapidly ablate the renal mesenchyme, 
resulting in a single layer of cysts, as seen in this study (Potter 1972).
A further result from Protocol 1 which is relevant to clinical management is 
the fact that urine concentrating ability remained normal in spite of the fact 
that changes in bladder morphology and compliance, as well as renal cystic 
change, had already become manifest. However, fetal medicine criteria for 
antenatal intervention as established by Johnson et al. (1994) state that 
three serial vesicocenteses taken at 48-72 hour intervals and showing a 
pattern of decreasing hypertonicity are required to identify fetuses that hold 
the greatest potential benefit from in-utero surgical intervention. My findings,
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however, suggest that decompression may have to be carried out earlier 
than this in order to better preserve bladder and kidney function.
Overall, it is evident that patients with PUV share only a common label; each 
obstruction is unique, and the resulting course varies. This is important to 
remember in the laboratory setting, where each obstruction that is surgically 
produced will also be quite variable.
4.4.2 Human pre- and post-natal bladder function
Sillen et al. (2000) evaluated the voiding pattern of preterm neonates at a 
mean of 32 weeks gestation, by means of four-hour voiding observation.
The neonates voided once an hour, and voided a mean of 53% of total 
capacity with a 58% frequency of “interrupted voiding”. Interrupted voiding 
was defined as two or three voids in less than 10 minutes, and was 
documented in 60% of preterm neonates, and later in 30% of term babies 
(Sillen et al. 2000, Sillen 2001). Natural fill urodynamic studies have shown 
that interrupted voiding remained prevalent in babies at six months of age; 
however, the bladder at this age empties to near completion (Yeung et al. 
1995). Yeung et al. (1995) attributed this voiding pattern to a 
dyscoordination between the sphincter and the detrusor, and also noted that 
detrusor instability is rare in the normal infant bladder. Mean voiding 
pressures at this stage were noted to be higher than those expected in older 
children with values reaching 117 cm H20  in males and 75 cm H20  in 
females (Yeung et al. 1995). Thus the standards for voiding pressures in
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healthy infants are imprecise and can be a median of more than 100 cm 
H20  in males, and 60-70 cm H20  in females (Wen & Tong 1998).
Urodynamic studies in babies born with PUV have revealed even higher 
voiding pressures (162 cm H20) than those found in normal bladders 
described above, with a high incidence of instability, leading the authors to 
describe these bladders as “hypercontractile” (Holmdahl et al. 1996). 
Instability was present in 88% of patients at presentation, at a mean 
pressure if 60 cmH20. Compliance was calculated from the increase in basic 
detrusor pressure at expected normal bladder capacity for patient age: a 
basic pressure increase of >20 cmH20  was considered to represent a poorly 
compliant bladder. Non-compliant bladders were noted in 50% of babies 
(Holmdahl et al. 1996).
Wen et al. (2006) compared valve bladder urodynamics in boys aged below 
and above two years of age. Changes in urodynamic patterns were noted at 
two years of age, when voiding pressures and bladder compliance were 
noted to be significantly reduced, whereas post-void residual and bladder 
capacity were increased. Interestingly, almost half of the older boys showed 
intermittent detrusor contraction during voiding, which the authors described 
as a “special voiding pattern”: the pattern was remarkably similar to the 
‘superimposed’ contractions typical of the fetal void (Fig. 39) (Wen et al. 
2006).
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It is of interest that Yeung et al. (1998) reported the clinical application of 
continuous real-time ambulatory urodynamic monitoring using infrared 
telemetry, in infants and young children. The system works via an 
ambulatory urodynamic recorder that converts digital pressure signals to 
modulated infrared waves which are then picked up by a receiver attached 
to the clinic ceiling. Thus the child is able to perform normal play and 
activity, while the clinician monitors the natural-fill urodynamics in a separate 
room (Yeung 1998). Therefore as technology is refined and radiotelemetry is 
adapted to allow human ambulatory urodynamics, the concept of its use in 
the prenatal setting may not be such a distant one.
In conclusion, it appears that neonatal bladder dysfunction may in fact be a 
continuum of the damage initiated in-utero. Although urodynamic findings in 
the fetal model and those in human neonates are not strictly comparable, it 
is interesting to note that the absence of bladder instability in normal 
newborns suggests that the finding of detrusor overactivity in utero may in 
fact be abnormal. On the other hand, “dyscoordinated” voids occurring two 
or three times per ten minutes was not unusual in the term baby, hence the 
significance of the frequent voids in the fetal model becomes questionable in 
the absence of a suitable control. Also, voiding pressures in human 
neonates were found to be considerably higher than those measured in 
utero, even in the presence of BOO. Holmdahl et al. (1996) documented a 
non-compliant bladder in 50% of infants born with PUV, implying that the 
other half may have a normal compliance: this variation was also noticed in 
the experimental setting. Of course one can only speculate on how the
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human fetal bladder functions, as antenatal urodynamics in the clinical 
setting are as yet not feasible.
4.4.3 Long-term outcome
The long-term effect of close follow-up and management of neonatal bladder 
dysfunction is as yet unknown, as the infants on whom urodynamic studies 
have been performed (largely in the last 10-15 years) have not as yet 
reached adulthood. Retrospective reviews have shown that boys with 
bladder dysfunction in childhood, particularly those with persistent poor 
compliance and instability, are more likely to develop ESRF (Lopez-Pereira 
et al. 2002). Holmdahl et al. (1996) retrospectively reviewed outcome in 
boys born with PUV and followed up from 4 years of age: a changing 
urodynamic pattern was noted, with decreasing instability, increasing 
bladder capacity, and poor bladder emptying. Postpubertal PUV patients 
had high capacity bladders with low contractility. Renal concentrating ability 
was normal in only 17% of patients studied (Holmdahl et al. 1996). It is 
hoped that the greater awareness of antenatal and neonatal bladder 
dysfunction and its careful management will improve outcome in this groups 
of patients.
4.5 Future work
My results have shown that antenatal urodynamics are feasible in the fetal 
lamb BOO model from 94 days gestation. However, my work in this thesis, 
and that of others, has shown that obstruction at this gestation induces a 
lesser degree of renal dysplasia than obstruction earlier in gestation. Hence
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it would be more useful to study the correlation between onset of bladder 
dysfunction and renal dysplasia in a younger fetus at or before mid­
gestation. This would entail a combination of improvement in technology 
with smaller implants and thinner lines, and better fetal operative skills to 
reduce fetal loss. It would also be useful to observe these changes for a 
period longer than nine days, when the bladder retains its compliance and 
contractility, but shorter than thirty days, when the bladder becomes 
hypocontractile and over compliant. My work in Protocol 1 showed that two 
bladders exhibited a reduced compliance (which is what occurs in a 
proportion of neonatal PUV bladders) whereas there was a large variability 
in the rest, possibly implying that the “ideal” period of observation should run 
a few days longer: I would hypothesise 15 days. In order to study the effect 
of vesico-amniotic shunting on bladder dynamics, further observation would 
then be required.
I therefore hypothesise that 15 days of BOO from 70 to 85 days gestation 
would result in a thick-walled bladder with a variable compliance as seen in 
newborns with PUV, and would result in associated urodynamic changes. 
Decompression at 90 days gestation would result in an improvement in 
intravesical pressures and detrusor overactivity over a further ten day period 
to 95 days. In addition, following observations by Kitagawa et al. (2007), it 
would be essential to study the effect of a shunt perse  on bladder 
morphology and function. Four experimental groups would be required: a 
control non-obstructed group (70-95 days gestation); a non-obstructed 
shunted group in which a shunt is inserted at 85 days and observed for a
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further 10 days; and two BOO groups, of which one is shunted at 85 days 
and observed for 10 days. Radio-telemetered urodynamics would be 
observed throughout, and ex-vivo cystometry performed following sacrifice.
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Figure 39. Intermittent detrusor contractions (arrow) during voiding 
noted during a urodynamic study on a 6 year old boy with a valve 
bladder.
(Wen etal. 2006)
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Table 5. Comparison between nine and thirty days BOO commencing at 75 days gestation.
Bladder feature 9 days BOO (75-84 days) 30 days BOO (75-105 days)
Weight Increase Increase
Wall thickness Increase Decrease
Urothelium Increase 4-8 cell layers Flattened, single cell layer
Urothelial apoptotic index Increased No difference
Asymmetric unit membrane Intact AUM and UP1b -
Lamina propria Thickened Flattened
Lamina propria apoptotic index No difference Increase
Detrusor muscle Intact, no difference Disrupted, increased area
Nerve bundles Reduced Reduced
Total protein/DNA
Increase in total protein and DNA but no difference in protein/ 
DNA ratio
Increase in total protein and DNA but no difference in 
protein/DNA ratio
Compliance Normal Increased compliance
Contractility
No difference, contractility cholinergic in origin. No purinergic 
component. Evidence of nitrergic relaxation.
Hypocontractile throughout; evidence of purinergic and 
nitrergic component
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7. APPENDICES
In all tables, * indicates a significant difference (p<0.05) and ** indicates a 
highly-significant (p<0.01) difference between groups.
Key
SvU = Sham versus urachal ligation only
SvLIU = Sham versus urachal and urethral occlusion
UvUU = Urachal ligation only versus urachal and urethral ligation
SvO = Sham versus obstructed (protocol 2 only)
M-W = Mann Whitney analysis
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Appendix 1. Protocol 1 fetal data.
Sham Urachal
ligation
Double
ligation
P values (M-W)
SvLI SvUU UvUU
Fetal age (years) 82 82 82
75 75 75
75 75 75
82 75 82
75
75
Median 78.5 75 75 0.65 0.74 0.91
Fetal weight (g) 650 700 620
400 400 400
500 450 450
350 550 800
650
850
Median 450 500 635 0.56 0.23 0.45
Occipito-snout 
length (cm)
77 72 72
67.5 67.5 68
68 69 69
63 71 68
78
80
Median 67.75 70 70.5 0.56 0.16 0.59
Crown-rump 
length (cm)
22.5 26.5 27
19.8 21.5 20.8
23 24 20.6
20 22.8 24
24
25
Median 21.25 23.4 24 0.20 0.11 0.91
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Appendix 2. Protocol 1 urine osmolality and sodium content.
Sham
Urachal
ligation
Double
ligation P-values (M-W)
SvU SvUU UvUU
Osmolality
(mOsm/Kg) 164 113 151
148 294 164
169 124 146
131 163 251
139
190
Median 156 143.5 157.5 0.73 0.46 0.61
Sodium
(mmol/L) 67 0 56
48 117 65
54 0 47
36 51 116
37
82
Median 51 25.5 60.5 0.90 0.25 0.48
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Appendix 3. Protocol 1 fetal bladder data.
Sham
Urachal
ligation
Double
ligation P values (M-W)
SvU SvUU UvUU
Bladder weight (g) 0.43 2.42 0.85
0.34 1.67 1.12
0.46 1.37 1.03
0.37 2.58 1.60
1.20
2.60
Median 0.41 2.04 1.16 *0.03 **0.01 0.15
Bladder:total fetal weight 
ratio 0.67 3.46 1.37
(*10-3) 0.85 4.17 2.81
0.92 3.03 2.29
1.07 4.70 2.00
1.84
3.06
Median 0.89 3.81 2.14 *0.03 **0.01 **0.01
Volume of urine drained 
from bladder 1.20 8.00 1.50
(ml) 1.20 0.40 0.50
2.50 1.30 1.20
1.60 22.0 3.50
3.40
40.50
Median 1.40 4.65 2.45 0.69 0.59 1.00
Bladder wall thickness 
(empty) (mm) 0.46 0.82 0.58
0.42 0.72 0.63
0.47 0.68 0.62
0.52 0.84 0.71
0.65
0.84
Median 0.47 0.77 0.64 *0.03 **0.01 0.17
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Appendix 4. Protocol 1 kidney data.
Sham
Urachal
ligation
Double
ligation
P
values
(M-W)
SvU SvUU UvUU
Right + left whole kidney 
weights (g) 6.24 17.25 10.70
5.48 7.85 9.88
5.96 6.90 5.55
4.62 8.04 8.10
8.20
10.50
Median 5.72 7.95 9.04 *0.02 *0.03 0.60
Right + left kidney weights
(g) 6.14 13.04 8.94
(after urine drained) 5.20 7.15 7.72
5.56 6.24 5.10
4.29 7.50 7.60
7.80
10.00
Median 5.38 7.32 7.76 *0.02 0.06 0.60
Right + left renal pelvis 
weights (g) 0.10 4.21 1.76
(i.e. weight of drained urine 
as 0.27 0.70 2.15
reflection of degree of 
hydronephrosis) 0.34 0.65 0.46
0.33 0.54 0.50
0.70
1.40
Median 0.30 0.68 1.05 *0.02 **0.01 0.91
Total drained renal: fetal 
weight ratio 9.44 18.62 14.42
(*10-3) 13.02 17.88 19.30
11.12 13.88 11.33
12.25 13.64 9.50
12.00
11.76
Median 11.68 15.88 11.88 *0.02 0.60 0.25
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Appendix 5. Protocol 1 protein estimation data.
Experimental
Group
Whole
bladder Sample
Absorbance
1
Absorbance
2
Concentration
1
Concentration
2 Mean
weight
(g) weight (g)
Sham 0.438 0.012 0.213 0.216 1140 1157 1148
0.341 0.019 0.346 0.273 1875 1473 1676
0.462 0.015 0.270 0.220 1457 1179 1318
0.373 0.013 0.220 0.280 1326 1171 1249
Urachal
ligation 2.420 0.014 0.173 0.177 918 940 929
1.668 0.012 0.190 0.163 1012 862 937
2.584 0.016 0.202 0.182 1079 968 1023
Double
ligation 0.850 0.024 0.173 0.177 918 940 929
1.125 0.023 0.325 0.303 1762 1640 1701
1.031 0.014 0.181 0.192 962 1023 993
1.600 0.014 0.193 0.201 1029 1073 1051
1.200 0.011 0.190 0.177 1012 940 976
2.600 0.027 0.261 0.292 1407 1579 1493
Total bladder
Total
protein Median P-values
protein (pg) (mg)
42645 42.64 SvU
30250 30.25
39808 39.80
35029 35.03 37.41 0.06
159521 159.52 SvUU
136018 136.01
166398 166.39 159.52 0.07
33194 33.19 UvUU
82162 82.16
72121 72.12
121055 121.05
110566 110.56
144337 144.33 96.36 *0.04
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Appendix 6. Protocol 1 DNA estimation data. Note on numbers: for 
technical reasons, only 3 of the 4 bladder samples were available for 
DNA analysis in the urachal-only group.
Whole
bladder Sample
Absorbance
1
Absorbance
2 Mean Concentration DNA per
weight (g) weight (g) (ng/ul) sample
Sham 0.438 0.029 0.433 0.437 0.435 1087 27187
0.341 0.026 0.305 0.280 0.293 731 18281
0.400 0.031 0.304 0.296 0.300 750 18750
0.462 0.023 0.301 0.333 0.317 792 19812
Urachal
ligation 2.420 0.035 0.156 0.160 0.158 395 9875
1.668 0.029 0.515 0.516 0.516 1288 32218
2.584 0.040 0.636 0.639 0.638 1593 39843
Double
ligation 0.850 0.038 0.398 0.400 0.399 997 24937
1.125 0.042 0.351 0.365 0.358 895 22375
1.031 0.027 0.476 0.480 0.478 1195 29875
1.600 0.044 0.480 0.480 0.480 1200 30000
1.200 0.028 0.337 0.338 0.338 843 21093
2.600 0.038 0.518 0.522 0.520 1300 32500
Total
bladder
Tot
bladder Median P-values
DNA (ng) DNA (mg)
410625 0.41 SvU
237030 0.23
242718 0.24
396250 0.39 0.32 0.06
692681 0.69 SvUU
1872504 1.87
2561100 2.56 1.87 **0.01
562251 0.56 UvUU
603642 0.60
1153600 1.15
1095890 1.09
894434 0.89
2241379 2.24 0.10 0.38
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Appendix 7. Protocol 1 protein: DNA ratio estimation data.
Total
protein
Total
bladder
Protein: DNA 
ratio P-values
(mg) DNA (mg)
Sham 42.64 0.41 103.85 SvU
30.25 0.23 127.62
39.80 0.24 164.01
35.03 0.39 88.40 0.63
Urachal
ligation 159.52 0.69 230.29 SvUU
136.01 1.87 72.64
166.39 2.56 64.97 0.35
Double
ligation 33.19 0.56 59.03 UvUU
82.16 0.60 136.11
72.12 1.15 62.51
121.05 1.09 110.46
110.56 0.89 123.61
144.33 2.24 64.39 0.80
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Appendix 8. Protocol 1 urothelial apoptotic index. Six propidium iodide- 
stained and TUNEL-stained counts per field (x200 magnification) per fetus 
were made. The total of six counts per fetus is shown for each experimental 
group. The apoptotic index for each experimental group was then derived.
Sham
Urachal
ligation
Double
ligation P-values
SvU SvUU UvUU
Total number of 
urothelial 998 3170 1807
cells counted (total of 
six 1217 1815 1219
counts per fetus) 2257 2219 1333
1197 1165 1972
1272
1089
Total cell count 5669 8369 8692
per experimental group
Number of apoptotic 
nuclei 2 72 30
(Total of six counts per 
fetus) 1 20 56
2 19 29
1 21 16
12
19
Total apoptosis count 6 132 162
per experimental group
Apoptotic index 0.11 1.58 1.86 *0.03 **0.01 0.67
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Appendix 9. Protocol 1 PGP 9.5 nerve bundle count. Six counts per 
x200 magnified field were performed per fetus. The sum of each count is 
shown and the median per experimental group derived.
Sham
Urachal
ligation
Double
ligation P-values
SvU SvUU UvUU
Total nerve 
bundle 44 9 4
count per fetus 60 44 13
(Sum of six 
counts 39 56 38
per x200 field) 33 5 22
18
5
Median 41.5 26.5 15.5 0.56 *0.02 0.52
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Appendix 10. Protocol 1 ex-vivo cystometry data.
Intravesical
volume
(ml)
Intravesical pressure 
(cmH20)
Sham Urachal ligation
Double
occlusion
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0.1 1.0 2.5 2.0 2.0 2.0 12.0 11.0 1.0 1.5
0.2 2.0 4.0 3.5 3.0 2.0 13.0 1.5 15.0 2.0 2.5
0.3 3.0 5.0 4.0 4.0 2.0 15.5 16.5 3.0 4.0
0.4 3.5 4.5 5.0 2.0 16.5 18.5 3.0 5.0
0.5 4.0. 6.0 5.0 5.5 2.0 17.0 2.0 19.5 3.5 1.0 6.0 1
0.6 6.5 5.0 6.0 4.0 18.0 4.0 7.0
0.7 7.0 6.0 6.5 6.8 18.5 4.5 7.5
0.8 7.0 6.0 7.0 7.2 19.0 4.8 7.5
0.9 6.5 6.0 8.0 19.5 5.0 7.5
1.0 6.0 7.0 4.0 20.0 2.0 3.0 5.5 1.0 7.5 1.0
1.1 6.0 21.0 7.5
1.2 6.5 7.0 21.0 6.0 7.5
1.3 22.0 7.5
1.4 7.0 6.5 7.5
1.5 1.5 7.5 1.5
1.6 7.0 7.0 7.5
1.7 7.5
1.8 7.0 7.0 7.5
1.9 7.5
2.0 7.0 6.0 2.0 3.0 7.0 2.0 7.5 1.5
2.5 7.5 2.0 7.5
3.0 8.5 2.0 3.0 8.0 3.0 7.5
3.5 9.0 3.0 7.5
4.0 9.5 2.5 4.0 9.0 3.0 2.0
4.5 9.0 3.0
5.0 10.5 2.5 3.0
5.5 9.0
6.0 11.0 2.5 3.0 2.5
7.0 11.0 2.5 3.5
8.0 11.0 3.0 3.5 2.5
9.0 3.0 3.5
10.0 3.0 3.5 2.5
12.0 3.0 3.0
14.0 4.0 3.0 3.0
16.0 5.0 3.0
18.0 6.0 3.0
20.0 6.5 3.0 4.0
22.0 7.0
24.0
5.0
5.0
5.5
6.0
Appendix 11. Protocol 2 fetal data.
All measurements taken at autopsy.
Sham Obstructed
P-value
(SvO)
Fetal weight (g) 1860 1372
380 1472
1063 1266
798
Median 1063 1319 0.86
Occipito-snout 
length (cm) 100 94
67 94
90 115
88
Median 90 94 0.63
Crown-rump 
length (cm) 32 35
20 29
27 30
26
Median 27 29 0.63
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Appendix 12. Protocol 2 fetal bladder and kidney data.
Sham Obstructed
P-value
(SvO)
Whole bladder weight (g) 1.30 1.30
0.40 0.80
0.60 0.80
1.20
Median 0.60 1.00 0.48
Bladder: fetal weight ratio x103 0.70 0.95
1.05 0.54
0.56 0.63
1.50
Median 0.70 0.79 1.00
Total kidney weight (g) 16.70 18.10
5.70 11.30
10.30 11.40
10.00
Median 10.30 11.35 0.63
Total bivalved kidney weight (g) 15.60 16.60
5.20 10.40
9.50 10.90
8.30
Median 9.50 10.65 0.63
Total weight of urine drained from 
kidneys (g) 1.10 1.50
0.50 0.90
0.80 0.50
1.70
Median 0.80 1.20 0.48
Bivalved kidney: fetal weight ratio 
x103 8.39 12.10
13.68 7.07
8.94 8.61
10.40
Median 8.94 9.51 0.86
Volume of urine aspirated (ml) 11.00 5.00
1.00 7.00
2.80 1.10
10.50
Median 2.80 6.00 0.86
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Appendix 13. Protocol 2 urothelial and detrusor apoptotic indices.
Sham Total Obstructed Total
P-value
(SvO)
Urothelial cell count (sum 
of six counts per x200 
field) 1325 1456 1518 4299 1248 1218 1312 1240 5018
Apoptotic nuclei count 
(sum of six counts) 4 4 12 20 14 6 6 18 44 0.23
Urothelial apoptotic index 0.47 0.88
Detrusor muscle count 
(sum of six counts) 1534 1312 1478 4324 1680 1532 1286 1422 5920
Detrusor apoptotic nuclei 53 14 20 87 78 33 14 29 154 0.72
Detrusor apoptotic index 2.01 2.60
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Appendix 14. Protocol 2 ex-vivo cystometry data.
Intravesical
volume
(ml) Intravesical pressure (cmH20)
S1 S2 S3 01 02 03 04
0 0 0 0 0 0 0 0
0.1 2.0 1.0 2.0 3.0 1.0 1.0 1.0
0.2 3.5 1.5 3.5 4.0 1.0 1.0 1.0
0.3 4.5 2.0 4.0 4.0 1.5 1.5 1.5
0.4 5.0 2.5 5.0 5.0 2.0 2.0 2.0
0.5 5.5 3.0 5.5 6.0 3.0 2.0 2.0
0.6 6.0 3.5 6.5 7.0 3.0 3.0 2.0
0.7 6.0 3.5 7.0 7.5 4.0 4.0 2.0
0.8 6.0 3.5 8.0 8.0 4.0 5.0 2.5
0.9 6.0 4.0 9.5 8.0 4.5 6.0 3.0
1.0 6.0 4.0 10.0 9.0 5.0 6.0 3.0
1.1
1.2 6.0 5.0 10.5 9.0 6.0 8.0 4.0
1.3
1.4 6.0 5.0 10.5 9.5 7.0 8.0 4.5
1.5
1.6 6.5 6.0 11.0 10.0 8.0 8.5 5.0
1.7
1.8 6.5 6.0. 11.0 10.0 8.5 9.0 5.0
1.9
2.0 6.5 6.5 11.0 10.0 8.5 9.0 6.0
2.5 6.5 10.5 9.5 11.0 6.0
3.0 6.5 11.0 10.0 11.0 6.0
3.5 7.0 11.0 10.5 13.0 7.0
4.0 7.0 11.5 11.0 13.0 7.0
4.5 7.5 11.5 11.0 14.0 7.5
5.0 8.0 12.0 11.5 14.0 7.5
5.5 8.0 12.0 14.0 7.5
6.0 8.0 12.0 7.5
6.5 12.5 8.0
7.0 8.0 13.0 8.0
8.0 8.5 8.5
9.0 9.0 9.0
10.0 9.0
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